10851844;Adverse Drug Reaction Reporting Systems;Drug Interactions*;Drug Therapy, Combination;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions;Humans
10883418;Biological Availability;Contraceptives, Oral, Synthetic/adverse effects;Contraceptives, Oral, Synthetic/pharmacokinetics;Cross-Over Studies;Dietary Fats/metabolism*;Estradiol/adverse effects;Estradiol/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Middle Aged;Norgestrel/adverse effects;Norgestrel/analogs & derivatives*;Norgestrel/pharmacokinetics*;Postmenopause/metabolism*;Women's Health
10890261;Administration, Oral;Aged;Beverages*;Chromatography, High Pressure Liquid;Citrus*/adverse effects;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/blood;Depression/blood;Depression/drug therapy*;Female;Food-Drug Interactions*;Humans;In Vitro Techniques;Male;Microsomes/drug effects;Microsomes/metabolism;Middle Aged;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/blood;Prospective Studies;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/pharmacokinetics*;Sertraline/administration & dosage;Sertraline/analogs & derivatives;Sertraline/antagonists & inhibitors;Sertraline/metabolism;Sertraline/pharmacokinetics*;Treatment Outcome
10994537;Acute Disease;Adult;Anticoagulants/adverse effects*;Drug Interactions;Drug and Narcotic Control;Female;Food-Drug Interactions;Garlic/adverse effects*;Ginkgo biloba/adverse effects*;Hematoma, Subdural/chemically induced;Humans;Medical History Taking;Nursing Assessment;Phytotherapy*;Plants, Medicinal*;Warfarin/adverse effects*
10994829;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;Beverages/adverse effects*;Beverages/analysis;Biological Availability;Calcium Channel Blockers/metabolism;Citrus/adverse effects*;Citrus/chemistry;Cyclosporine/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/drug effects;Dose-Response Relationship, Drug;Food-Drug Interactions/physiology*;Histamine H1 Antagonists/metabolism;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Immunosuppressive Agents/metabolism;Intestinal Mucosa/drug effects;Intestinal Mucosa/enzymology;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/drug effects;Psychotropic Drugs/metabolism;Tacrolimus/metabolism;Terfenadine/metabolism
11069440;Administration, Oral;Adult;Amlodipine/adverse effects;Amlodipine/pharmacokinetics*;Amlodipine/pharmacology*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics;Antihypertensive Agents/pharmacology;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology*;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Injections, Intravenous;Male;Middle Aged;Placebos;Pulse;Stereoisomerism
11078178;Age Factors;Angiotensin-Converting Enzyme Inhibitors/pharmacology;Blood Pressure/drug effects*;Blood Pressure/physiology*;Calcium Channel Blockers/pharmacology;Double-Blind Method;Enalapril/pharmacology*;Female;Food-Drug Interactions/physiology;Humans;Hypertension/physiopathology*;Isradipine/pharmacology*;Male;Middle Aged;Patient Compliance;Sex Factors;Sodium Chloride, Dietary/administration & dosage*;Sodium Chloride, Dietary/adverse effects*;Time Factors
11141164;Beverages/adverse effects*;Citrus*;Food-Drug Interactions*;Humans;Torsades de Pointes/chemically induced*
7722194;Administration, Oral;Alcoholic Beverages/adverse effects;Allium;Anticoagulants/administration & dosage;Anticoagulants/pharmacology*;Beverages;Caffeine/pharmacology;Coumarins/administration & dosage;Coumarins/pharmacology;Dietary Fats/pharmacology;Food-Drug Interactions*;Humans;Peptide Hydrolases/administration & dosage;Peptide Hydrolases/pharmacology;Silicones/administration & dosage;Silicones/pharmacology;Vitamin K/administration & dosage;Vitamin K/pharmacology;Vitamins/administration & dosage;Vitamins/pharmacology
11210398;Administration, Oral;Adult;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/pharmacokinetics;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting/metabolism*;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Middle Aged;Tacrolimus/adverse effects;Tacrolimus/pharmacokinetics*
11216183;Anti-Ulcer Agents/adverse effects*;Anti-Ulcer Agents/pharmacokinetics;Arrhythmias, Cardiac/chemically induced*;Aryl Hydrocarbon Hydroxylases*;Beverages;Cisapride/adverse effects*;Cisapride/pharmacokinetics;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Oxidoreductases, N-Demethylating/drug effects;Oxidoreductases, N-Demethylating/metabolism
11332259;Adult;Antihypertensive Agents/adverse effects*;Diagnostic Errors*;Female;Food-Drug Interactions*;Glycyrrhiza/adverse effects*;Humans;Hydrochlorothiazide/adverse effects;Hypertension/chemically induced*;Hypertension/diagnosis;Hypertension/drug therapy;Hypokalemia/etiology;Medical History Taking;Muscle Cramp;Netherlands;Plants, Medicinal*;Tea/adverse effects*
11334062;Cyclosporine/adverse effects*;Food-Drug Interactions*;Humans;Immunosuppressive Agents/adverse effects*;Intestinal Absorption/drug effects*;Nutritional Status/drug effects;Organ Transplantation*;Pharmacokinetics;Postoperative Complications;Treatment Outcome
11361049;Adult;Area Under Curve;Biological Availability;Confidence Intervals;Cross-Over Studies;Dietary Fats;Food-Drug Interactions*;Gastrointestinal Diseases/chemically induced;Half-Life;Headache/chemically induced;Humans;Least-Squares Analysis;Male;Metabolic Clearance Rate;Middle Aged;Quinoxalines/adverse effects;Quinoxalines/blood;Quinoxalines/pharmacokinetics*;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*
11426073;Adult;Anti-HIV Agents/adverse effects*;Anti-HIV Agents/therapeutic use;Antidepressive Agents, Second-Generation/adverse effects*;Antidepressive Agents, Second-Generation/pharmacokinetics;Antidepressive Agents, Second-Generation/therapeutic use;Cytochrome P-450 Enzyme System/metabolism;Depression/complications;Depression/drug therapy*;Drug Interactions;Female;Fluoxetine/adverse effects;Fluoxetine/pharmacokinetics;Fluoxetine/therapeutic use;Food-Drug Interactions;HIV Infections/complications;HIV Infections/drug therapy*;Humans;Male;Middle Aged;Serotonin Syndrome/chemically induced*;Serotonin Uptake Inhibitors/adverse effects*;Serotonin Uptake Inhibitors/pharmacokinetics;Serotonin Uptake Inhibitors/therapeutic use
11531805;Adolescent;Adult;Anaphylaxis/etiology*;Animals;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Aspirin/adverse effects*;Brachyura;Decapoda (Crustacea);Exercise*;Food Hypersensitivity/etiology*;Food-Drug Interactions*;Humans;Male;Middle Aged;Shellfish/adverse effects;Triticum/adverse effects
11549099;3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors*;Adolescent;Adult;Aged;Aged, 80 and over;Aging/metabolism;Area Under Curve;Bronchodilator Agents/administration & dosage;Bronchodilator Agents/adverse effects;Bronchodilator Agents/pharmacokinetics*;Carboxylic Acids;Cyclic Nucleotide Phosphodiesterases, Type 4;Cyclohexanecarboxylic Acids;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Nitriles;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*
11552202;Adult;Aged;Anticoagulants/blood;Anticoagulants/pharmacology*;Biological Availability;Dietary Proteins/adverse effects;Drug Evaluation;Drug Monitoring;Drug Resistance;Enteral Nutrition/adverse effects*;Food, Formulated/adverse effects*;Food, Formulated/analysis;Food-Drug Interactions*;Humans;Male;Warfarin/blood;Warfarin/pharmacology*
11572503;Administration, Oral;Beverages/adverse effects*;Biological Availability;Child;Citrus/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Flavoring Agents/administration & dosage;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/administration & dosage;Hypnotics and Sedatives/adverse effects*;Hypnotics and Sedatives/pharmacokinetics;Injections, Intravenous;Intestinal Absorption/drug effects;Intestines/enzymology;Liver/enzymology;Midazolam/administration & dosage;Midazolam/adverse effects*;Midazolam/pharmacokinetics;Mixed Function Oxygenases/antagonists & inhibitors;Taste/drug effects
11605310;Acetaminophen/administration & dosage;Acetaminophen/adverse effects*;Acetaminophen/blood;Adult;Aged;Alanine Transaminase/metabolism;Alcoholism/complications*;Alcoholism/metabolism;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/adverse effects*;Analgesics, Non-Narcotic/blood;Aspartate Aminotransferases/metabolism;Chemical and Drug Induced Liver Injury*;Cytochrome P-450 CYP2E1/metabolism;Diagnosis, Differential;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Humans;Liver/drug effects*;Liver/enzymology;Liver/metabolism*;Liver Diseases/blood;Liver Diseases/enzymology;Liver Function Tests;Treatment Outcome
11718495;Administration, Oral;Adult;Aminosalicylic Acid/pharmacology;Antacids/pharmacology*;Antibiotics, Antitubercular/administration & dosage;Antibiotics, Antitubercular/adverse effects;Antibiotics, Antitubercular/pharmacokinetics*;Area Under Curve;Beverages;Citrus;Clofazimine/pharmacology;Cross-Over Studies;Cycloserine/administration & dosage;Cycloserine/adverse effects;Cycloserine/pharmacokinetics*;Dietary Fats/pharmacology*;Drug Interactions;Electrophoresis, Capillary;Ethionamide/pharmacology;Fasting/physiology*;Female;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Male
11724078;Adult;Aminosalicylic Acid/administration & dosage*;Aminosalicylic Acid/adverse effects;Aminosalicylic Acid/pharmacokinetics*;Antacids/pharmacology;Antitubercular Agents/administration & dosage*;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics*;Area Under Curve;Beverages;Citrus;Cross-Over Studies;Dietary Fats/pharmacology;Double-Blind Method;Drug Combinations;Drug Interactions;Female;Food-Drug Interactions;Half-Life;Humans;Male;Powders;Therapeutic Equivalency
11763808;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Anticoagulants/therapeutic use;Diet;Female;Food-Drug Interactions*;Hemostatics/administration & dosage;Hemostatics/adverse effects*;Hemostatics/therapeutic use;Humans;International Normalized Ratio;Seaweed/chemistry*;Vitamin K/administration & dosage;Vitamin K/adverse effects*;Vitamin K/therapeutic use;Warfarin/administration & dosage;Warfarin/adverse effects*;Warfarin/therapeutic use
11816871;Adult;Beverages/adverse effects*;Citrus*;Clozapine/adverse effects;Clozapine/analogs & derivatives*;Clozapine/pharmacokinetics*;Clozapine/therapeutic use;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Prospective Studies;Psychiatric Status Rating Scales;Schizophrenia/blood*;Schizophrenia/drug therapy
11823753;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Administration, Oral;Adult;Area Under Curve;Beverages/adverse effects*;Biological Availability;Carrier Proteins/metabolism;Citrus;Double-Blind Method;Female;Flavonoids/metabolism;Food-Drug Interactions/physiology*;Fruit*;HeLa Cells;Histamine H1 Antagonists/pharmacokinetics*;Humans;Intestinal Absorption;Male;Malus;Membrane Transport Proteins*;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/metabolism*;Organic Anion Transporters, Sodium-Dependent;Symporters;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics*
11823754;Adult;Area Under Curve;Beverages/adverse effects*;Biological Availability;Biotransformation;Blood Pressure/drug effects;Calibration;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions/physiology*;Heart Rate/drug effects;Humans;Male;Mixed Function Oxygenases/metabolism;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Purines;Quality Control;Sildenafil Citrate;Sulfones
11837383;Adult;Aged;Angiotensin-Converting Enzyme Inhibitors/administration & dosage;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics*;Angiotensin-Converting Enzyme Inhibitors/pharmacology*;Area Under Curve;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions;Half-Life;Humans;Isoquinolines/administration & dosage;Isoquinolines/adverse effects;Isoquinolines/blood;Isoquinolines/pharmacokinetics*;Isoquinolines/pharmacology*;Kinetics;Male;Middle Aged;Peptidyl-Dipeptidase A/blood;Tetrahydroisoquinolines*
11865964;Adult;Analysis of Variance;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics;Area Under Curve;Chemistry, Pharmaceutical;Cross-Over Studies;Dietary Fats/pharmacokinetics;Eating/physiology*;Endothelin Receptor Antagonists*;Fasting/metabolism;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Receptors, Endothelin/physiology;Sulfonamides/adverse effects;Sulfonamides/blood;Sulfonamides/pharmacokinetics*
11936567;Administration, Oral;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects;Anti-HIV Agents/blood;Area Under Curve;Biological Availability;Confidence Intervals;Cross-Over Studies;Didanosine/administration & dosage;Didanosine/adverse effects;Didanosine/blood*;Dietary Fats/blood;Fasting/blood;Female;Food-Drug Interactions/physiology*;Humans;Male;Microspheres;Tablets, Enteric-Coated
11936572;Adult;Analysis of Variance;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics;Area Under Curve;Beverages*;Calcium/pharmacokinetics*;Ciprofloxacin/blood*;Ciprofloxacin/pharmacokinetics;Citrus/metabolism*;Cross-Over Studies;Female;Food, Fortified*/adverse effects;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Statistics, Nonparametric;Therapeutic Equivalency
11953660;Biological Availability;Enteral Nutrition;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Pharmacokinetics;Treatment Outcome
11956673;Adult;Beverages*;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/urine;Chromatography, High Pressure Liquid;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Flavanones*;Flavonoids/blood;Flavonoids/pharmacokinetics;Flavonoids/urine;Food-Drug Interactions;Humans;Hydrocortisone/analogs & derivatives*;Hydrocortisone/urine;Male;Mixed Function Oxygenases/metabolism;Smoking/blood*;Stereoisomerism;Verapamil/adverse effects;Verapamil/blood;Verapamil/pharmacokinetics*;Verapamil/urine
11957745;Animals;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics*;Drug Interactions;Food-Drug Interactions;Humans;Hydroxymethylglutaryl CoA Reductases/adverse effects;Hydroxymethylglutaryl CoA Reductases/pharmacokinetics*
7836549;Aged;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Humans;Intestinal Absorption;Middle Aged;Tacrine/adverse effects;Tacrine/blood;Tacrine/pharmacokinetics*
11966676;Amlodipine/pharmacokinetics*;Beverages/adverse effects*;Biological Availability;Citrus*;Food-Drug Interactions*;Humans
11971236;Dietary Supplements/adverse effects*;Food-Drug Interactions;Germany;Humans;Kava/adverse effects*;Liver Diseases/etiology*;United States;United States Food and Drug Administration
12004838;Anticholesteremic Agents/pharmacology;Beverages/adverse effects*;Calcium Channel Blockers/pharmacology;Citrus/adverse effects*;Food-Drug Interactions*;Humans
12009003;Adolescent;Adult;Anticonvulsants/adverse effects*;Anticonvulsants/therapeutic use;Biotin/blood;Calcium/blood;Carnitine/blood;Carnitine/deficiency;Dietetics;Edema/chemically induced;Folic Acid/blood;Food-Drug Interactions*;Humans;Middle Aged;Seizures/drug therapy*;Serum Albumin/analysis;Serum Albumin/drug effects*;Valproic Acid/adverse effects*;Valproic Acid/therapeutic use;Weight Gain/drug effects
12014354;Aged;Aged, 80 and over;Anacardiaceae*/adverse effects;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Blood Coagulation/drug effects;Blood Coagulation Disorders/chemically induced;Food-Drug Interactions*;Fruit/adverse effects;Humans;International Normalized Ratio/adverse effects;Male;Middle Aged;Warfarin/adverse effects;Warfarin/therapeutic use*
12051573;Administration, Oral;Adult;Antiparasitic Agents/administration & dosage;Antiparasitic Agents/adverse effects*;Antiparasitic Agents/pharmacokinetics*;Area Under Curve;Food-Drug Interactions;Humans;Male;Maximum Tolerated Dose;Thiazoles/administration & dosage;Thiazoles/adverse effects*;Thiazoles/blood;Thiazoles/pharmacokinetics*
7857345;Adult;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Humans;Immunologic Factors/adverse effects;Immunologic Factors/blood;Immunologic Factors/pharmacokinetics*;Male;Pyrrolidonecarboxylic Acid/adverse effects;Pyrrolidonecarboxylic Acid/analogs & derivatives*;Pyrrolidonecarboxylic Acid/blood;Pyrrolidonecarboxylic Acid/pharmacokinetics;Spectrophotometry, Ultraviolet;Therapeutic Equivalency;Thiazoles/adverse effects;Thiazoles/blood;Thiazoles/pharmacokinetics*;Thiazolidines
12095536;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adolescent;Adult;Antitussive Agents/pharmacokinetics*;Aryl Hydrocarbon Hydroxylases*;Beverages/adverse effects*;Biological Availability;Biotransformation;Citrus*;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dealkylation;Dextromethorphan/pharmacokinetics*;Digestive System/enzymology;Digestive System/metabolism*;Female;Food-Drug Interactions*;Humans;Male;Membrane Proteins/metabolism;Oxidoreductases, N-Demethylating/antagonists & inhibitors*;Oxidoreductases, N-Demethylating/metabolism;Phenotype;Reproducibility of Results
12125178;Alcoholic Beverages/adverse effects*;Biological Availability;Drug Interactions*;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics;Risk Factors
12162471;Adolescent;Adult;Area Under Curve;Capsules/administration & dosage;Capsules/pharmacokinetics;Carbamates;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/physiology;Food-Drug Interactions;Health;Humans;Male;Middle Aged;Organophosphates/administration & dosage;Organophosphates/adverse effects;Organophosphates/blood;Organophosphates/pharmacokinetics*;Prodrugs/administration & dosage;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects;Sulfonamides/blood;Sulfonamides/pharmacokinetics*;Suspensions/administration & dosage;Suspensions/pharmacokinetics;Tablets/administration & dosage;Tablets/pharmacokinetics
12165187;Adverse Drug Reaction Reporting Systems;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions*;Food-Drug Interactions;Humans;Iatrogenic Disease*;Internet;Interprofessional Relations;Plant Preparations/adverse effects*
12171043;Anti-HIV Agents/adverse effects;Anti-HIV Agents/therapeutic use*;Food-Drug Interactions*;HIV Infections/drug therapy*;Humans
12362927;Administration, Oral;Adolescent;Adult;Antiparasitic Agents/administration & dosage;Antiparasitic Agents/adverse effects;Antiparasitic Agents/pharmacokinetics*;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Humans;Ivermectin/administration & dosage;Ivermectin/adverse effects;Ivermectin/pharmacokinetics*;Male;Middle Aged;Mydriasis/chemically induced;Pupil/drug effects
12371301;Anticholesteremic Agents/pharmacokinetics*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 Enzyme System/metabolism;Drug Synergism*;Food-Drug Interactions*;Humans;Simvastatin/pharmacokinetics*
12387000;Diabetes Mellitus, Type 2/diet therapy*;Dietary Fiber/analysis;Dietary Supplements*/adverse effects;Dietary Supplements*/analysis;Diglycerides/analysis;Food, Organic*/adverse effects;Food, Organic*/analysis;Food-Drug Interactions;Glycoside Hydrolase Inhibitors;Humans;Hypercholesterolemia/diet therapy;Hyperglycemia/diet therapy;Hypertension/drug therapy
12389073;Administration, Oral;Adult;Aged;Antineoplastic Agents, Phytogenic/administration & dosage;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/blood;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Area Under Curve;Beverages/adverse effects*;Biological Availability;Carcinoma, Small Cell/drug therapy;Chromatography, High Pressure Liquid;Citrus paradisi/adverse effects*;Cross-Over Studies;Etoposide/administration & dosage;Etoposide/adverse effects;Etoposide/blood;Etoposide/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Infusions, Intravenous;Lung Neoplasms/drug therapy;Male;Middle Aged;Pilot Projects
7859239;Adult;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Double-Blind Method;Fasting;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Theophylline/administration & dosage;Theophylline/adverse effects;Theophylline/pharmacokinetics*;Therapeutic Equivalency
12389876;Antineoplastic Agents/economics;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use*;Benzamides;Clinical Trials as Topic;Drug Interactions;Drug Resistance, Neoplasm;Food-Drug Interactions;Gastrointestinal Neoplasms/drug therapy;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy;Patient Education as Topic;Piperazines/economics;Piperazines/pharmacology;Piperazines/therapeutic use*;Pyrimidines/economics;Pyrimidines/pharmacology;Pyrimidines/therapeutic use*;Sarcoma/drug therapy;Stromal Cells
12426769;Animals;Anticoagulants/adverse effects*;Drug Interactions;Food-Drug Interactions;Herb-Drug Interactions;Humans;Phytotherapy;Plants, Medicinal;Warfarin/adverse effects*
12463728;Adult;Anti-Anxiety Agents/blood;Anti-Anxiety Agents/pharmacokinetics*;Area Under Curve;Benzodiazepines*;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/adverse effects*;Fasting;Food-Drug Interactions*;Half-Life;Humans;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/pharmacokinetics*;Male;Postprandial Period;Time Factors
12492049;Biological Availability;Carbamates;Dietary Fats/administration & dosage;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Infections/metabolism*;HIV Protease Inhibitors/adverse effects;HIV Protease Inhibitors/pharmacokinetics*;HIV Protease Inhibitors/therapeutic use;Humans;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*;Sulfonamides/therapeutic use;Vitamin E/administration & dosage
12520629;Administration, Oral;Adolescent;Adult;Biological Availability;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Sex Factors;Sodium Oxybate/administration & dosage;Sodium Oxybate/adverse effects;Sodium Oxybate/pharmacokinetics*;Solutions
12551706;Adult;Antiparkinson Agents/adverse effects;Antiparkinson Agents/blood;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Benserazide/adverse effects;Benserazide/blood;Benserazide/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Drug Combinations;Fasting;Female;Food*;Food-Drug Interactions;Half-Life;Humans;Levodopa/adverse effects;Levodopa/blood;Levodopa/pharmacokinetics*;Male;Time Factors;Tyrosine/analogs & derivatives*;Tyrosine/blood
12578152;Adolescent;Adult;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacology*;Food-Drug Interactions*;Humans;Ketolides*;Macrolides*;Male;Middle Aged
12611197;Beverages/adverse effects*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans
7899788;Adolescent;Adult;Albendazole/adverse effects;Albendazole/pharmacokinetics*;Albendazole/therapeutic use*;Animals;Biological Availability;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions;Humans;Ivermectin/adverse effects;Ivermectin/therapeutic use*;Male;Microfilariae/drug effects;Middle Aged;Onchocerca/drug effects;Onchocerca/embryology;Onchocerca/growth & development;Onchocerciasis/drug therapy*;Onchocerciasis/parasitology
12611563;Animals;Arthritis, Rheumatoid/therapy;Asthma/therapy;Cardiomyopathies/therapy;Disease Progression;Food-Drug Interactions;HIV Infections/prevention & control;Humans;Hypothyroidism/therapy;Infertility, Male/therapy;Liver Diseases/blood;Male;Neoplasms/prevention & control;Selenium/adverse effects;Selenium/deficiency;Selenium/therapeutic use*
12634980;Administration, Oral;Aged;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics;Aryl Hydrocarbon Hydroxylases/genetics;Case-Control Studies;Cytochrome P-450 CYP2C9;Dose-Response Relationship, Drug;Drug Interactions;Drug Overdose;Female;Food-Drug Interactions;Genotype;Hemorrhage/chemically induced;Humans;Inpatients;International Normalized Ratio;Male;Mutation;Polymorphism, Genetic;Prospective Studies;Risk Factors;Vitamin K/administration & dosage
12638394;3',5'-Cyclic-GMP Phosphodiesterases;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclic Nucleotide Phosphodiesterases, Type 5;Dietary Fats/administration & dosage*;Drug Administration Schedule;Erectile Dysfunction/drug therapy;Food-Drug Interactions;Half-Life;Humans;Imidazoles/administration & dosage;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Male;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*;Phosphoric Diester Hydrolases/metabolism*;Piperazines/administration & dosage;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Postprandial Period;Sulfones;Time Factors;Triazines;Vardenafil Dihydrochloride
12638395;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclooxygenase 2;Cyclooxygenase 2 Inhibitors;Cyclooxygenase Inhibitors/administration & dosage;Cyclooxygenase Inhibitors/adverse effects;Cyclooxygenase Inhibitors/pharmacokinetics*;Dietary Fats;Dose-Response Relationship, Drug;Drug Administration Schedule;Fasting;Female;Food-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors*;Male;Membrane Proteins;Middle Aged;Prostaglandin-Endoperoxide Synthases;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Sulfones/administration & dosage;Sulfones/adverse effects;Sulfones/pharmacokinetics*;Tablets;Time Factors
12653694;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Aspirin/adverse effects*;Asthma/complications;Drug Eruptions/drug therapy;Drug Eruptions/etiology*;Food-Drug Interactions/physiology;Humans;Urticaria/chemically induced*;Urticaria/complications;Urticaria/drug therapy
12723461;Administration, Oral;Adult;Area Under Curve;Biomarkers;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Half-Life;Humans;Hydrogen-Ion Concentration;Imidazoles/administration & dosage;Imidazoles/pharmacokinetics*;Imidazoles/pharmacology;Male;Mitogen-Activated Protein Kinases/antagonists & inhibitors*;Pyridines/administration & dosage;Pyridines/pharmacokinetics*;Pyridines/pharmacology;p38 Mitogen-Activated Protein Kinases
12743672;Administration, Oral;Adult;Analysis of Variance;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology*;Area Under Curve;Azetidines/adverse effects;Azetidines/pharmacokinetics*;Azetidines/pharmacology*;Benzylamines;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions;Glycine/analogs & derivatives*;Glycine/blood;Half-Life;Humans;Male;Metabolic Clearance Rate;Partial Thromboplastin Time;Prodrugs/adverse effects;Prodrugs/pharmacokinetics;Prodrugs/pharmacology;Prothrombin Time;Thrombin/antagonists & inhibitors*
12807517;11-beta-Hydroxysteroid Dehydrogenases;Adult;Aldosterone/blood;Beverages/adverse effects*;Citrus paradisi*;Depression, Chemical;Edema/etiology*;Edema/metabolism;Female;Food-Drug Interactions*;Humans;Hydroxysteroid Dehydrogenases/antagonists & inhibitors*;Hydroxysteroid Dehydrogenases/metabolism;Mineralocorticoids/metabolism*;Potassium/blood;Renin/blood
12811362;Adult;Area Under Curve;Beverages*;Biotransformation;Calcium Channel Blockers/pharmacokinetics;Citrus*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Drug Interactions;Enzyme Inhibitors/pharmacology*;Felodipine/pharmacokinetics;Female;Food-Drug Interactions*;Furocoumarins/pharmacology*;Half-Life;Humans;Male;Middle Aged;NADP/metabolism;Radiation-Sensitizing Agents/pharmacology*;Wine*
8321071;Biological Availability;Food/adverse effects*;Humans;Intestinal Absorption*;Pharmacokinetics*
12830268;Anticoagulants/administration & dosage;Anticoagulants/antagonists & inhibitors*;Drug Monitoring;Food-Drug Interactions*;Humans;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Warfarin/administration & dosage;Warfarin/antagonists & inhibitors*
12860494;Adult;Area Under Curve;Blood Glucose/analysis;Cross-Over Studies;Cyclohexanes/adverse effects;Cyclohexanes/pharmacokinetics*;Cyclohexanes/pharmacology;Double-Blind Method;Food-Drug Interactions*;Gastric Emptying/drug effects*;Half-Life;Humans;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology;Insulin/blood;Male;Middle Aged;Phenylalanine/adverse effects;Phenylalanine/analogs & derivatives;Phenylalanine/pharmacokinetics*;Phenylalanine/pharmacology;Time Factors
12920426;Adult;Antidepressive Agents, Second-Generation/pharmacokinetics*;Area Under Curve;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Fluvoxamine/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Humans;Male
12936879;Absorption;Beverages*/adverse effects*;Citrus paradisi*/adverse effects;Food-Drug Interactions/physiology*;Humans
14517193;Administration, Oral;Adolescent;Adult;Antiparasitic Agents/adverse effects;Antiparasitic Agents/pharmacokinetics*;Antiparasitic Agents/therapeutic use*;Cohort Studies;Dose-Response Relationship, Drug;Double-Blind Method;Eating;Fasting;Food-Drug Interactions;Humans;Macrolides/adverse effects;Macrolides/pharmacokinetics*;Macrolides/therapeutic use*;Male;Middle Aged;Nausea/chemically induced;Onchocerciasis/drug therapy*;Treatment Outcome;Vomiting/chemically induced
14518700;Adult;Cross-Over Studies;Drug Administration Schedule;Drug Therapy, Combination;Fasting;Food*;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/virology;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/adverse effects*;HIV Protease Inhibitors/pharmacokinetics;HIV Protease Inhibitors/therapeutic use;Humans;Indinavir/administration & dosage*;Indinavir/adverse effects;Indinavir/pharmacokinetics;Indinavir/therapeutic use;Kidney Diseases/chemically induced;Kidney Diseases/prevention & control*;Middle Aged;Ritonavir/administration & dosage*;Ritonavir/adverse effects;Ritonavir/pharmacokinetics;Ritonavir/therapeutic use
14531370;Adolescent;Adult;Aged;Anesthetics/administration & dosage;Anesthetics/adverse effects;Anesthetics/metabolism;Dietary Supplements*/adverse effects;Drug Interactions;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Plant Preparations/metabolism;Preanesthetic Medication/adverse effects;Surveys and Questionnaires
14533574;Drug Interactions*;Food-Drug Interactions*;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Nurse's Role;Patient Education as Topic;Phytotherapy/adverse effects*;Preoperative Care/methods*;Preoperative Care/nursing;Surgery, Plastic/nursing;Time Factors
14558393;Dietary Supplements*/adverse effects;Drug Interactions;Food-Drug Interactions;Humans;Physician-Patient Relations
14574774;Depressive Disorder/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use*;Netherlands;Phenelzine/adverse effects;Phenelzine/therapeutic use;Secondary Prevention;Time Factors;Tranylcypromine/adverse effects;Tranylcypromine/therapeutic use
692645;Biogenic Amines/adverse effects;Biogenic Amines/analysis;Cheese/analysis;Food Analysis*;Fruit/analysis;Histamine/analysis;Humans;Hungary;Hypertension/etiology;Meat/analysis;Monoamine Oxidase Inhibitors/therapeutic use;Tyramine/adverse effects;Tyramine/analysis*;Vegetables/analysis;Wine/analysis
8520091;Anticonvulsants/pharmacokinetics;Anticonvulsants/pharmacology*;Anticonvulsants/therapeutic use;Clinical Trials as Topic;Epilepsy/drug therapy;Folic Acid/pharmacology*;Folic Acid Deficiency/drug therapy;Food, Fortified;Food-Drug Interactions*;Humans;Phenytoin/pharmacokinetics;Phenytoin/pharmacology*;Phenytoin/therapeutic use
14576716;Adult;Adverse Drug Reaction Reporting Systems;Age Factors;Aged;California;Diet*;Dietary Supplements/adverse effects;Dietary Supplements/utilization*;Educational Status;Female;Food-Drug Interactions;Health Maintenance Organizations/statistics & numerical data*;Humans;Male;Middle Aged;Nutrition Surveys;Risk Factors;Sex Factors
14606933;Administration, Oral;Adolescent;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions/physiology;Half-Life;Humans;Male;Tacrolimus/administration & dosage;Tacrolimus/adverse effects;Tacrolimus/analogs & derivatives*;Tacrolimus/pharmacokinetics*
14616409;Administration, Oral;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Food*;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Time Factors;Triazoles/administration & dosage;Triazoles/adverse effects;Triazoles/pharmacokinetics*;Voriconazole
14672861;Dietary Fats/administration & dosage;Dietary Proteins/administration & dosage;Environmental Exposure/adverse effects*;Female;Food-Drug Interactions*;Humans;Lead Poisoning/etiology*;New South Wales;Nutritional Status*;Pregnancy;Pregnancy Complications/etiology;Public Health;Trace Elements/administration & dosage;Vitamins/administration & dosage
14675888;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/adverse effects*;Diagnosis, Differential;Electrocardiography;Food-Drug Interactions;Heart Block/chemically induced*;Heart Block/diagnosis*;Heart Block/physiopathology;Honey/adverse effects*;Humans;Male;Middle Aged;Verapamil/administration & dosage;Verapamil/adverse effects*
14679681;Aged;Aged, 80 and over;Anticoagulants/adverse effects*;Food-Drug Interactions*;Garlic/adverse effects*;Humans;International Normalized Ratio;Male;Phenindione/adverse effects*;Phenindione/analogs & derivatives*
14684645;Aged;Anticoagulants/adverse effects*;Beverages/adverse effects*;Fatal Outcome;Food-Drug Interactions*;Gastrointestinal Hemorrhage/chemically induced;Heart Diseases/chemically induced;Hemorrhage/chemically induced*;Humans;International Normalized Ratio;Male;Pericardium;Vaccinium macrocarpon*;Warfarin/adverse effects*
14734983;Food-Drug Interactions*;Humans;Infusions, Intravenous/adverse effects*;Infusions, Intravenous/nursing;Injections, Intravenous/adverse effects*;Injections, Intravenous/nursing;Parenteral Nutrition, Total/adverse effects*;Parenteral Nutrition, Total/nursing
14749688;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Phytotherapy*;Plants, Medicinal/adverse effects*
14973309;Administration, Oral;Adult;Antiviral Agents/adverse effects;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics;Antiviral Agents/urine;Area Under Curve;Capsules;Chromatography, High Pressure Liquid;Dietary Fats;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Half-Life;Humans;Male;Mass Spectrometry;Middle Aged;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Ribavirin/adverse effects;Ribavirin/analogs & derivatives*;Ribavirin/blood;Ribavirin/pharmacokinetics*;Ribavirin/urine;Time Factors
8592993;Adult;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/adverse effects;Anti-Infective Agents/pharmacokinetics*;Biotransformation;Blood Proteins/metabolism;Creatinine/blood;Creatinine/urine;Feces/chemistry;Fluoroquinolones*;Food-Drug Interactions;Half-Life;Humans;Male;Piperazines/administration & dosage;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Probenecid/pharmacology;Quinolones/administration & dosage;Quinolones/adverse effects;Quinolones/pharmacokinetics*;Renal Agents/pharmacology;Saliva/metabolism
14980003;Animals;Antimalarials/adverse effects;Antimalarials/blood;Antimalarials/metabolism*;Blood Proteins/metabolism*;Electrocardiography/drug effects;Fasting;Food-Drug Interactions;Lipoproteins/metabolism*;Long QT Syndrome/chemically induced*;Long QT Syndrome/metabolism;Phenanthrenes/adverse effects;Phenanthrenes/blood;Phenanthrenes/metabolism*;Postprandial Period;Protein Binding;Rabbits
15011605;Acquired Immunodeficiency Syndrome/drug therapy*;Anti-HIV Agents/administration & dosage*;Anti-HIV Agents/adverse effects;Dose-Response Relationship, Drug;Drug Synergism;Drug Therapy, Combination;Food-Drug Interactions;Humans;Indinavir/administration & dosage*;Indinavir/adverse effects;Randomized Controlled Trials as Topic;Ritonavir/administration & dosage;Ritonavir/adverse effects
15017321;Anticoagulants*/administration & dosage;Anticoagulants*/adverse effects;Anticoagulants*/metabolism;Aryl Hydrocarbon Hydroxylases/genetics;Community Health Nursing/methods;Cytochrome P-450 CYP2C9;Drug Interactions;Drug Monitoring/methods;Drug Monitoring/nursing;Food-Drug Interactions;Home Care Services;Humans;International Normalized Ratio;Liver/metabolism;Metabolic Clearance Rate;Patient Education as Topic/methods;Prothrombin Time;Vitamin K*/administration & dosage;Vitamin K*/adverse effects;Warfarin*/administration & dosage;Warfarin*/adverse effects;Warfarin*/metabolism
15033405;Chemistry, Pharmaceutical;Contraceptives, Oral, Combined/administration & dosage*;Contraceptives, Oral, Combined/adverse effects;Contraceptives, Postcoital/administration & dosage*;Contraceptives, Postcoital/adverse effects;Female;Food-Drug Interactions;Humans;Nausea/chemically induced;Norethindrone/administration & dosage;Randomized Controlled Trials as Topic
15132100;Anticholesteremic Agents/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans;Rhabdomyolysis/chemically induced*;Simvastatin/adverse effects*
15145962;Beverages/adverse effects*;Citrus*;Dietary Supplements;Drug Interactions*;Drug Labeling/legislation & jurisprudence;Female;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Male;Pharmacogenetics;Sex Factors
15206993;Adult;Anticholesteremic Agents/pharmacokinetics*;Citrus*;Cross-Over Studies;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Simvastatin/analogs & derivatives*;Simvastatin/metabolism;Simvastatin/pharmacokinetics*
15211967;Acenocoumarol/pharmacokinetics;Acenocoumarol/therapeutic use*;Aged;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use*;Enteral Nutrition/adverse effects*;Food, Formulated/adverse effects*;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Monitoring, Physiologic;Protein Binding
8617704;Acute Disease;Animals;Beer;Cheese/adverse effects;Depressive Disorder/drug therapy;Diet/adverse effects*;Fishes;Food-Drug Interactions*;Fruit;Humans;Hypertension/chemically induced;Hypertension/prevention & control*;Meat;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Poultry;Tyramine/adverse effects;Vegetables
15311686;Adjuvants, Immunologic/administration & dosage;Adjuvants, Immunologic/therapeutic use*;Adolescent;Adult;Aged;B-Lymphocytes/drug effects;B-Lymphocytes/immunology;B-Lymphocytes/radiation effects;Benzimidazoles/administration & dosage;Benzimidazoles/therapeutic use*;Child;Combined Modality Therapy;Diet Therapy/methods;Food-Drug Interactions*;Humans;Middle Aged;Psoriasis*/diet therapy;Psoriasis*/drug therapy;Psoriasis*/immunology;Radioactive Pollutants/adverse effects*;Radioisotopes;T-Lymphocytes/drug effects;T-Lymphocytes/immunology;T-Lymphocytes/radiation effects;Treatment Outcome;Ukraine
15341178;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Nurse's Role;Patient Education as Topic;Phytotherapy*/adverse effects;Phytotherapy*/nursing
15346578;Anti-Allergic Agents/adverse effects;Dietary Supplements;Drug Interactions*;Food-Drug Interactions;Polypharmacy*;Terfenadine/adverse effects
15449971;Beverages*;Cardiovascular Agents/adverse effects;Cardiovascular Agents/pharmacokinetics*;Cardiovascular Agents/therapeutic use;Cardiovascular Diseases/drug therapy*;Citrus paradisi*;Food-Drug Interactions*;Humans
15456329;Adolescent;Adult;Aged;Animals;Anti-Inflammatory Agents, Non-Steroidal*/metabolism;Anti-Inflammatory Agents, Non-Steroidal*/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal*/therapeutic use;Arthritis, Rheumatoid/drug therapy*;Butanones*/metabolism;Butanones*/pharmacokinetics;Butanones*/therapeutic use;Child;Child, Preschool;Clinical Trials as Topic;Cyclooxygenase Inhibitors*/adverse effects;Cyclooxygenase Inhibitors*/therapeutic use;Drug Interactions;Food-Drug Interactions;Humans;Middle Aged;Osteoarthritis/drug therapy*;Stomach Diseases/chemically induced*
15477727;Dietary Supplements/adverse effects*;Food, Organic*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans
15488686;Absorption/drug effects;Administration, Oral;Animals;Antineoplastic Agents/adverse effects;Antineoplastic Agents/therapeutic use;Area Under Curve;Biological Availability*;Capsules/administration & dosage;Capsules/chemistry;Capsules/pharmacokinetics;Chemistry, Pharmaceutical/methods*;Clinical Trials, Phase I as Topic;Clinical Trials, Phase II as Topic;Dogs;Drug Administration Schedule;Drug Evaluation, Preclinical;Fasting/metabolism;Food-Drug Interactions;Humans;Male;Models, Animal;Morpholines/metabolism;Morpholines/pharmacology*;Morpholines/therapeutic use;Nanostructures/chemistry*;Nausea/chemically induced;Nausea/prevention & control;Substance P/antagonists & inhibitors;Substance P/metabolism;Substance P/pharmacology;Tablets/administration & dosage;Tablets/chemistry;Tablets/pharmacokinetics;Technology, Pharmaceutical/methods;Technology, Pharmaceutical/trends;Upper Gastrointestinal Tract/drug effects;Upper Gastrointestinal Tract/metabolism;Vomiting/chemically induced;Vomiting/prevention & control
15497788;Acenocoumarol/adverse effects;Acenocoumarol/pharmacokinetics*;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Administration Routes;Enteral Nutrition/adverse effects*;Food, Formulated;Food-Drug Interactions*;Humans
15561855;Adolescent;Adult;Aged;Aged, 80 and over;Anti-Bacterial Agents/pharmacokinetics*;Anti-Bacterial Agents/therapeutic use*;Area Under Curve;Bronchitis/drug therapy;Bronchitis/microbiology;Community-Acquired Infections/drug therapy*;Community-Acquired Infections/metabolism*;Drug Interactions;Female;Fluoroquinolones/pharmacokinetics*;Fluoroquinolones/therapeutic use*;Food-Drug Interactions;Humans;Male;Mass Spectrometry;Middle Aged;Models, Biological;Pneumonia/drug therapy;Pneumonia/microbiology;Population;Reproducibility of Results;Respiratory Tract Infections/drug therapy*;Respiratory Tract Infections/metabolism*;Sinusitis/drug therapy;Sinusitis/microbiology
8700059;Algorithms*;Decision Trees*;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Nursing Assessment;Phenytoin/adverse effects*
15570603;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Administration, Oral;Animals;Area Under Curve;Beverages/adverse effects*;Biological Availability;Citrus;Food-Drug Interactions/physiology*;Fruit*;Histamine H1 Antagonists/pharmacokinetics*;Intestinal Absorption;Male;Malus;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/metabolism;Rats;Rats, Sprague-Dawley;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics*
15621963;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/blood*;Atorvastatin Calcium;Beverages;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Heptanoic Acids/adverse effects;Heptanoic Acids/blood*;Humans;Male;Middle Aged;Pyrroles/adverse effects;Pyrroles/blood*;Rhabdomyolysis/blood*;Rhabdomyolysis/etiology
15635342;Child;Child Health Services;Chronic Disease/therapy;Communication;Complementary Therapies/adverse effects*;Complementary Therapies/methods*;Complementary Therapies/standards;Complementary Therapies/utilization;Dietary Supplements/utilization*;Disabled Children/statistics & numerical data*;Drug Interactions;Female;Food-Drug Interactions;Humans;Male;Professional-Family Relations*;Treatment Outcome
15635366;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects*;Blood Pressure/drug effects*;Cheese;Depression/drug therapy;Food-Drug Interactions*;Humans;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Nutrition Policy*;Tyramine/administration & dosage*;United States
8707145;Caffeine/adverse effects*;Food-Drug Interactions*;Humans;Nicotine/adverse effects*;Nursing Assessment
15682573;Anticoagulants/agonists;Benzodiazepines/agonists;Beverages/adverse effects*;Calcium Channel Blockers/blood;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Food-Drug Interactions*;Humans;Warfarin/agonists
15823765;Administration, Oral;Adult;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Analgesics, Opioid/therapeutic use;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Area Under Curve;Cross-Over Studies;Drug Combinations;Food-Drug Interactions;Half-Life;Humans;Ibuprofen/pharmacokinetics*;Ibuprofen/therapeutic use;Intestinal Absorption;Male;Metabolic Clearance Rate;Oxycodone/adverse effects;Oxycodone/pharmacokinetics*;Oxycodone/therapeutic use;Pain, Postoperative/drug therapy;Tablets;Therapeutic Equivalency
15831778;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Half-Life;Humans;Hydromorphone/administration & dosage;Hydromorphone/adverse effects;Hydromorphone/pharmacokinetics*;Male
15832116;Administration, Oral;Deglutition Disorders/drug therapy*;Deglutition Disorders/nursing;Delayed-Action Preparations;Drug Administration Schedule;Enteral Nutrition/adverse effects;Food-Drug Interactions;Humans;Intestinal Absorption
15889002;Absorption;Dietary Fiber/adverse effects*;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
8713690;Animals;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase/metabolism;Monoamine Oxidase/physiology;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology*;Monoamine Oxidase Inhibitors/therapeutic use
15915310;Complementary Therapies/standards*;Dietary Supplements/adverse effects;Dietary Supplements/standards*;Evidence-Based Medicine*;Food-Drug Interactions;Herb-Drug Interactions;Herbal Medicine/standards*;Humans;Practice Guidelines as Topic;Self Medication
15951007;Clinical Trials as Topic;Dietary Supplements/adverse effects*;Evidence-Based Medicine;Fatty Acids, Omega-3/adverse effects*;Fatty Acids, Omega-3/therapeutic use*;Fibrinolytic Agents/adverse effects*;Fibrinolytic Agents/therapeutic use*;Food-Drug Interactions*;Hemorrhage/etiology*;Humans;Thrombosis/prevention & control*
15980352;Adolescent;Adult;Benzoates*/administration & dosage;Benzoates*/adverse effects;Benzoates*/metabolism;Benzoates*/pharmacokinetics;CCR5 Receptor Antagonists*;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;HIV Fusion Inhibitors*/administration & dosage;HIV Fusion Inhibitors*/adverse effects;HIV Fusion Inhibitors*/metabolism;HIV Fusion Inhibitors*/pharmacokinetics;Humans;Male;Middle Aged;Piperazines;Spiro Compounds*/administration & dosage;Spiro Compounds*/adverse effects;Spiro Compounds*/metabolism;Spiro Compounds*/pharmacokinetics
15991880;Adult;Anticonvulsants/adverse effects;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dibenzazepines/adverse effects;Dibenzazepines/blood;Dibenzazepines/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged
15999499;Adult;Alcohol Drinking*;Erectile Dysfunction/drug therapy;Food-Drug Interactions*;Humans;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Male;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Sulfones/adverse effects;Sulfones/pharmacokinetics;Triazines/adverse effects;Triazines/pharmacokinetics;Vardenafil Dihydrochloride
16035690;Animals;Bleeding Time;Clinical Trials as Topic;Drug Evaluation, Preclinical;Evidence-Based Medicine;Food-Drug Interactions;Garlic*/adverse effects;Garlic*/chemistry;Garlic*/physiology;Humans;Hyperlipidemias/prevention & control;Hypertension/prevention & control;Infection Control;Neoplasms/prevention & control;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/standards;Research Design/standards
16043212;Coumarins/administration & dosage;Coumarins/adverse effects;Coumarins/pharmacokinetics;Dietary Supplements*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;Pharmacogenetics/methods;Warfarin/administration & dosage*;Warfarin/adverse effects;Warfarin/pharmacokinetics*
16048029;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Benzodiazepines/metabolism;Beverages/adverse effects;Biological Availability;Calcium Channel Blockers/metabolism;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism*;Cyclosporine/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Intestinal Absorption/drug effects
8851570;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Atovaquone;Biological Availability;Food-Drug Interactions;HIV Seropositivity/metabolism*;Humans;Male;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects;Naphthoquinones/pharmacokinetics*;Suspensions
16076481;Animals;Blood Coagulation/drug effects*;Blood Coagulation/physiology*;Clinical Trials as Topic;Dietary Supplements/adverse effects*;Dietary Supplements/classification*;Evidence-Based Medicine;Fibrinolytic Agents/adverse effects*;Fibrinolytic Agents/classification;Fibrinolytic Agents/therapeutic use*;Food-Drug Interactions*;Hemorrhage/etiology*;Hemorrhage/prevention & control;Humans;Risk Assessment/methods;Risk Factors
16158798;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;Binding, Competitive;Biological Availability;Citrus paradisi/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Flavonoids/pharmacokinetics;Food-Drug Interactions*;Furocoumarins/pharmacokinetics;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Hypnotics and Sedatives/metabolism;Liver/metabolism;Oxidation-Reduction
16164493;Adult;Aged;Area Under Curve;Blood Specimen Collection;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Estradiol/adverse effects;Estradiol/analogs & derivatives*;Estradiol/pharmacokinetics;Female;Food-Drug Interactions;Hormones/blood;Humans;Mass Spectrometry;Middle Aged;Postmenopause/physiology*;Selective Estrogen Receptor Modulators/adverse effects*;Selective Estrogen Receptor Modulators/pharmacokinetics*
16181450;Antioxidants/therapeutic use;Cholecalciferol/therapeutic use;Diet/adverse effects*;Fatty Acids, Unsaturated/therapeutic use;Food-Drug Interactions;Glutens/adverse effects;Humans;Oxidative Stress;Psoriasis/diet therapy*;Psoriasis/drug therapy;Psoriasis/etiology*;Vitamin B 12/therapeutic use
16190498;Anticoagulants*;Food-Drug Interactions*;Humans;International Normalized Ratio;Phytotherapy/adverse effects*;Urinary Tract Infections/prevention & control*;Vaccinium macrocarpon*;Warfarin*
16192747;Anti-Bacterial Agents/pharmacokinetics;Anti-Bacterial Agents/therapeutic use;Anticonvulsants/pharmacokinetics;Anticonvulsants/therapeutic use;Antifungal Agents/adverse effects;Antifungal Agents/therapeutic use*;Clinical Trials as Topic;Cross Infection/prevention & control*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Drug Monitoring;Echinocandins;Food-Drug Interactions;Humans;Immunocompromised Host;Intensive Care Units;Lipopeptides;Liver/drug effects;Liver/enzymology;Mycoses/drug therapy*;Mycoses/prevention & control;Peptides, Cyclic/adverse effects;Peptides, Cyclic/therapeutic use*;Polypharmacy;Pyrimidines/adverse effects;Pyrimidines/therapeutic use*;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use;Triazoles/adverse effects;Triazoles/therapeutic use*;Voriconazole
16199918;Calcium Channel Blockers/adverse effects*;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions*;Humans
16239022;Clinical Trials as Topic*;Dietary Supplements/adverse effects*;Evidence-Based Medicine*;Fibrinolytic Agents/adverse effects*;Food, Organic/adverse effects*;Food-Drug Interactions*;Humans;Plants, Medicinal/adverse effects*;Risk Assessment/methods*;Risk Factors
16265911;Adult;Dietary Supplements*;Drug Interactions;Drug Labeling;Female;Food Additives*/adverse effects;Food-Drug Interactions;Humans;Legislation, Drug;Legislation, Food;Male;Plant Structures*/adverse effects;Plants, Medicinal*/adverse effects;Russia;Safety
16268317;Citrus paradisi/adverse effects;Drug Interactions*;Drug Therapy/nursing*;Food-Drug Interactions;Humans;Hypericum/adverse effects
8857072;Adrenergic Agents/pharmacology*;Adult;Analysis of Variance;Benzamides/adverse effects;Benzamides/therapeutic use*;Blood Pressure/drug effects;Double-Blind Method;Drug Interactions;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Hypertension/chemically induced;Injections, Intravenous;Male;Moclobemide;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Selegiline/adverse effects;Selegiline/therapeutic use*;Tyramine/pharmacology*
16288258;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Enzyme Inhibitors/adverse effects;Food-Drug Interactions*;Humans
16291710;Adenine/adverse effects;Adenine/analogs & derivatives*;Adenine/blood;Adenine/pharmacokinetics;Adult;Anti-HIV Agents/adverse effects;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics*;Didanosine/adverse effects;Didanosine/blood;Didanosine/pharmacokinetics*;Drug Interactions;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Male;Organophosphonates/adverse effects;Organophosphonates/blood;Organophosphonates/pharmacokinetics*;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Tenofovir
16291715;Administration, Oral;Adult;Antidepressive Agents, Second-Generation/administration & dosage;Antidepressive Agents, Second-Generation/adverse effects;Antidepressive Agents, Second-Generation/pharmacokinetics*;Biological Availability;Citalopram/administration & dosage;Citalopram/adverse effects;Citalopram/pharmacokinetics*;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Infusions, Intravenous;Male;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/pharmacokinetics*
16305298;Dietary Supplements/adverse effects;Drug Evaluation/methods*;Food-Drug Interactions*;Humans;Intestinal Absorption;Nutritional Status;Pharmaceutical Services;Pharmacokinetics
16306299;Biological Availability;Drug Administration Routes;Enteral Nutrition/adverse effects;Enteral Nutrition/methods*;Food-Drug Interactions/physiology*;Humans;Pharmaceutical Preparations/administration & dosage*
16326816;Animals;Area Under Curve;Beverages*/adverse effects;Biological Availability;Carbamazepine/pharmacokinetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors*/adverse effects;Food-Drug Interactions*;Fruit*;Male;Metabolic Clearance Rate;Rats;Rats, Wistar
16337049;Anticoagulants/pharmacology*;Aspirin/pharmacology;Azetidines/pharmacology;Benzylamines/pharmacology;Calcium Channel Blockers/pharmacology*;Food Additives/adverse effects*;Food-Drug Interactions*;Honey/adverse effects*;Humans;Soy Foods/adverse effects*
16357446;Antitubercular Agents/adverse effects*;Antitubercular Agents/therapeutic use;Cheese*;Fish Products*;Food-Drug Interactions*;Humans;Isoniazid/adverse effects*;Isoniazid/therapeutic use;Risk Factors;Tuberculosis/drug therapy;Wine*
8857073;Adult;Analysis of Variance;Anti-Allergic Agents/adverse effects;Anti-Allergic Agents/chemistry;Anti-Allergic Agents/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Double-Blind Method;Drug Design;Drug Hypersensitivity/drug therapy;Drug Packaging;Food-Drug Interactions;Histamine/pharmacology;Humans;Male;Middle Aged
16365957;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Citrus paradisi/chemistry;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Furocoumarins/metabolism;Humans;Male;Piperazines/blood;Purines;Sildenafil Citrate;Sulfones;Vasodilator Agents/blood
16425970;Adult;Analysis of Variance;Area Under Curve;Biological Availability;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics;Chromatography, High Pressure Liquid;Clinical Chemistry Tests;Cross-Over Studies;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/administration & dosage;Eating/drug effects;European Union;Fasting;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Humans;Hydrogen-Ion Concentration;Male;Mass Spectrometry;Nifedipine/adverse effects;Nifedipine/blood;Nifedipine/pharmacokinetics*;Solubility;Tablets;Technology, Pharmaceutical/methods;Time Factors
16428030;Antidepressive Agents/adverse effects;Antidepressive Agents/chemical synthesis;Antidepressive Agents/therapeutic use;Depression/drug therapy*;Dermatitis, Phototoxic/etiology;Food-Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use;Risk Assessment
16520665;Adolescent;Adult;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Male;Middle Aged;Protein-Tyrosine Kinases/antagonists & inhibitors*;Protein-Tyrosine Kinases/metabolism;Pyrroles/adverse effects;Pyrroles/blood;Pyrroles/pharmacokinetics*
16569183;Enteral Nutrition*/adverse effects;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Pharmacy Service, Hospital;Prospective Studies
16610971;Administration, Oral;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Blood Coagulation/drug effects;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Vitamin K/adverse effects;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/pharmacology*
8881693;Dermatitis, Phototoxic/pathology*;Female;Food-Drug Interactions;Humans;Middle Aged;PUVA Therapy/adverse effects*;Vegetables/adverse effects*
16613116;Beverages/adverse effects*;Food-Drug Interactions*;Humans;Vaccinium macrocarpon/adverse effects*;Warfarin/adverse effects*
16638738;Adult;Aluminum Hydroxide/pharmacology;Antacids/pharmacology*;Cross-Over Studies;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Drug Combinations;Drug Interactions;Factor Xa Inhibitors;Fasting/metabolism;Food-Drug Interactions*;Histamine H2 Antagonists/pharmacology;Humans;Intestinal Absorption/drug effects;Magnesium Hydroxide/pharmacology;Male;Morpholines/adverse effects;Morpholines/blood;Morpholines/pharmacokinetics*;Morpholines/pharmacology;Prothrombin Time;Ranitidine/pharmacology*;Rivaroxaban;Thiophenes/adverse effects;Thiophenes/blood;Thiophenes/pharmacokinetics*;Thiophenes/pharmacology
16699355;Anticoagulants/therapeutic use*;Cross-Sectional Studies;Female;Food-Drug Interactions;Health Knowledge, Attitudes, Practice*;Heart Valve Prosthesis Implantation*/adverse effects;Humans;International Normalized Ratio;Male;Middle Aged;Patient Education as Topic/methods;Population Surveillance;Thromboembolism/etiology;Thromboembolism/prevention & control;Vitamin K/metabolism;Warfarin/therapeutic use*
16772772;Aged;Anticoagulants/adverse effects*;Beverages/adverse effects*;Drug Synergism;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans;Hypoprothrombinemias/chemically induced*;International Normalized Ratio*;Male;Vaccinium macrocarpon*;Warfarin/adverse effects*
16773618;Aged;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects*;Combined Modality Therapy;Cross-Over Studies;Diet, Protein-Restricted*/adverse effects;Drug Therapy, Combination;Female;Food-Drug Interactions*;Humans;Levodopa/administration & dosage;Levodopa/adverse effects*;Male;Middle Aged;Neurologic Examination*;Parkinson Disease/diet therapy*;Parkinson Disease/physiopathology;Patient Satisfaction;Pilot Projects;Postprandial Period*/physiology;Single-Blind Method
16814135;Beverages/adverse effects*;Biological Availability;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/therapeutic use;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Hypertension/drug therapy*;Intestines/enzymology
16850557;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism
16855078;Administration, Cutaneous;Administration, Oral;Adolescent;Adult;Blood Pressure/drug effects*;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions;Heart Rate/drug effects;Humans;Hypertension/chemically induced*;Hypertension/physiopathology;Male;Middle Aged;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Reference Values;Selegiline/administration & dosage;Selegiline/adverse effects*;Time Factors;Tranylcypromine/administration & dosage;Tranylcypromine/adverse effects;Tyramine/administration & dosage;Tyramine/adverse effects*
2248078;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects*;Benzamides/administration & dosage;Benzamides/adverse effects*;Depressive Disorder/drug therapy*;Follow-Up Studies;Humans;Moclobemide;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*
8888098;Deamino Arginine Vasopressin/adverse effects*;Food-Drug Interactions;Humans;Renal Agents/adverse effects*;Water Intoxication/etiology*
16856145;Administration, Oral;Aged;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects*;Blood Pressure/drug effects*;Dose-Response Relationship, Drug;Double-Blind Method;Drug Therapy, Combination;Female;Food-Drug Interactions*;Heart Rate/drug effects*;Humans;Indans/administration & dosage;Indans/adverse effects*;Levodopa/administration & dosage;Levodopa/adverse effects;Male;Middle Aged;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Parkinson Disease/drug therapy*;Risk Factors;Tyramine*/administration & dosage
16871472;Adult;Alprazolam/therapeutic use;Animals;Antidepressive Agents, Second-Generation/therapeutic use;Antidepressive Agents, Tricyclic/adverse effects*;Anxiety/complications;Anxiety/drug therapy;Clomipramine/adverse effects*;Drug Eruptions/pathology*;Female;Food-Drug Interactions*;Gadus morhua*;Humans;Hypnotics and Sedatives/therapeutic use;Meat/adverse effects*;Obsessive-Compulsive Disorder/complications;Obsessive-Compulsive Disorder/drug therapy;Paroxetine/therapeutic use;Urticaria/chemically induced*;Urticaria/pathology*
16905501;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*
16905502;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Hemorrhage/etiology;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*
16945054;Anticoagulants/adverse effects*;Beverages*;Food-Drug Interactions;Humans;International Normalized Ratio;Vaccinium macrocarpon*;Warfarin/adverse effects*
16988203;3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors*;Administration, Oral;Adult;Aminopyridines/administration & dosage;Aminopyridines/blood;Aminopyridines/metabolism;Aminopyridines/pharmacokinetics*;Area Under Curve;Benzamides/administration & dosage;Benzamides/blood;Benzamides/metabolism;Benzamides/pharmacokinetics*;Cross-Over Studies;Cyclic Nucleotide Phosphodiesterases, Type 4;Cyclopropanes/administration & dosage;Cyclopropanes/blood;Cyclopropanes/metabolism;Cyclopropanes/pharmacokinetics;Dietary Fats/administration & dosage*;Dietary Fats/adverse effects;Dietary Fats/pharmacokinetics;Fasting;Female;Food-Drug Interactions*;Half-Life;Headache/diagnosis;Headache/epidemiology;Humans;Male;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*
16988211;Adult;Amlodipine/adverse effects;Amlodipine/pharmacokinetics*;Anticholesteremic Agents/pharmacokinetics;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics;Area Under Curve;Atorvastatin Calcium;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/adverse effects;Dietary Fats/pharmacokinetics;Disorders of Excessive Somnolence/chemically induced;Dose-Response Relationship, Drug;Drug Combinations;Female;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Heptanoic Acids/adverse effects;Heptanoic Acids/pharmacokinetics*;Humans;Male;Middle Aged;Pyrroles/adverse effects;Pyrroles/pharmacokinetics*;Tablets;Therapeutic Equivalency
8901078;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Biological Availability;Delayed-Action Preparations;Dietary Fats/pharmacology*;Female;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Humans;Male;Middle Aged;Nausea/chemically induced;Oxycodone/administration & dosage;Oxycodone/adverse effects;Oxycodone/pharmacokinetics*
16989032;Bacteriuria/prevention & control;Double-Blind Method;Female;Food-Drug Interactions;Fruit;Humans;Phytotherapy;Plant Preparations*/therapeutic use;Randomized Controlled Trials as Topic;Self Care/methods;Urinary Tract Infections*/prevention & control;Urinary Tract Infections*/therapy;Vaccinium macrocarpon*;Warfarin
17023070;Anticoagulants/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Warfarin/adverse effects*
17101740;Citrus paradisi/adverse effects*;Citrus paradisi/chemistry;Clinical Trials as Topic;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions*;Humans;Molecular Structure;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemistry
17112309;Aged;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drug-Related Side Effects and Adverse Reactions/etiology;Food-Drug Interactions*;Humans
17146730;Acetamides/administration & dosage*;Acetamides/adverse effects;Acetamides/blood;Acetamides/pharmacokinetics*;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Fasting/blood;Female;Food-Drug Interactions;Humans;Indoles/administration & dosage*;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Male;Maximum Tolerated Dose;Middle Aged;Neoplasms/drug therapy*;Neoplasms/metabolism;Neoplasms/pathology;Netherlands;Pilot Projects;Postprandial Period;Treatment Outcome;Tubulin Modulators/administration & dosage*;Tubulin Modulators/adverse effects;Tubulin Modulators/blood;Tubulin Modulators/pharmacokinetics*
17212251;Aged;Diuretics/adverse effects*;Food-Drug Interactions;Humans;Minerals/adverse effects*;Salts/adverse effects*;Sodium/deficiency*;Sodium Chloride, Dietary/administration & dosage
17215845;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;Adult;Aged;Aged, 80 and over;Beverages/adverse effects*;Biological Availability;Blotting, Western;Carrier Proteins/biosynthesis*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/biosynthesis;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/genetics;Female;Fluorescent Antibody Technique;Food-Drug Interactions*;Histamine H1 Antagonists/blood;Humans;Immunohistochemistry;Intestines/metabolism*;Male;Middle Aged;Organic Anion Transporters/biosynthesis;Organic Anion Transporters/genetics;Pharmaceutical Preparations/metabolism*;RNA/biosynthesis;RNA/genetics;Reverse Transcriptase Polymerase Chain Reaction;Terfenadine/analogs & derivatives;Terfenadine/blood
17253883;Anti-Bacterial Agents/pharmacology*;Area Under Curve;Biological Availability;Biotransformation;Carbamates/administration & dosage;Carbamates/pharmacokinetics*;Carbamates/pharmacology;Cyclohexanes/administration & dosage;Cyclohexanes/pharmacokinetics*;Cyclohexanes/pharmacology;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Drug Administration Schedule;Drug Interactions;Enzyme Induction/drug effects;Enzyme Inhibitors/pharmacology*;Fasting;Food-Drug Interactions*;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology;Intestinal Absorption;Phenylalanine/administration & dosage;Phenylalanine/analogs & derivatives*;Phenylalanine/pharmacokinetics;Phenylalanine/pharmacology;Piperidines/administration & dosage;Piperidines/pharmacokinetics*;Piperidines/pharmacology;Postprandial Period
8930779;Adult;Analysis of Variance;Biological Availability;Chromatography;Cross-Over Studies;Delayed-Action Preparations;Drug Combinations;Ephedrine/administration & dosage;Ephedrine/adverse effects;Ephedrine/blood;Ephedrine/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/adverse effects;Histamine H1 Antagonists/blood;Histamine H1 Antagonists/pharmacokinetics*;Humans;Loratadine/administration & dosage;Loratadine/adverse effects;Loratadine/blood;Loratadine/pharmacokinetics*;Male;Vasoconstrictor Agents/administration & dosage;Vasoconstrictor Agents/adverse effects;Vasoconstrictor Agents/blood;Vasoconstrictor Agents/pharmacokinetics*
17269895;Animals;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions*;Humans;Intestine, Small/metabolism*;Models, Biological;Prognosis
17296276;Administration, Oral;Animals;Brain/metabolism;Chylomicrons/blood;Chylomicrons/metabolism*;DDT/administration & dosage;DDT/blood;DDT/pharmacokinetics*;DDT/toxicity;Dietary Fats/administration & dosage;Dietary Fats/adverse effects*;Facial Muscles/drug effects;Food-Drug Interactions*;Hyperlipidemias/blood;Hyperlipidemias/etiology;Hyperlipidemias/metabolism*;Infusions, Intravenous;Male;Peanut Oil;Plant Oils/administration & dosage;Plant Oils/adverse effects*;Postprandial Period;Protein Binding;Rats;Rats, Wistar;Tremor/chemically induced;Triglycerides/blood;Triglycerides/metabolism*
17322161;Anticoagulants/adverse effects*;Aryl Hydrocarbon Hydroxylases;Beverages;Clinical Trials as Topic;Cytochrome P-450 CYP2C9;Drug Monitoring;Female;Flavonoids;Food-Drug Interactions*;Hemorrhage/chemically induced;Humans;International Normalized Ratio;Male;Vaccinium macrocarpon*;Vitamin K Deficiency;Warfarin/adverse effects*;Warfarin/pharmacokinetics*
17328583;Adolescent;Adult;Aged;Antacids/pharmacology;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/pharmacokinetics*;Azithromycin/administration & dosage;Azithromycin/adverse effects;Azithromycin/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/pharmacology;Drug Interactions;Female;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Humans;Male;Microspheres;Middle Aged;Sample Size
17346019;Alcohol Drinking/adverse effects*;Alcohol Drinking/epidemiology;Alcohol Drinking/metabolism;Alcohol Drinking/prevention & control*;Alcoholic Beverages/analysis;Attitude to Health;Ethanol/analysis;Food-Drug Interactions;Health Behavior;Health Knowledge, Attitudes, Practice;Health Promotion/organization & administration*;Helping Behavior;Humans;Life Style*;Nurse's Role/psychology*;Patient Education as Topic/organization & administration;Social Support;United Kingdom/epidemiology
17368832;Anticoagulants/antagonists & inhibitors*;Food-Drug Interactions*;Humans;International Normalized Ratio;Tea/adverse effects*;Vegetables*;Vitamin K/pharmacology;Warfarin/antagonists & inhibitors*
17389552;Adolescent;Adult;Area Under Curve;Circadian Rhythm;Codon, Nonsense/antagonists & inhibitors*;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Immunoblotting;Male;Oxadiazoles/administration & dosage;Oxadiazoles/adverse effects;Oxadiazoles/pharmacokinetics*
17389557;Adolescent;Adult;Area Under Curve;Cross-Over Studies;Darunavir;Drug Combinations;Fasting;Female;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/adverse effects;HIV Protease Inhibitors/pharmacokinetics*;HIV Seronegativity;Half-Life;Humans;Male;Middle Aged;Ritonavir/administration & dosage;Ritonavir/adverse effects;Ritonavir/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*
17463218;Adolescent;Adult;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects*;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats;Fasting;Food;Food-Drug Interactions*;Gastric Emptying;Humans;Male;Mass Spectrometry;Middle Aged;Nucleic Acid Synthesis Inhibitors;Rifamycins/administration & dosage;Rifamycins/adverse effects*;Rifamycins/blood;Rifamycins/pharmacokinetics*;Therapeutic Equivalency
17468508;Animals;Attitude of Health Personnel;Catechin;Diet;Eating;Food-Drug Interactions;Humans;Hypertension/prevention & control;Milk/adverse effects*;Milk Proteins/adverse effects;Postprandial Period;Swine;Swine, Miniature;Tea*;Vasodilation
9022564;Acute Kidney Injury/chemically induced;Aminoglycosides;Amphotericin B/adverse effects;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Animals;Anti-Bacterial Agents/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Antihypertensive Agents/pharmacology;Antihypertensive Agents/therapeutic use;Cisplatin/adverse effects;Contrast Media/adverse effects;Diet, Sodium-Restricted/adverse effects*;Food-Drug Interactions*;Humans;Hypertension/therapy*;Immunosuppressive Agents/adverse effects;Renal Circulation/drug effects
17495279;Adolescent;Adult;Antipsychotic Agents/administration & dosage*;Antipsychotic Agents/adverse effects;Antipsychotic Agents/blood;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Fasting;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Piperidines/administration & dosage*;Piperidines/adverse effects;Piperidines/blood;Piperidines/pharmacokinetics*;Psychotic Disorders;Serotonin 5-HT2 Receptor Agonists*;Tablets;Therapeutic Equivalency;Urea/administration & dosage;Urea/adverse effects;Urea/analogs & derivatives*;Urea/blood;Urea/pharmacokinetics
17530235;Citrus paradisi*;Drug Overdose;Food-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage*;Immunosuppressive Agents/adverse effects*;Immunosuppressive Agents/pharmacokinetics;Liver Transplantation;Middle Aged;Tacrolimus/administration & dosage*;Tacrolimus/adverse effects*;Tacrolimus/pharmacokinetics
17542349;Administration, Oral;Adolescent;Adult;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Male;Middle Aged;Organic Chemicals/administration & dosage;Organic Chemicals/adverse effects;Organic Chemicals/pharmacokinetics;Serotonin Receptor Agonists/administration & dosage;Serotonin Receptor Agonists/adverse effects;Serotonin Receptor Agonists/pharmacokinetics*
17545920;Animals;Antineoplastic Agents, Hormonal/pharmacology;Apoptosis/drug effects;Bone Density/drug effects*;Bone Density Conservation Agents/pharmacology*;Breast Neoplasms/drug therapy*;Breast Neoplasms/pathology;Cell Line, Tumor;Cell Proliferation/drug effects;Combined Modality Therapy;Food-Drug Interactions*;Lignans/pharmacology*;Mice;Mice, Nude;Ovariectomy;Premenopause;Seeds;Sesamum*;Tamoxifen/antagonists & inhibitors*;Tumor Burden/drug effects;Xenograft Model Antitumor Assays
17612708;Administration, Cutaneous;Antidepressive Agents*/adverse effects;Antidepressive Agents*/pharmacology;Antidepressive Agents*/therapeutic use;Depression/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors*/adverse effects;Monoamine Oxidase Inhibitors*/pharmacology;Monoamine Oxidase Inhibitors*/therapeutic use;Selegiline*/adverse effects;Selegiline*/pharmacology;Selegiline*/therapeutic use
17617289;Adult;Asthenia/chemically induced;Biological Availability;Capsules;Clonidine/administration & dosage;Clonidine/adverse effects;Clonidine/analogs & derivatives*;Clonidine/blood;Clonidine/pharmacokinetics;Cross-Over Studies;Dietary Fats*;Dosage Forms;Female;Food-Drug Interactions;Humans;Male;Muscle Relaxants, Central/administration & dosage*;Muscle Relaxants, Central/adverse effects;Muscle Relaxants, Central/blood;Muscle Relaxants, Central/pharmacokinetics*;Tablets
17640157;Depressive Disorder/drug therapy;Diet;Food-Drug Interactions*;Humans;Hypertension/chemically induced;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Tyramine/metabolism
17656620;Adamantane/administration & dosage;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Administration, Oral;Adult;Area Under Curve;Confidence Intervals;Cross-Over Studies;Dietary Fats*;Dipeptidyl-Peptidase IV Inhibitors*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Half-Life;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics*;Male;Models, Statistical;Nitriles/administration & dosage;Nitriles/adverse effects;Nitriles/pharmacokinetics*;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics*
17688173;Adult;Anti-Infective Agents/chemistry;Anti-Infective Agents/metabolism*;Anti-Infective Agents/pharmacokinetics*;Beverages/adverse effects*;Biological Availability;Calcium Carbonate/adverse effects;Chemistry, Pharmaceutical;Ciprofloxacin/chemistry;Ciprofloxacin/metabolism*;Ciprofloxacin/pharmacokinetics*;Citrus*;Cross-Over Studies;Drug Monitoring;Female;Food-Drug Interactions;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Linear Models;Male;Metabolic Clearance Rate;Nigeria;Solubility;Spectrophotometry, Ultraviolet;Tablets;Time Factors;Vitis*
9049582;Administration, Oral;Adult;Cholesterol/blood*;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Male;Phenylurea Compounds/adverse effects;Phenylurea Compounds/pharmacokinetics*;Single-Blind Method;Sterol O-Acyltransferase/antagonists & inhibitors*;Sterol O-Acyltransferase/blood*
17691921;Adult;Beverages/analysis;Blood Pressure/drug effects;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology*;Citrus/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics*;Cytochrome P-450 Enzyme System/metabolism*;DNA/genetics;DNA/isolation & purification;Felodipine/adverse effects;Felodipine/pharmacokinetics*;Felodipine/pharmacology*;Food-Drug Interactions*;Furocoumarins/chemistry;Furocoumarins/pharmacology*;Genotype;Heart Rate/drug effects;Humans;Hydroxylation;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Molecular Sequence Data;Polymorphism, Genetic;Testosterone/metabolism
17875111;Aged;Aspirin/adverse effects*;Aspirin/pharmacokinetics;Beverages;Citrus*;Food-Drug Interactions*;Humans;Male;Platelet Aggregation Inhibitors/adverse effects*;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics;Purpura/chemically induced;Tetrazoles/adverse effects*;Tetrazoles/blood;Tetrazoles/pharmacokinetics
17906915;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Dietary Supplements/adverse effects;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects;Registries
17916059;Antidepressive Agents, Second-Generation/therapeutic use*;Anxiety Disorders/drug therapy*;Biological Availability;Citalopram/adverse effects;Citalopram/pharmacokinetics;Citalopram/therapeutic use*;Depressive Disorder, Major/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans
17919554;Aged;Anticoagulants/adverse effects*;Atrial Fibrillation/blood;Atrial Fibrillation/drug therapy*;Beverages*;Blood Coagulation Disorders/blood;Blood Coagulation Disorders/chemically induced*;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Vaccinium macrocarpon*;Warfarin/adverse effects*
17955954;Animals;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use;Drug Interactions;Food-Drug Interactions*;Humans;Plant Preparations/adverse effects*
17958008;Beverages/adverse effects;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans
17966839;Adult;Aged;Analysis of Variance;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacokinetics*;Farnesyltranstransferase/antagonists & inhibitors;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/pharmacokinetics*
17967158;Aged;Animals;Drug Interactions/physiology*;Food-Drug Interactions/physiology;Humans;Medication Errors/adverse effects;Polypharmacy*
17971226;Beverages/adverse effects*;Biological Availability;Calcium Channel Blockers/pharmacology;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans
18007569;Absorption;Administration, Oral;Adolescent;Adult;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*
18035186;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacology;Antiparkinson Agents/therapeutic use*;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;Humans;Indans/administration & dosage;Indans/adverse effects;Indans/pharmacology;Indans/therapeutic use*;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use*;Neuroprotective Agents/administration & dosage;Neuroprotective Agents/adverse effects;Neuroprotective Agents/pharmacology;Neuroprotective Agents/therapeutic use*;Parkinson Disease/drug therapy*;Selegiline/administration & dosage;Selegiline/adverse effects;Selegiline/pharmacology;Selegiline/therapeutic use
18042475;Administration, Oral;Adult;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;China;Chromatography, High Pressure Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting;Female;Fluorobenzenes/administration & dosage*;Fluorobenzenes/adverse effects;Fluorobenzenes/pharmacokinetics*;Food-Drug Interactions;Hospitals, University;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Mass Spectrometry;Pyrimidines/administration & dosage*;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Rosuvastatin Calcium;Sex Factors;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*
18074531;Adrenergic beta-Antagonists/adverse effects*;Arrhythmias, Cardiac/chemically induced*;Calcium Channel Blockers/adverse effects*;Citrus paradisi;Coronary Vasospasm/chemically induced;Depression/chemically induced;Depression, Chemical;Drug Interactions;Food-Drug Interactions;Heart Rate/drug effects;Humans;Lipid Metabolism Disorders/chemically induced;Myocardial Contraction/drug effects;Sympathetic Nervous System/physiopathology
18074548;Anaphylaxis/chemically induced;Anti-Allergic Agents/adverse effects*;Anti-Allergic Agents/pharmacology;Arrhythmias, Cardiac/chemically induced;Citrus paradisi;Cystitis/chemically induced;Drug Interactions;Food-Drug Interactions;Histamine/physiology;Histamine H1 Antagonists/adverse effects*;Histamine H1 Antagonists/pharmacology;Humans;Seizures/chemically induced*;Sleep Wake Disorders/chemically induced*
18084364;Citrus/adverse effects;Citrus paradisi/adverse effects;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Fruit/adverse effects*;Humans;Pharmaceutical Preparations/metabolism*;Punicaceae/adverse effects;Vitis/adverse effects
18162024;Adolescent;Adult;Aged;Aged, 80 and over;Depressive Disorder, Major/drug therapy*;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Duloxetine Hydrochloride;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Outpatients;Serotonin Uptake Inhibitors/administration & dosage*;Serotonin Uptake Inhibitors/adverse effects;Thiophenes/administration & dosage*;Thiophenes/adverse effects;Treatment Outcome
18176118;Administration, Oral;Adult;Aged;Algorithms;Area Under Curve;Creatine Kinase/blood;Cross-Over Studies;Dose-Response Relationship, Drug;Erlotinib Hydrochloride;Exanthema/chemically induced;Fasting;Food-Drug Interactions*;Glossitis/chemically induced;Hematuria/chemically induced;Humans;Liver/drug effects;Liver/enzymology;Male;Middle Aged;Molecular Structure;Patient Dropouts/statistics & numerical data;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics;Quinazolines/chemistry;Quinazolines/metabolism;Quinazolines/pharmacokinetics*;Receptor, Epidermal Growth Factor/antagonists & inhibitors*;Time Factors;gamma-Glutamyltransferase/blood
18272698;Aged;Enteral Nutrition/adverse effects*;Food-Drug Interactions/physiology*;Humans;Levodopa/adverse effects*;Levodopa/pharmacokinetics;Male;Parkinson Disease/metabolism;Parkinson Disease/therapy
18285619;Administration, Oral;Adult;Area Under Curve;Biological Availability;Blood Pressure/drug effects;Capsules;Cross-Over Studies;Dextroamphetamine/administration & dosage;Dextroamphetamine/adverse effects;Dextroamphetamine/chemistry;Dextroamphetamine/metabolism;Dextroamphetamine/pharmacokinetics*;Eating/physiology*;Fasting/physiology*;Female;Flushing/chemically induced;Food-Drug Interactions;Half-Life;Headache/chemically induced;Humans;Hyperkinesis/chemically induced;Lisdexamfetamine Dimesylate;Lysine/chemistry;Lysine/metabolism;Male;Metabolic Clearance Rate;Molecular Structure;Tachycardia/chemically induced
18363537;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Dietary Carbohydrates/administration & dosage;Dietary Proteins/pharmacology*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/pharmacokinetics*
18363644;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Beverages/adverse effects;Citrus paradisi*;Cytochrome P-450 CYP3A/biosynthesis;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Induction;Evidence-Based Medicine;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Hypericum*;Immunosuppressive Agents/adverse effects*;Kidney Transplantation*;Liver/drug effects*;Liver/enzymology;Plant Preparations/adverse effects;Receptors, Steroid/drug effects;Receptors, Steroid/metabolism;Risk Assessment;Up-Regulation
18380391;Beverages/adverse effects*;Food-Drug Interactions;Glycyrrhiza/adverse effects*;Glycyrrhiza/chemistry;Humans;Hypertension/diagnosis;Hypertension/etiology*;Tea/adverse effects*
18382075;Aged;Aged, 80 and over;Biological Availability;Female;Food-Drug Interactions*;Health Status*;Humans;Intestinal Absorption;Male;Nutritional Status/drug effects*;Nutritional Status/physiology*;Pharmaceutical Preparations/administration & dosage*;Pharmacokinetics
9129556;Anti-Allergic Agents/adverse effects;Anti-Asthmatic Agents/adverse effects;Citrus*;Food-Drug Interactions*;Humans;Pharmacology;Societies;Terfenadine/adverse effects;Torsades de Pointes/chemically induced;United States;United States Food and Drug Administration
18438069;Beverages*;Dose-Response Relationship, Drug;Food-Drug Interactions;Glycyrrhiza/adverse effects*;Humans;Hypertension/chemically induced*;Hypertension/etiology;Rhabdomyolysis/chemically induced*;Rhabdomyolysis/etiology;Tea/adverse effects*
18484490;Administration, Oral;Administration, Rectal;Alendronate/administration & dosage;Alendronate/chemistry;Alendronate/pharmacokinetics*;Animals;Biological Availability;Bone Density Conservation Agents/administration & dosage;Bone Density Conservation Agents/chemistry;Bone Density Conservation Agents/pharmacokinetics*;Chemical Phenomena;Chemistry, Pharmaceutical;Chemistry, Physical;Diffusion;Food-Drug Interactions;Intestinal Absorption/physiology*;Isotope Labeling;Male;Rabbits;Solubility;Technetium/chemistry
18552451;Blood Pressure/drug effects;Carbolines/administration & dosage*;Carbolines/adverse effects;Carbolines/pharmacokinetics;Carbolines/pharmacology;Cyclic GMP/metabolism;Erectile Dysfunction/drug therapy*;Food-Drug Interactions;Humans;Male;Muscle Relaxation/drug effects;Muscle, Smooth/metabolism;Penis/blood supply;Penis/metabolism;Phosphodiesterase 5 Inhibitors*;Phosphodiesterase Inhibitors/administration & dosage*;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics;Phosphodiesterase Inhibitors/pharmacology;Randomized Controlled Trials as Topic;Tadalafil
18589558;Adolescent;Adult;Aged;Area Under Curve;Capsules;Chromatography, High Pressure Liquid;Fasting/physiology;Female;Food-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/pharmacokinetics*;Male;Middle Aged;Tacrolimus/administration & dosage;Tacrolimus/adverse effects;Tacrolimus/pharmacokinetics*;Tandem Mass Spectrometry;Therapeutic Equivalency
18663908;Beverages*;Biological Availability;Citrus paradisi/metabolism*;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Flavonoids/pharmacology*;Food-Drug Interactions*;Humans;Psychotropic Drugs/pharmacokinetics;Psychotropic Drugs/pharmacology*
18717508;Analgesics, Opioid/therapeutic use*;Chronic Disease;Clinical Trials as Topic;Delayed-Action Preparations;Drug Interactions;Follow-Up Studies;Food-Drug Interactions;Humans;Oxymorphone/adverse effects;Oxymorphone/pharmacokinetics;Oxymorphone/pharmacology;Oxymorphone/therapeutic use*;Pain/drug therapy*
18721117;Biological Availability;Clinical Trials as Topic;Delayed-Action Preparations;Diabetes Mellitus, Type 2/drug therapy*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Metformin/administration & dosage*;Metformin/adverse effects;Metformin/pharmacokinetics;Renal Insufficiency/complications
18768996;Antineoplastic Agents*/adverse effects;Antineoplastic Agents*/pharmacokinetics;Antineoplastic Agents*/pharmacology;Antineoplastic Agents*/therapeutic use;Breast Neoplasms*/drug therapy;Breast Neoplasms*/pathology;Drug Resistance, Neoplasm;Female;Food-Drug Interactions;Humans;Neoplasm Metastasis;Protein Kinase Inhibitors*/adverse effects;Protein Kinase Inhibitors*/pharmacokinetics;Protein Kinase Inhibitors*/pharmacology;Protein Kinase Inhibitors*/therapeutic use;Quinazolines*/adverse effects;Quinazolines*/pharmacokinetics;Quinazolines*/pharmacology;Quinazolines*/therapeutic use;Receptor, ErbB-2/metabolism
18793575;Adult;Area Under Curve;Chromatography, Liquid;Cross-Over Studies;Dietary Fats/pharmacology;Endothelin A Receptor Antagonists;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Tandem Mass Spectrometry
18793577;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Half-Life;Humans;Male;Methylphenidate/administration & dosage;Methylphenidate/adverse effects;Methylphenidate/pharmacokinetics*;Therapeutic Equivalency
9129557;Adult;Anti-Allergic Agents/pharmacokinetics*;Anti-Asthmatic Agents/pharmacokinetics*;Area Under Curve;Beverages;Citrus/adverse effects*;Electrocardiography/drug effects;Food-Drug Interactions*;Humans;Male;Oxidation-Reduction;Reference Values;Terfenadine/pharmacokinetics*
18926963;Acenocoumarol/administration & dosage*;Administration, Oral;Adult;Age Factors;Aged;Aged, 80 and over;Anticoagulants/administration & dosage*;Drug Interactions;Educational Status;Family Practice;Female;Food-Drug Interactions;Health Knowledge, Attitudes, Practice*;Hemorrhage/chemically induced*;Hemorrhage/prevention & control;Humans;Male;Medicine;Middle Aged;Patient Care Team*;Residence Characteristics;Specialization;Surveys and Questionnaires;Young Adult
18927522;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages/adverse effects;Citrus paradisi;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Drug Interactions;Enzyme Inhibitors/adverse effects;Food-Drug Interactions;Herb-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Muscular Diseases/chemically induced*;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/metabolism;Simvastatin/adverse effects*;Simvastatin/metabolism;Solute Carrier Organic Anion Transporter Family Member 1b1;Tea
18955941;Antidepressive Agents/adverse effects;Antidepressive Agents/pharmacokinetics;Antidepressive Agents/therapeutic use*;Brain/drug effects;Cheese/adverse effects;Depressive Disorder/blood;Depressive Disorder/drug therapy*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacokinetics;Monoamine Oxidase Inhibitors/therapeutic use*;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/therapeutic use;Tyramine/adverse effects;Tyramine/metabolism
18998611;Acetaminophen/adverse effects*;Acetaminophen/pharmacokinetics;Acetaminophen/therapeutic use;Analgesics, Non-Narcotic/adverse effects*;Analgesics, Non-Narcotic/pharmacokinetics;Analgesics, Non-Narcotic/therapeutic use;Arthritis/drug therapy;Food-Drug Interactions;Humans;Wine/adverse effects*
19014837;Adolescent;Adult;Area Under Curve;Blood Glucose/analysis;Chromatography, High Pressure Liquid;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics;Dipeptidyl-Peptidase IV Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Glucagon-Like Peptide 1/blood;Half-Life;Humans;Insulin/blood;Korea;Male;Metabolic Clearance Rate;Organic Chemicals/adverse effects;Organic Chemicals/pharmacokinetics;Organic Chemicals/pharmacology*;Piperidones;Pyrimidines;Young Adult
19014838;Adult;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Chemistry, Pharmaceutical;Clarithromycin/administration & dosage*;Clarithromycin/adverse effects;Clarithromycin/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Fasting;Food-Drug Interactions;Half-Life;Humans;Jordan;Male;Metabolic Clearance Rate;Tablets;Therapeutic Equivalency
19026256;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/agonists;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Bipolar Disorder/blood*;Bipolar Disorder/drug therapy;Cross-Over Studies;Dietary Fats/metabolism*;Drug Administration Schedule;Energy Intake/physiology*;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Piperazines/administration & dosage;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Psychotic Disorders/blood*;Psychotic Disorders/drug therapy;Schizophrenia/blood*;Schizophrenia/drug therapy;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*;Young Adult
19048359;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Administration, Oral;Animals;Beverages/adverse effects*;Caco-2 Cells;Cell Polarity;Citrus paradisi*/chemistry;Colchicine/administration & dosage;Colchicine/metabolism*;Dose-Response Relationship, Drug;Flavanones/isolation & purification;Flavanones/pharmacology;Food-Drug Interactions*;Fruit;Furocoumarins/isolation & purification;Furocoumarins/pharmacology;Humans;Ileum/drug effects;Ileum/metabolism*;Intestinal Absorption*/drug effects;Jejunum/drug effects;Jejunum/metabolism*;Male;Permeability;Quinidine/pharmacology;Rats;Rats, Wistar;Risk Assessment;Time Factors;Tubulin Modulators/administration & dosage;Tubulin Modulators/metabolism*;Verapamil/pharmacology
19052281;Dosage Forms;Drug Incompatibility;Enteral Nutrition/adverse effects;Enteral Nutrition/methods*;Food-Drug Interactions;Humans;Pharmaceutical Preparations/administration & dosage*;Practice Guidelines as Topic
9144013;Aged;Aged, 80 and over;Animals;Female;Food-Drug Interactions*;Histamine/poisoning*;Humans;Isoniazid/administration & dosage;Isoniazid/adverse effects*;Tuberculosis, Lymph Node/drug therapy*;Tuna*
19058474;Aged;Anticoagulants/adverse effects*;Anticoagulants/metabolism;Beverages/adverse effects;Fatal Outcome;Flavonoids/adverse effects;Food-Drug Interactions*;Gastrointestinal Hemorrhage/chemically induced*;Humans;Male;Pericardial Effusion/chemically induced*;Phytotherapy/adverse effects;Vaccinium macrocarpon/adverse effects*;Vaccinium macrocarpon/metabolism;Warfarin/adverse effects*;Warfarin/metabolism
19075045;Administration, Oral;Adult;African Americans/genetics;African Americans/statistics & numerical data;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/adverse effects;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/pharmacokinetics;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Area Under Curve;Carbonated Beverages*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Eating;European Continental Ancestry Group/genetics;European Continental Ancestry Group/statistics & numerical data;Fasting;Female;Food-Drug Interactions*;Gastric Mucosa/drug effects*;Gastric Mucosa/metabolism;Humans;Hydrogen-Ion Concentration/drug effects;Intestinal Absorption/drug effects;Male;Middle Aged;Omeprazole/administration & dosage;Omeprazole/adverse effects;Omeprazole/blood;Omeprazole/pharmacokinetics;Suspensions;Triazoles/administration & dosage;Triazoles/adverse effects;Triazoles/blood;Triazoles/pharmacokinetics*;Young Adult
19126824;Aged;Female;Food-Drug Interactions/physiology*;Humans;International Normalized Ratio/methods;Tea/adverse effects*;Tea/metabolism;Warfarin/adverse effects*;Warfarin/metabolism
19133704;Administration, Oral;Adult;Area Under Curve;Benzhydryl Compounds/administration & dosage;Benzhydryl Compounds/adverse effects;Benzhydryl Compounds/pharmacokinetics*;Biological Availability;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/pharmacokinetics*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Postprandial Period;Randomized Controlled Trials as Topic;Young Adult
19167586;Administration, Oral;Adolescent;Adrenergic alpha-2 Receptor Agonists;Adrenergic alpha-Agonists/administration & dosage;Adrenergic alpha-Agonists/adverse effects;Adrenergic alpha-Agonists/pharmacokinetics*;Adult;Area Under Curve;Asthenia/chemically induced;Biological Availability;Blood Pressure/drug effects;Capsules;Clonidine/adverse effects;Clonidine/analogs & derivatives*;Clonidine/blood;Clonidine/pharmacokinetics;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting;Female;Food;Food-Drug Interactions;Half-Life;Humans;Male;Malus*;Middle Aged;Young Adult
19188677;Adult;Aged;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Quinazolines/adverse effects;Quinazolines/pharmacokinetics*;Solubility
19206053;Adult;Aged;Arrhythmias, Cardiac/chemically induced;Biological Availability;Biotransformation;Citrus paradisi/metabolism;Drug Interactions;Female;Food-Drug Interactions;Humans;Hypericum/adverse effects;Hypericum/metabolism;Intestinal Absorption;Male;Membrane Transport Proteins/physiology*;Middle Aged;Muscular Diseases/chemically induced;Pharmacokinetics*;Xenobiotics/pharmacokinetics
19222985;Chronic Disease;Depressive Disorder, Major/diagnosis;Depressive Disorder, Major/drug therapy*;Depressive Disorder, Major/psychology;Drug Interactions;Drug Resistance;Electroconvulsive Therapy;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Risk Factors
19243207;Adult;Amitriptyline/administration & dosage;Amitriptyline/adverse effects;Amitriptyline/analogs & derivatives*;Amitriptyline/pharmacokinetics;Antidepressive Agents, Tricyclic/administration & dosage;Antidepressive Agents, Tricyclic/adverse effects;Antidepressive Agents, Tricyclic/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Sample Size;Young Adult
2489809;Animals;Aspirin;Drug Interactions;Duodenal Ulcer/chemically induced*;Rats;Stomach Ulcer/chemically induced*;Sucrose/adverse effects*
9155792;Adult;Cheese/adverse effects*;Emergencies;Female;Food-Drug Interactions*;Humans;Hypertension/drug therapy;Hypertension/etiology*;Hypertension/nursing;Monoamine Oxidase Inhibitors/adverse effects*
19253346;Administration, Oral;Animals;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Azetidines/administration & dosage;Azetidines/pharmacology;Benzylamines/administration & dosage;Benzylamines/pharmacology;Biological Availability;Blood Coagulation/drug effects;Drug Design;Factor Xa Inhibitors;Food-Drug Interactions*;Humans;Rats;Thrombin/antagonists & inhibitors;Vitamin K/antagonists & inhibitors;Vitamin K/pharmacokinetics*;Vitamin K Deficiency/blood
19255348;Drug Interactions/physiology;Food-Drug Interactions/physiology;Humans;Patient Education as Topic/methods*;Practice Guidelines as Topic*;Rheumatic Heart Disease/drug therapy;Therapeutic Equivalency;Warfarin/administration & dosage*;Warfarin/adverse effects;Warfarin/pharmacokinetics*
19281729;Administration, Oral;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use*;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Fasting;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Middle Aged;Neoplasms/drug therapy*;Therapeutic Equivalency;Topotecan/adverse effects;Topotecan/pharmacokinetics*;Topotecan/therapeutic use*
19293342;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Ghrelin/agonists*;Human Growth Hormone/metabolism;Humans;Indoles;Insulin-Like Growth Factor I/metabolism;Male;Oligopeptides/adverse effects;Oligopeptides/pharmacokinetics*;Oligopeptides/pharmacology*;Tryptophan/analogs & derivatives
19328861;Aged;Antacids/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biotransformation;Double-Blind Method;Drug Interactions;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Linear Models;Male;Middle Aged;Pyridones/adverse effects;Pyridones/pharmacokinetics*;Therapeutic Equivalency
19373300;Antidepressive Agents/adverse effects*;Beverages;Drug Interactions;Food-Drug Interactions;Humans;Isocarboxazid/adverse effects;Monoamine Oxidase Inhibitors/adverse effects*;Patient Education as Topic;Phenelzine/adverse effects;Risk Factors;Serotonin Syndrome/chemically induced;Tranylcypromine/adverse effects
19398716;Abdominal Pain/chemically induced;Aged;Aged, 80 and over;Biotransformation;Dose-Response Relationship, Drug;Female;Fever/chemically induced;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Glutathione/administration & dosage;Glutathione/adverse effects;Glutathione/analogs & derivatives*;Glutathione/pharmacokinetics;Glutathione/therapeutic use;Humans;Male;Maximum Tolerated Dose;Middle Aged;Myelodysplastic Syndromes/drug therapy*;Neutropenia/chemically induced;Prodrugs/administration & dosage;Prodrugs/adverse effects;Prodrugs/pharmacokinetics;Prodrugs/therapeutic use*;Tablets
19446149;Administration, Oral;Adult;Aluminum Hydroxide/pharmacology;Antacids/pharmacology*;Area Under Curve;Benzoates/administration & dosage;Benzoates/adverse effects;Benzoates/pharmacokinetics*;Biological Availability;Calcium, Dietary/pharmacology;Capsules;Cross-Over Studies;Dietary Fats/pharmacology;Drug Combinations;Drug Interactions;Female;Food-Drug Interactions*;Humans;Hydrazines/administration & dosage;Hydrazines/adverse effects;Hydrazines/pharmacokinetics*;Magnesium/pharmacology;Male;Middle Aged;Pyrazoles/administration & dosage;Pyrazoles/adverse effects;Pyrazoles/pharmacokinetics*;Receptors, Thrombopoietin/agonists;Tablets;Young Adult
19458055;Abdominal Pain/chemically induced;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Biological Availability;Diarrhea/chemically induced;Drug Administration Schedule;Eating;Fasting;Female;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Middle Aged;Nausea/chemically induced;Neoplasms/drug therapy;Neoplasms/metabolism*;Neoplasms/pathology;Organoplatinum Compounds/administration & dosage;Organoplatinum Compounds/adverse effects;Organoplatinum Compounds/pharmacokinetics*;Vomiting/chemically induced
19473600;Adolescent;Adult;Benzhydryl Compounds/adverse effects;Benzhydryl Compounds/blood;Benzhydryl Compounds/pharmacokinetics*;Cross-Over Studies;Fasting;Food*;Food-Drug Interactions*;Humans;Male;Middle Aged;Muscarinic Antagonists/adverse effects;Muscarinic Antagonists/blood;Muscarinic Antagonists/pharmacokinetics*
9160173;Anticholesteremic Agents/pharmacokinetics*;Anticholesteremic Agents/therapeutic use*;Arteriosclerosis/drug therapy;Arteriosclerosis/etiology;Brain/metabolism;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/therapeutic use*;Fatty Acids, Monounsaturated/pharmacokinetics;Fatty Acids, Monounsaturated/therapeutic use;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors*;Hypercholesterolemia/complications;Hypercholesterolemia/drug therapy;Indoles/pharmacokinetics;Indoles/therapeutic use;Liver/metabolism;Lovastatin/analogs & derivatives;Lovastatin/pharmacokinetics;Lovastatin/therapeutic use;Pravastatin/pharmacokinetics;Pravastatin/therapeutic use;Simvastatin
19476741;Adjuvants, Immunologic/pharmacology;Adjuvants, Immunologic/therapeutic use;Animals;Diabetes Mellitus/therapy;Food-Drug Interactions;Grifola*/chemistry;Humans;Neoplasms/therapy;beta-Glucans/analysis
19480806;Dietetics/education;Enteral Nutrition/adverse effects;Enteral Nutrition/methods;Enteral Nutrition/standards;Evidence-Based Medicine;Feeding Behavior;Food Preservation/standards;Food Service, Hospital/standards;Food, Formulated/adverse effects;Food, Formulated/standards;Food-Drug Interactions;Humans;Malnutrition/diagnosis;Malnutrition/prevention & control;Malnutrition/therapy;Mass Screening/methods;Mass Screening/standards;Medical Records/standards;Nutrition Assessment;Nutritional Support/standards*;Parenteral Nutrition/adverse effects;Parenteral Nutrition/methods;Parenteral Nutrition/standards;Parenteral Nutrition Solutions/administration & dosage;Parenteral Nutrition Solutions/chemistry;Parenteral Nutrition Solutions/standards;Patient Care Planning;Quality Assurance, Health Care;Risk Factors;Spain;Surveys and Questionnaires
19553405;Adult;Aged;Aged, 80 and over;Anticoagulants/pharmacokinetics*;Beverages/adverse effects*;Double-Blind Method;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Vaccinium macrocarpon/adverse effects*;Warfarin/pharmacokinetics*
19572422;Adult;Aged;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacology;Anti-HIV Agents/therapeutic use;Child;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Fasting;Female;Food-Drug Interactions;Glucuronosyltransferase/genetics;Glucuronosyltransferase/metabolism;HIV Infections/drug therapy*;HIV Integrase Inhibitors/administration & dosage;HIV Integrase Inhibitors/adverse effects;HIV Integrase Inhibitors/pharmacokinetics;HIV Integrase Inhibitors/pharmacology*;HIV Integrase Inhibitors/therapeutic use;Humans;Inactivation, Metabolic;Intestinal Absorption;Male;Microsomes, Liver/enzymology;Polypharmacy;Pregnancy;Pregnancy Complications, Infectious/drug therapy;Pyrrolidinones/administration & dosage;Pyrrolidinones/adverse effects;Pyrrolidinones/pharmacokinetics;Pyrrolidinones/pharmacology*;Pyrrolidinones/therapeutic use;Raltegravir Potassium
19585717;Arrhythmias, Cardiac/chemically induced*;Clinical Trials as Topic;Drug Approval;Drug Interactions;Exercise Tolerance/drug effects;Food-Drug Interactions;France;Humans;Intermittent Claudication/drug therapy*;Mortality;Pentoxifylline/administration & dosage;Pentoxifylline/adverse effects;Pentoxifylline/therapeutic use;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/therapeutic use;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use;Randomized Controlled Trials as Topic;Risk;Tetrazoles/administration & dosage;Tetrazoles/adverse effects*;Tetrazoles/therapeutic use;Walking
19591515;Administration, Oral;Adolescent;Adult;Clozapine/administration & dosage;Clozapine/adverse effects;Clozapine/pharmacokinetics*;Cross-Over Studies;Fasting;Food-Drug Interactions*;Humans;Male;Middle Aged
19601724;Animals;Anti-Allergic Agents*/administration & dosage;Anti-Allergic Agents*/adverse effects;Anti-Allergic Agents*/pharmacokinetics;Anti-Allergic Agents*/therapeutic use;Carrier Proteins/metabolism;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Diet*;Dose-Response Relationship, Drug;Drug Interactions*;Drug Therapy, Combination;Food-Drug Interactions;Humans;Models, Biological
19617468;Administration, Oral;Antifungal Agents/administration & dosage*;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics;Area Under Curve;Drug Administration Schedule;Food-Drug Interactions;Gastric Mucosa/metabolism;Humans;Mycoses/drug therapy*;Triazoles/administration & dosage*;Triazoles/adverse effects;Triazoles/blood;Triazoles/pharmacokinetics
19637955;Anticoagulants/pharmacokinetics*;Female;Food-Drug Interactions*;Fruit/adverse effects*;Humans;Middle Aged;Punicaceae/adverse effects*;Venous Thrombosis/drug therapy;Warfarin/pharmacokinetics*
19646718;Adult;Atrial Fibrillation/chemically induced;Autoimmune Diseases/epidemiology;Comorbidity;Contraindications;Dose-Response Relationship, Drug;Drug Interactions;Estrogens/pharmacokinetics;Estrogens/physiology;Female;Food-Drug Interactions;Gastritis/epidemiology;Heart Diseases/epidemiology;Hormone Replacement Therapy*;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy*;Intestinal Absorption/drug effects;Male;Middle Aged;Osteoporosis/chemically induced;Pregnancy;Pregnancy Complications/epidemiology;Thyrotropin/blood;Thyroxine/administration & dosage;Thyroxine/adverse effects;Thyroxine/blood;Thyroxine/pharmacokinetics;Thyroxine/therapeutic use*
19663519;Adolescent;Adult;Age Factors;Aged;Dosage Forms;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Evaluation;Electrocardiography/drug effects;Female;Food-Drug Interactions;Glycation End Products, Advanced/antagonists & inhibitors*;Humans;Male;Middle Aged;Pyridinium Compounds/administration & dosage*;Pyridinium Compounds/adverse effects;Pyridinium Compounds/pharmacokinetics;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics;Therapeutic Equivalency
19667002;Drug Incompatibility;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/administration & dosage*;Practice Guidelines as Topic
19728565;Adolescent;Adult;Amodiaquine/administration & dosage;Amodiaquine/adverse effects;Amodiaquine/pharmacokinetics*;Antimalarials/administration & dosage;Antimalarials/adverse effects;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/administration & dosage;Artemisinins/adverse effects;Artemisinins/pharmacokinetics*;Biological Availability;Cross-Over Studies;Drug Combinations;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Spectrometry, Mass, Electrospray Ionization;Young Adult
19766437;Absorption;Anticoagulants/adverse effects*;Anticoagulants/metabolism*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism*;Drug Overdose;Female;Food-Drug Interactions;Humans;Middle Aged;Phenindione/adverse effects;Phenindione/analogs & derivatives*;Phenindione/metabolism;Severity of Illness Index;Vitamin K/antagonists & inhibitors*
19779132;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;Adrenergic beta-1 Receptor Antagonists;Adrenergic beta-Antagonists/pharmacokinetics*;Animals;Beverages*/adverse effects;Biological Transport/drug effects;Cell Culture Techniques;Cell Membrane Permeability/drug effects;Citrus paradisi/chemistry*;Dose-Response Relationship, Drug;Flavanones/adverse effects;Flavanones/isolation & purification;Food-Drug Interactions*;Humans;Intestinal Absorption*;LLC-PK1 Cells;Oocytes/metabolism;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/biosynthesis;Propanolamines/pharmacokinetics*;Rats;Rats, Wistar;Species Specificity;Swine;Transfection;Xenopus laevis
19823793;Age Factors;Aged;Aged, 80 and over;Cytochrome P-450 Enzyme System/physiology;Diagnosis, Differential;Drug Interactions/physiology*;Drug Therapy, Combination/adverse effects*;Drug Tolerance/physiology;Drug-Related Side Effects and Adverse Reactions/diagnosis;Drug-Related Side Effects and Adverse Reactions/etiology*;Drug-Related Side Effects and Adverse Reactions/physiopathology;Food-Drug Interactions;Geriatrics*;Herb-Drug Interactions;Humans;Isoenzymes/physiology;Metabolic Clearance Rate/physiology;Pharmacokinetics*;Polypharmacy*
19881206;Administration, Oral;Angiotensin-Converting Enzyme Inhibitors/administration & dosage;Angiotensin-Converting Enzyme Inhibitors/metabolism;Antineoplastic Agents, Phytogenic/administration & dosage;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/metabolism;Benzimidazoles/administration & dosage;Benzimidazoles/metabolism;Benzoates/administration & dosage;Benzoates/metabolism;Camptothecin/administration & dosage;Camptothecin/adverse effects;Camptothecin/analogs & derivatives;Camptothecin/metabolism;Coumaric Acids;Cyclohexanes/administration & dosage;Cyclohexanes/metabolism*;Drug Interactions;Flavonoids;Food-Drug Interactions;Functional Food;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/metabolism*;Intestinal Absorption*;Monocarboxylic Acid Transporters/physiology;Phenols;Phenylalanine/administration & dosage;Phenylalanine/analogs & derivatives*;Phenylalanine/metabolism;Polyphenols
19922894;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Capsules;Chromatography, High Pressure Liquid;Cross-Over Studies;Diclofenac/administration & dosage;Diclofenac/adverse effects;Diclofenac/pharmacokinetics*;Female;Food-Drug Interactions;Gelatin;Humans;Intestinal Absorption;Male;Young Adult
9205821;Administration, Oral;Adult;Analysis of Variance;Area Under Curve;Biological Availability;Blood Cell Count/drug effects;Blood Chemical Analysis;Blood Pressure/drug effects;Body Temperature/drug effects;Chromatography, Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Electrocardiography/drug effects;Endopeptidases/metabolism;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/urine;Food-Drug Interactions;Heart Rate/drug effects;Humans;Japan;Male;Mass Spectrometry;Pilot Projects;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/blood;Pyrrolidines/pharmacokinetics*;Pyrrolidines/urine
19925488;Adult;Anaphylaxis/etiology*;Anaphylaxis/immunology;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Aspirin/adverse effects*;Exercise*;Female;Food-Drug Interactions;Humans;Immunoglobulin E/analysis;Male;Skin Tests;Wheat Hypersensitivity/complications*;Wheat Hypersensitivity/immunology
19948946;Adolescent;Adult;Aged;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Beverages;Citrus paradisi*;Cross-Over Studies;Food-Drug Interactions*;Fusion Proteins, bcr-abl/metabolism;Headache/chemically induced;Humans;Male;Middle Aged;Protein-Tyrosine Kinases/metabolism;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Vomiting/chemically induced;Young Adult
20001610;Anti-HIV Agents/chemistry;Anti-HIV Agents/therapeutic use*;Benzoxazines/adverse effects;Benzoxazines/chemistry;Benzoxazines/metabolism;Benzoxazines/pharmacokinetics;Benzoxazines/therapeutic use*;Chemistry, Pharmaceutical;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/virology;HIV-1;Humans;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/chemistry;Reverse Transcriptase Inhibitors/metabolism;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use*
20014671;Alcoholic Beverages/adverse effects;Calcium, Dietary/adverse effects;Citrus paradisi/adverse effects;Dietary Fiber/adverse effects;Dietary Proteins/adverse effects;Drug Prescriptions/nursing;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Nurse Practitioners/organization & administration*;Patient Education as Topic/organization & administration;Safety Management;Vitamin K/adverse effects
20028328;Animals;Cardiovascular Diseases/prevention & control*;Dietary Fiber;Dietary Supplements*;Fatty Acids/pharmacology;Food-Drug Interactions;Herb-Drug Interactions;Humans;Salvia*/chemistry;Seeds/chemistry;alpha-Linolenic Acid/pharmacology
20029019;Anticoagulants/therapeutic use*;Female;Food-Drug Interactions*;Fruit/adverse effects*;Hematoma/diagnosis;Hematoma/etiology*;Humans;International Normalized Ratio;Middle Aged;Punicaceae/adverse effects*;Warfarin/therapeutic use*
20040339;Administration, Oral;Adult;Area Under Curve;Cimetidine/pharmacokinetics;Cimetidine/pharmacology;Cross-Over Studies;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Drug Interactions;Female;Food-Drug Interactions*;Histamine H2 Antagonists/pharmacokinetics;Histamine H2 Antagonists/pharmacology;Humans;Hypoglycemic Agents/pharmacology;Male;Metformin/pharmacokinetics;Metformin/pharmacology;Middle Aged;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Uracil/adverse effects;Uracil/analogs & derivatives*;Uracil/pharmacokinetics;Young Adult
20044363;Dosage Forms;Drug Incompatibility;Enteral Nutrition/adverse effects*;Enteral Nutrition/methods*;Food-Drug Interactions;Humans;Practice Guidelines as Topic*;Prescription Drugs*
20053516;Animals;Anti-Infective Agents/chemistry*;Anti-Infective Agents/metabolism;Biological Availability;Calcium/chemistry;Caseins/chemistry;Chromatography, High Pressure Liquid;Ciprofloxacin/chemistry*;Ciprofloxacin/metabolism;Food-Drug Interactions*;Hydrogen-Ion Concentration;Kinetics;Lipids/chemistry;Milk/adverse effects*;Reproducibility of Results;Solid Phase Extraction;Solubility;Spectrometry, Mass, Electrospray Ionization;Tablets
20065263;Antioxidants/administration & dosage;Antioxidants/adverse effects*;Arecaceae/chemistry*;Beverages/adverse effects*;Blood Coagulation/drug effects;Fatty Acids/adverse effects;Food-Drug Interactions*;Fruit/chemistry*;Humans;United States;Vitamin K/adverse effects;Warfarin/administration & dosage;Warfarin/adverse effects*
9211455;Biological Availability;Diet;Enteral Nutrition/adverse effects;Enteral Nutrition/nursing*;Food-Drug Interactions*;Gastric Emptying/physiology;Humans;Intubation, Gastrointestinal;Sorbitol/adverse effects
20081065;Administration, Oral;Adolescent;Adult;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics*;Area Under Curve;Bleeding Time;Dose-Response Relationship, Drug;Factor Xa/metabolism;Factor Xa Inhibitors*;Food-Drug Interactions;Half-Life;Humans;International Normalized Ratio;Male;Middle Aged;Partial Thromboplastin Time;Prothrombin Time;Pyridines/adverse effects*;Pyridines/pharmacokinetics*;Single-Blind Method;Tablets;Thiazoles/adverse effects*;Thiazoles/pharmacokinetics*;Young Adult
20110012;Adolescent;Adult;Antiparkinson Agents/administration & dosage*;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Benzothiazoles/administration & dosage*;Benzothiazoles/adverse effects;Benzothiazoles/pharmacokinetics*;Biological Availability;Body Mass Index;Chemistry, Pharmaceutical;Delayed-Action Preparations;Dietary Fats;Food-Drug Interactions;Humans;Male;Reproducibility of Results;Young Adult
20137764;Adult;Amines/pharmacokinetics;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Carbamates/adverse effects;Carbamates/pharmacokinetics*;Cross-Over Studies;Cyclohexanecarboxylic Acids/pharmacokinetics;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Prodrugs;Young Adult;gamma-Aminobutyric Acid/adverse effects;gamma-Aminobutyric Acid/analogs & derivatives*;gamma-Aminobutyric Acid/pharmacokinetics
20137768;Adolescent;Adult;Area Under Curve;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Chromatography, Liquid/methods;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Humans;Male;Nifedipine/administration & dosage;Nifedipine/adverse effects;Nifedipine/pharmacokinetics*;Osmosis;Tablets;Tandem Mass Spectrometry/methods;Therapeutic Equivalency;Young Adult
20197487;Administration, Oral;Adult;Antimalarials/administration & dosage;Antimalarials/adverse effects;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/administration & dosage;Artemisinins/adverse effects;Artemisinins/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;Male;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects;Naphthoquinones/pharmacokinetics*;Tablets;Tandem Mass Spectrometry;Young Adult
20374180;Amlodipine/administration & dosage*;Amlodipine/blood*;Beverages/adverse effects;Blood Pressure/drug effects;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/blood*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Hypertension/blood;Hypertension/drug therapy*;Hypertension/physiopathology;Japan;Male;Middle Aged;Nifedipine/administration & dosage*;Nifedipine/blood*
20400647;Adult;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/chemistry;Antifungal Agents/pharmacokinetics*;Ascorbic Acid/administration & dosage*;Beverages/analysis*;Biological Availability;Biotransformation;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Humans;Itraconazole/adverse effects;Itraconazole/analogs & derivatives*;Itraconazole/blood;Itraconazole/chemistry;Itraconazole/pharmacokinetics*;Male;Miconazole/blood;Miconazole/chemistry;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry;Young Adult
20432867;Animals;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Bacteria/metabolism;Bifidobacterium;Drug Interactions;Food-Drug Interactions;Humans;Intestines/metabolism;Intestines/microbiology;Lactobacillus rhamnosus;Probiotics/administration & dosage*;Probiotics/adverse effects;Vitamin K/biosynthesis;Vitamin K/metabolism;Warfarin/administration & dosage*
20457501;Animals;Anti-Infective Agents/pharmacokinetics*;Biological Availability;Caseins/metabolism*;Cattle;Ciprofloxacin/chemistry;Ciprofloxacin/pharmacokinetics*;Food-Drug Interactions*;Milk/adverse effects*;Solubility;Tablets
20457591;Adolescent;Adult;Cross-Over Studies;Dietary Fats/administration & dosage*;Female;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Integrase Inhibitors/adverse effects;HIV Integrase Inhibitors/blood;HIV Integrase Inhibitors/pharmacokinetics*;Humans;Male;Middle Aged;Pyrrolidinones/adverse effects;Pyrrolidinones/blood;Pyrrolidinones/pharmacokinetics*;Raltegravir Potassium;Young Adult
9220063;Anaphylaxis/diagnosis;Animals;Antitubercular Agents/adverse effects*;Diagnosis, Differential;Food-Drug Interactions*;Foodborne Diseases/diagnosis*;Foodborne Diseases/etiology;Humans;Isoniazid/adverse effects*;Tuna*
20481649;Animals;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Antifungal Agents/pharmacology;Area Under Curve;Biological Availability;Drug Interactions;Drug Resistance, Fungal;Food-Drug Interactions;Fungi/drug effects;Humans;Mycoses/drug therapy*;Mycoses/microbiology;Triazoles/adverse effects;Triazoles/pharmacokinetics*;Triazoles/pharmacology
20484610;Adult;Amines/administration & dosage;Amines/adverse effects;Amines/blood;Amines/pharmacokinetics*;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/adverse effects;Analgesics, Non-Narcotic/blood;Analgesics, Non-Narcotic/pharmacokinetics;Anticonvulsants/administration & dosage;Anticonvulsants/adverse effects;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Cross-Over Studies;Cyclohexanecarboxylic Acids/administration & dosage;Cyclohexanecarboxylic Acids/adverse effects;Cyclohexanecarboxylic Acids/blood;Cyclohexanecarboxylic Acids/pharmacokinetics*;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/adverse effects;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/administration & dosage*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Gastric Emptying/drug effects;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Stomach/metabolism*;Young Adult;gamma-Aminobutyric Acid/administration & dosage;gamma-Aminobutyric Acid/adverse effects;gamma-Aminobutyric Acid/blood;gamma-Aminobutyric Acid/pharmacokinetics*
20509982;Appetite/drug effects;Dietary Supplements;Drug Monitoring;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Nutritional Status
20512335;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Beverages/adverse effects;Biological Availability;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Drug Labeling;Female;Food-Drug Interactions*;Humans;Indoles/administration & dosage;Indoles/pharmacokinetics*;Male;Midazolam/metabolism;Middle Aged;Neoplasms/drug therapy;Neoplasms/pathology;Pyrroles/administration & dosage;Pyrroles/pharmacokinetics*
20520305;Fabaceae/adverse effects*;Fabaceae/metabolism;Food-Drug Interactions/physiology*;Humans;Hypertension/chemically induced;Hypertension/metabolism;Levodopa/adverse effects;Levodopa/metabolism;Tyramine/adverse effects;Tyramine/metabolism
20529767;Antineoplastic Agents/therapeutic use;Benzamides;Drug Eruptions/prevention & control;Drug Interactions;Drug Resistance, Neoplasm;Erythropoietin/therapeutic use;Fertility/drug effects;Food-Drug Interactions;France;Granulocyte Colony-Stimulating Factor/therapeutic use;Heart Diseases/chemically induced;Heart Diseases/prevention & control;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy*;Metabolic Diseases/chemically induced;Metabolic Diseases/prevention & control;Neutropenia/chemically induced;Neutropenia/prevention & control;Piperazines/therapeutic use;Protein Kinase Inhibitors/adverse effects*;Protein-Tyrosine Kinases/antagonists & inhibitors;Pyrimidines/adverse effects*;Pyrimidines/therapeutic use;Recombinant Proteins
20534818;Administration, Oral;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Anticoagulants/urine;Area Under Curve;Asian Continental Ancestry Group;Blood Coagulation/drug effects*;Body Mass Index;Chromatography, Liquid;Cross-Over Studies;Dietary Fats*;European Continental Ancestry Group;Factor Xa Inhibitors*;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Models, Biological;Partial Thromboplastin Time;Prothrombin Time;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/blood;Pyridines/pharmacokinetics*;Pyridines/urine;Tandem Mass Spectrometry;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/blood;Thiazoles/pharmacokinetics*;Thiazoles/urine;Young Adult
20584229;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Anticoagulants/metabolism;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects*;Benzimidazoles/metabolism;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Dabigatran;Drug Interactions;Food-Drug Interactions;Humans;Morpholines/administration & dosage;Morpholines/adverse effects*;Morpholines/metabolism;Pyrazoles/administration & dosage;Pyrazoles/adverse effects*;Pyrazoles/metabolism;Pyridones/administration & dosage;Pyridones/adverse effects*;Pyridones/metabolism;Rivaroxaban;Thiophenes/administration & dosage;Thiophenes/adverse effects*;Thiophenes/metabolism;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*;beta-Alanine/metabolism
20628041;Antiparkinson Agents/adverse effects*;Carbidopa/administration & dosage;Drug Therapy, Combination;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Intensive Care Units;Length of Stay;Levodopa/adverse effects*;Male;Middle Aged;Neuroleptic Malignant Syndrome/etiology*;Parkinson Disease/drug therapy
20630973;Aged;Anticoagulants/adverse effects*;Brassica/adverse effects*;Diet/adverse effects;Dyspnea/chemically induced;Female;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans;International Normalized Ratio;Pulmonary Embolism/drug therapy;Recurrence;Vitamin K Deficiency/etiology*;Warfarin/adverse effects*
9274239;Adolescent;Adult;Age Factors;Aged;Calcium Compounds/therapeutic use*;Calcium, Dietary/administration & dosage*;Calcium, Dietary/adverse effects;Child;Child, Preschool;Female;Food, Fortified*;Food-Drug Interactions;Humans;Infant;Infant, Newborn;Male;Middle Aged;Nutritional Requirements*;Pregnancy;Sex Factors
20642557;Aged;Aged, 80 and over;Anticoagulants/pharmacology*;Anticoagulants/therapeutic use;Cardiovascular Diseases/drug therapy*;Food-Drug Interactions*;Humans;Male;Middle Aged;Prospective Studies;Prothrombin Time*;Vaccinium macrocarpon/adverse effects*;Warfarin/pharmacology*;Warfarin/therapeutic use
20652662;Adult;Cheese/adverse effects*;Chest Pain/drug therapy;Chest Pain/etiology;Chest Pain/physiopathology;Electrocardiography;Female;Food-Drug Interactions*;Heart/drug effects;Heart/physiopathology;Humans;Injections, Intravenous;Monoamine Oxidase Inhibitors/adverse effects*;Morphine/therapeutic use;Myocardial Infarction/blood;Myocardial Infarction/chemically induced*;Myocardial Infarction/physiopathology;Nitroprusside/therapeutic use;Phenelzine/adverse effects*;Treatment Outcome;Troponin I/blood;Vasodilator Agents/therapeutic use
20653361;Animals;Antifungal Agents/therapeutic use*;Azoles/therapeutic use*;Disease Management;Drug Interactions*/physiology;Food-Drug Interactions*/physiology;Humans;Mycoses/drug therapy*;Mycoses/etiology;Transplantation*/adverse effects
20694287;Dietary Fiber*;Food-Drug Interactions*;Humans
20852003;Acetamides/adverse effects;Acetamides/blood;Acetamides/pharmacokinetics*;Acetamides/therapeutic use;Adult;Biological Availability;Capsules;Cross-Over Studies;Food-Drug Interactions;Half-Life;Humans;Hypnotics and Sedatives/adverse effects;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/pharmacokinetics*;Hypnotics and Sedatives/therapeutic use;Isoquinolines/adverse effects;Isoquinolines/blood;Isoquinolines/pharmacokinetics*;Isoquinolines/therapeutic use;Male;Orexin Receptors;Reaction Time/drug effects;Receptors, G-Protein-Coupled/antagonists & inhibitors*;Receptors, Neuropeptide/antagonists & inhibitors*;Tablets;Task Performance and Analysis;Therapeutic Equivalency;Wakefulness/drug effects;Young Adult
20864621;Administration, Oral;Adolescent;Adult;Biotransformation;Cytochrome P-450 CYP2D6/metabolism;Dizziness/chemically induced;Double-Blind Method;Drug Administration Schedule;Electrocardiography;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/urine;Female;Food-Drug Interactions*;Glucosyltransferases/antagonists & inhibitors*;Heart Rate/drug effects;Humans;Intestinal Absorption;Male;Models, Biological;Nausea/chemically induced;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/blood;Pyrrolidines/pharmacokinetics*;Pyrrolidines/urine;Vomiting/chemically induced;Young Adult
20869315;Antacids/adverse effects;Anti-Infective Agents/adverse effects;Anticonvulsants/adverse effects;Antiemetics/adverse effects;Antineoplastic Agents/adverse effects;Child;Complementary Therapies/adverse effects;Drug Interactions*;Food-Drug Interactions;Humans;Neoplasms/drug therapy*
20926751;Adenosine A1 Receptor Antagonists/administration & dosage;Adenosine A1 Receptor Antagonists/adverse effects;Adenosine A1 Receptor Antagonists/blood;Adenosine A1 Receptor Antagonists/pharmacokinetics*;Administration, Oral;Adolescent;Adult;Aged;Biological Availability;Cross-Over Studies;Diuretics/administration & dosage;Diuretics/adverse effects;Diuretics/blood;Diuretics/pharmacokinetics*;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Sex Characteristics;Xanthines/administration & dosage;Xanthines/adverse effects;Xanthines/blood;Xanthines/pharmacokinetics*;Young Adult
20928982;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/history*;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use;Drug Interactions;Drug Monitoring;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/drug therapy;History, 20th Century;History, 21st Century;Humans;International Normalized Ratio;Mixed Function Oxygenases/antagonists & inhibitors;Patient Education as Topic;Thrombophilia/drug therapy;Thrombosis/prevention & control;Vitamin K/metabolism;Vitamin K/therapeutic use;Vitamin K Epoxide Reductases;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/history*;Warfarin/pharmacokinetics;Warfarin/therapeutic use
20959524;Adult;Benzothiazoles/administration & dosage;Benzothiazoles/adverse effects*;Benzothiazoles/analysis;Benzothiazoles/pharmacokinetics*;Dopamine Agonists/administration & dosage;Dopamine Agonists/adverse effects*;Dopamine Agonists/analysis;Dopamine Agonists/pharmacokinetics*;Dose-Response Relationship, Drug;Double-Blind Method;Drugs, Investigational/administration & dosage;Drugs, Investigational/adverse effects*;Drugs, Investigational/analysis;Drugs, Investigational/pharmacokinetics*;Female;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Male;Metabolic Clearance Rate;Middle Aged;Plasma/chemistry;Urine/chemistry
20970282;Aged, 80 and over;Amiodarone/adverse effects*;Arrhythmias, Cardiac/chemically induced;Arrhythmias, Cardiac/therapy;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Electric Countershock;Electrocardiography;Emergency Service, Hospital;Female;Food-Drug Interactions*;Humans;Torsades de Pointes/chemically induced;Torsades de Pointes/therapy
20980999;Administration, Oral;Adult;Aged;Cohort Studies;Cross-Over Studies;Dietary Fats/metabolism*;Fatigue/chemically induced;Female;Food-Drug Interactions/physiology*;Humans;Hypertension/chemically induced;Male;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism*;Pyrimidines/administration & dosage;Pyrimidines/adverse effects*;Pyrimidines/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects*;Sulfonamides/pharmacokinetics*
21038340;Aryl Hydrocarbon Hydroxylases/chemistry*;Aryl Hydrocarbon Hydroxylases/metabolism;Binding Sites;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP2D6/chemistry*;Cytochrome P-450 CYP2D6/metabolism;Humans;Molecular Dynamics Simulation;Protein Binding;Protein Structure, Tertiary;Quantitative Structure-Activity Relationship;Small Molecule Libraries/chemical synthesis;Small Molecule Libraries/chemistry*;Small Molecule Libraries/toxicity
21085830;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics;Antitubercular Agents/therapeutic use*;Brazil;Chemical and Drug Induced Liver Injury;Drug Interactions;Female;Food-Drug Interactions;Humans;Pregnancy;Risk Factors;Tuberculosis/drug therapy*;Tuberculosis/metabolism
21085831;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics;Antitubercular Agents/therapeutic use*;Drug Interactions;Female;Food-Drug Interactions;Humans;Pregnancy;Pregnancy Complications/drug therapy;Tuberculosis/drug therapy*;Tuberculosis, Multidrug-Resistant/drug therapy
21098692;Adult;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical/methods;Confidence Intervals;Cross-Over Studies;Delayed-Action Preparations;Diet, High-Fat*;Fasting;Female;Food-Drug Interactions*;Humans;Hydromorphone/administration & dosage*;Hydromorphone/adverse effects;Hydromorphone/chemistry;Hydromorphone/pharmacokinetics*;Male;Naltrexone/administration & dosage;Therapeutic Equivalency
21120480;Adult;Aged;Area Under Curve;Cross-Over Studies;Dose-Response Relationship, Drug;Electrocardiography/drug effects;Fasting/metabolism;Female;Food-Drug Interactions;Humans;Magnetic Resonance Imaging;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/pathology;Quinazolines/adverse effects;Quinazolines/pharmacokinetics*;Quinazolines/therapeutic use*;Tomography, X-Ray Computed;Treatment Outcome;Young Adult
21124269;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Antioxidants/administration & dosage*;Antioxidants/adverse effects;Beverages/adverse effects*;Food-Drug Interactions*;Gastrointestinal Hemorrhage/etiology;Gastrointestinal Hemorrhage/prevention & control;Health Knowledge, Attitudes, Practice;Humans;Vaccinium macrocarpon*;Warfarin/administration & dosage*;Warfarin/adverse effects
21125816;Administration, Oral;Adult;Antiviral Agents/administration & dosage;Antiviral Agents/adverse effects;Antiviral Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Calibration;Chromatography, High Pressure Liquid;Cross-Over Studies;Fasting/metabolism;Female;Food-Drug Interactions;Ganciclovir/pharmacokinetics;Guanine/administration & dosage;Guanine/adverse effects;Guanine/analogs & derivatives*;Guanine/pharmacokinetics;Humans;Male;Mass Spectrometry;Reproducibility of Results;Tablets;Young Adult
21142260;Animals;Beverages;Biological Availability;Citrus paradisi/chemistry*;Cytochrome P-450 Enzyme System/adverse effects;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*
9333047;Adolescent;Adult;Anti-Infective Agents/adverse effects;Anti-Infective Agents/pharmacokinetics*;Anti-Ulcer Agents/pharmacology*;Area Under Curve;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;Half-Life;Humans;Levofloxacin*;Male;Ofloxacin/adverse effects;Ofloxacin/pharmacokinetics*;Reference Values;Spectrophotometry, Ultraviolet;Sucralfate/pharmacology*
21147941;Administration, Cutaneous;Antidepressive Agents/adverse effects*;Antidepressive Agents/therapeutic use;Blood Pressure/drug effects*;Cheese;Depressive Disorder, Major/drug therapy;Feeding Behavior;Food-Drug Interactions;Humans;Hypertension/chemically induced*;Hypertension/prevention & control;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Myocardium;Risk Factors;Selegiline/adverse effects;Selegiline/pharmacokinetics;Selegiline/therapeutic use*;Tyramine
21162177;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/metabolism*;Beverages/adverse effects;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism;Food-Drug Interactions*;Fruit;Health Knowledge, Attitudes, Practice*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism*;Patient Education as Topic
21163558;Antioxidants/analysis;Combined Modality Therapy;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/diet therapy*;Diabetes Mellitus, Type 2/drug therapy*;Diabetes Mellitus, Type 2/enzymology;Dyslipidemias/prevention & control;Female;Food-Drug Interactions*;Glyburide/adverse effects;Glyburide/therapeutic use*;Glycated Hemoglobin A/analysis;Humans;Hyperglycemia/prevention & control;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/therapeutic use*;Male;Middle Aged;Oxidoreductases/blood;Sesame Oil/adverse effects;Sesame Oil/therapeutic use*;Severity of Illness Index
21185864;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Atrial Fibrillation/complications;Atrial Fibrillation/drug therapy*;Clinical Trials as Topic;Food-Drug Interactions;Heparin, Low-Molecular-Weight/therapeutic use*;Humans;Thromboembolism/drug therapy*;Thromboembolism/etiology;Thromboembolism/prevention & control;Venous Thrombosis/complications;Venous Thrombosis/drug therapy*;Venous Thrombosis/prevention & control;Warfarin/therapeutic use
21194458;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Critical Care*;Drug Monitoring;Food-Drug Interactions;Humans;Hypoalbuminemia/drug therapy;Hypoalbuminemia/therapy;Parenteral Nutrition*/adverse effects
21235125;Anti-Allergic Agents/pharmacokinetics;Anti-Anxiety Agents/pharmacokinetics;Anti-Bacterial Agents/pharmacokinetics;Antimalarials/pharmacokinetics;Beverages/adverse effects*;Biological Availability;Calcium Channel Blockers/pharmacokinetics;Citrus paradisi/adverse effects*;Food-Drug Interactions*;HIV Protease Inhibitors/pharmacokinetics;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Risk Factors
21248612;Administration, Oral;Adolescent;Adult;Antifibrinolytic Agents/administration & dosage;Antifibrinolytic Agents/adverse effects;Antifibrinolytic Agents/therapeutic use*;Delayed-Action Preparations;Diet, High-Fat*;Fasting;Female;Food-Drug Interactions;Humans;Menorrhagia/drug therapy*;Middle Aged;Tablets;Time Factors;Tranexamic Acid/administration & dosage;Tranexamic Acid/adverse effects;Tranexamic Acid/therapeutic use;Treatment Outcome;Young Adult
21254874;Animals;Beverages*/adverse effects;Beverages*/analysis;Citrus paradisi*/adverse effects;Citrus paradisi*/chemistry;Food-Drug Interactions*;Humans;Pharmacokinetics*
21257798;Adolescent;Adult;Area Under Curve;Biological Availability;Double-Blind Method;Female;Food-Drug Interactions;Humans;Janus Kinases/antagonists & inhibitors;Male;Middle Aged;Neutropenia/chemically induced;Pyrazoles/adverse effects;Pyrazoles/pharmacokinetics*;Pyrazoles/pharmacology*;STAT3 Transcription Factor/blood;Young Adult
21268318;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice*;Humans;Patient Education as Topic;Rhabdomyolysis/chemically induced;Rhabdomyolysis/prevention & control*;Simvastatin/administration & dosage;Simvastatin/adverse effects*
21298205;Anti-Arrhythmia Agents/adverse effects;Anti-Arrhythmia Agents/pharmacokinetics;Anti-Arrhythmia Agents/therapeutic use*;Beverages*;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/metabolism;Citrus paradisi*;Food-Drug Interactions;Humans
21301274;Beverages/adverse effects*;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Vaccinium macrocarpon*;Warfarin/adverse effects*
21359645;Administration, Oral;Anticoagulants*/adverse effects;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Food/adverse effects*;Food-Drug Interactions*;Humans;Warfarin*/adverse effects;Warfarin*/pharmacokinetics;Warfarin*/therapeutic use
21422239;Administration, Oral;Adolescent;Adult;Biological Availability;Blood Cell Count;Butyrates/administration & dosage;Butyrates/adverse effects*;Butyrates/analysis;Butyrates/pharmacokinetics*;Dose-Response Relationship, Drug;Double-Blind Method;Drugs, Investigational/administration & dosage;Drugs, Investigational/adverse effects*;Drugs, Investigational/analysis;Drugs, Investigational/pharmacokinetics*;Female;Fetal Hemoglobin/analysis;Food-Drug Interactions;Half-Life;Hematinics/administration & dosage;Hematinics/adverse effects*;Hematinics/analysis;Hematinics/pharmacokinetics*;Humans;Male;Metabolic Clearance Rate;Plasma/chemistry;Reticulocytes/drug effects;Urine/chemistry;Young Adult
21432599;Attention Deficit Disorder with Hyperactivity/diagnosis;Attention Deficit Disorder with Hyperactivity/drug therapy*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/therapeutic use*;Child;Cross-Over Studies;Delayed-Action Preparations/adverse effects;Delayed-Action Preparations/therapeutic use*;Female;Food Deprivation;Food-Drug Interactions*;Humans;Male;Methylphenidate/administration & dosage;Methylphenidate/adverse effects;Methylphenidate/therapeutic use*;Single-Blind Method
21443600;Administration, Oral;Adolescent;Adult;Biological Availability;Cross-Over Studies;Dermatologic Agents/administration & dosage;Dermatologic Agents/adverse effects;Dermatologic Agents/blood*;Fasting/blood;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Tretinoin/administration & dosage;Tretinoin/adverse effects;Tretinoin/blood*;Young Adult
21453201;Animals;Clinical Trials as Topic/methods;Drug Interactions/physiology;Drug-Related Side Effects and Adverse Reactions/chemically induced*;Drug-Related Side Effects and Adverse Reactions/metabolism;Drug-Related Side Effects and Adverse Reactions/prevention & control;Food-Drug Interactions/physiology;Humans;Indans/adverse effects;Indans/pharmacokinetics;Indans/therapeutic use*;Parkinson Disease/drug therapy*;Parkinson Disease/metabolism;Serotonin Agents/adverse effects;Serotonin Agents/pharmacokinetics;Serotonin Agents/therapeutic use;Treatment Outcome
21474406;Administration, Oral;Aged;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Food-Drug Interactions;Hospital Units*;Humans;Inpatients/psychology*;International Normalized Ratio;Knowledge;Middle Aged;Patient Education as Topic*;Physical and Rehabilitation Medicine*;Prospective Studies;Rehabilitation*;Self Medication;Surveys and Questionnaires;Vitamin K/antagonists & inhibitors
2642594;Anti-Bacterial Agents/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Antineoplastic Agents/pharmacokinetics;Cardiovascular Agents/pharmacokinetics;Food/adverse effects*;Humans;Intestinal Absorption;Pharmacokinetics*
21501216;Aged;Analysis of Variance;Anticholesteremic Agents/blood*;Anticholesteremic Agents/therapeutic use;Atorvastatin Calcium;Beverages*;Citrus paradisi/metabolism*;Cohort Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Heptanoic Acids/blood*;Heptanoic Acids/therapeutic use;Humans;Lipid Metabolism/drug effects;Lipid Metabolism Disorders/blood;Lipid Metabolism Disorders/drug therapy*;Male;Middle Aged;Pyrroles/blood*;Pyrroles/therapeutic use;Time Factors
21508758;Dietary Supplements*/adverse effects;Female;Food-Drug Interactions;Herb-Drug Interactions;Humans;Legislation, Food;Physician-Patient Relations;Plant Preparations/adverse effects;United States
21515596;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Atrial Fibrillation/epidemiology*;Cardiology/standards*;Europe;Hemorrhage/chemically induced;Hemorrhage/epidemiology*;Humans;Risk Factors;Societies, Medical/standards;Stroke/epidemiology;Stroke/prevention & control;Thrombosis/epidemiology*;Thrombosis/prevention & control
21517925;Administration, Oral;Adult;Asian Continental Ancestry Group;China;Chromatography, Liquid/methods*;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Half-Life;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Isoindoles/administration & dosage;Isoindoles/adverse effects;Isoindoles/pharmacokinetics*;Male;Tablets;Tandem Mass Spectrometry/methods*;Young Adult
21532276;Administration, Oral;Alendronate/administration & dosage;Alendronate/pharmacokinetics*;Alendronate/urine;Animals;Bone Density Conservation Agents/administration & dosage;Bone Density Conservation Agents/pharmacokinetics*;Bone Density Conservation Agents/urine;Calcium/analysis;Food-Drug Interactions;Male;Mineral Waters/adverse effects*;Mineral Waters/analysis;Rats;Rats, Wistar;Time Factors
21535728;Allyl Compounds/administration & dosage;Allyl Compounds/adverse effects*;Animals;Biological Availability;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Dietary Supplements/adverse effects*;Food-Drug Interactions;Garlic/chemistry;Half-Life;Male;Metabolic Clearance Rate;Nifedipine/blood;Nifedipine/pharmacokinetics*;Plant Extracts/adverse effects;Plant Extracts/chemistry;Plant Roots/chemistry;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/adverse effects*;Random Allocation;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Sulfides/administration & dosage;Sulfides/adverse effects*;Time Factors;Vasodilator Agents/blood;Vasodilator Agents/pharmacokinetics*
21544521;Animal Feed/adverse effects;Animals;Behavior, Animal/drug effects*;Body Temperature/drug effects;Body Weight/drug effects*;Dietary Fats*/administration & dosage;Dietary Fats*/adverse effects;Dopamine Agonists/pharmacology*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Male;Quinpirole/pharmacology*;Rats;Rats, Sprague-Dawley;Receptors, Dopamine/metabolism*;Yawning/drug effects
21545633;Antimetabolites, Antineoplastic;Biological Transport/drug effects;Carbonated Beverages/adverse effects*;Cola/adverse effects*;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Kidney/metabolism;Liver/metabolism;Lymphoma/drug therapy;Lymphoma/urine;Male;Methotrexate/pharmacokinetics*;Methotrexate/therapeutic use;Middle Aged;Urine/chemistry
21548660;Adult;Area Under Curve;Benzopyrans/adverse effects;Benzopyrans/blood;Benzopyrans/metabolism;Benzopyrans/pharmacokinetics*;Biotransformation/physiology;Cross-Over Studies;Dopamine beta-Hydroxylase/antagonists & inhibitors;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/metabolism;Enzyme Inhibitors/pharmacokinetics;Food Deprivation/physiology;Food-Drug Interactions/physiology*;Humans;Imidazoles/adverse effects;Imidazoles/blood;Imidazoles/metabolism;Imidazoles/pharmacokinetics*;Male;Therapeutic Equivalency;Young Adult
21610201;Adolescent;Adult;Area Under Curve;Benzofurans/adverse effects*;Benzofurans/pharmacokinetics;Benzofurans/pharmacology;Blood Glucose/drug effects*;C-Peptide/secretion;Dietary Fats/administration & dosage;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Insulin/secretion;Male;Middle Aged;Receptors, G-Protein-Coupled/agonists*;Sulfones/adverse effects*;Sulfones/pharmacokinetics;Sulfones/pharmacology;Young Adult
9503566;Blood Pressure/drug effects*;Diet*;Food-Drug Interactions*;Humans;Monoamine Oxidase/metabolism;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology*;Substrate Specificity;Tyramine/administration & dosage*;Tyramine/metabolism
21628600;Antiparkinson Agents/adverse effects;Antiparkinson Agents/therapeutic use*;Brain/drug effects*;Brain/enzymology;Dietary Proteins/adverse effects;Dietary Proteins/metabolism*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Hypertension/etiology;Hypertension/prevention & control;Indans/adverse effects;Indans/therapeutic use*;Monoamine Oxidase/metabolism*;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Parkinson Disease/drug therapy*;Parkinson Disease/enzymology;Patient Safety;Risk Assessment;Risk Factors;Treatment Outcome;Tyramine/adverse effects;Tyramine/metabolism*
21682192;ATP Binding Cassette Transporter, Sub-Family B/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages*;Citrus paradisi*;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Flavonoids/adverse effects;Food-Drug Interactions*;Furocoumarins/adverse effects;Humans;Intestinal Absorption/drug effects*;Intestines/metabolism*
21691746;Adolescent;Adult;Aniline Compounds/administration & dosage*;Aniline Compounds/adverse effects;Aniline Compounds/pharmacokinetics;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Chromatography, Liquid;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Nitriles/administration & dosage*;Nitriles/adverse effects;Nitriles/pharmacokinetics;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics;Proto-Oncogene Proteins c-abl/antagonists & inhibitors;Quinolines/administration & dosage*;Quinolines/adverse effects;Quinolines/pharmacokinetics;Tandem Mass Spectrometry;Tissue Distribution;Young Adult;src-Family Kinases/antagonists & inhibitors
21704240;Adult;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cholesterol Ester Transfer Proteins/antagonists & inhibitors;Cross-Over Studies;Dietary Fats/administration & dosage*;Drug Administration Schedule;Food-Drug Interactions*;Humans;Male;Sulfhydryl Compounds/administration & dosage;Sulfhydryl Compounds/adverse effects;Sulfhydryl Compounds/pharmacokinetics*;Time Factors;Young Adult
21704241;Administration, Oral;Adolescent;Adult;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Dietary Fats/administration & dosage;Fasting;Female;Fenofibrate/administration & dosage;Fenofibrate/adverse effects;Fenofibrate/analogs & derivatives*;Fenofibrate/pharmacokinetics;Food-Drug Interactions*;Humans;Male;Prodrugs;Tablets;Therapeutic Equivalency;Young Adult
21705359;Antihypertensive Agents/therapeutic use;Blood Pressure/physiology;Cost-Benefit Analysis;Diet/adverse effects;Diet, Sodium-Restricted/methods;Dose-Response Relationship, Drug;Food-Drug Interactions;Health Promotion/economics;Health Promotion/methods;Heart Failure/etiology*;Heart Failure/physiopathology;Heart Failure/prevention & control;Humans;Hypertension/etiology*;Hypertension/physiopathology;Hypertension/prevention & control;Hypertrophy, Left Ventricular/etiology;Hypertrophy, Left Ventricular/physiopathology;Life Style;Obesity/prevention & control;Risk Factors;Sodium Chloride, Dietary/adverse effects*;Ventricular Dysfunction, Left/etiology;Ventricular Dysfunction, Left/physiopathology;Weight Loss
21715058;Acenocoumarol/adverse effects*;Acenocoumarol/pharmacokinetics;Alcoholic Beverages/adverse effects*;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics;Conjunctival Diseases/etiology*;Cooking*;Dipteryx/adverse effects*;Ethanol/pharmacokinetics;Eye Hemorrhage/etiology*;Flavoring Agents/adverse effects*;Food Labeling;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans;Internet;Legislation, Drug;Patient Education as Topic;Spain;United States;United States Food and Drug Administration;Vitamin K/antagonists & inhibitors;Vomiting/etiology
21720234;Bipolar Disorder/blood*;Bipolar Disorder/drug therapy;Carbonated Beverages/adverse effects*;Cola*/adverse effects;Food-Drug Interactions/physiology*;Humans;Lithium/blood*;Lithium/therapeutic use;Male;Middle Aged
21721019;Animals;Arylsulfotransferase/biosynthesis*;Arylsulfotransferase/genetics;Caffeine/administration & dosage*;Caffeine/adverse effects;Central Nervous System Stimulants/administration & dosage;Enzyme Induction*;Female;Food-Drug Interactions;Intestinal Mucosa/enzymology*;Intestinal Mucosa/metabolism;Intestine, Small/enzymology*;Intestine, Small/metabolism;Liver/enzymology*;Liver/metabolism;Male;Organ Specificity;Phosphodiesterase Inhibitors/administration & dosage;Purinergic P1 Receptor Antagonists/administration & dosage;RNA, Messenger/metabolism;Random Allocation;Rats;Rats, Sprague-Dawley;Sex Characteristics;Sulfotransferases/biosynthesis*;Sulfotransferases/genetics
21733905;Adolescent;Antifungal Agents/pharmacokinetics*;Antifungal Agents/therapeutic use;Enteral Nutrition/adverse effects*;Food-Drug Interactions;Hematopoietic Stem Cell Transplantation/methods;Humans;Male;Mycoses/prevention & control;Pyrimidines/pharmacokinetics*;Pyrimidines/therapeutic use;Suspensions;Triazoles/pharmacokinetics*;Triazoles/therapeutic use;Voriconazole
9505992;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Area Under Curve;Bilirubin/metabolism*;Cross-Over Studies;Cyclosporins/administration & dosage;Cyclosporins/pharmacokinetics*;Dietary Fats/adverse effects*;Food-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/pharmacokinetics*
21803422;Adult;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Linagliptin;Male;Middle Aged;Purines/adverse effects;Purines/pharmacokinetics*;Quinazolines/adverse effects;Quinazolines/pharmacokinetics*;Tandem Mass Spectrometry;Young Adult
21812328;Antioxidants/analysis;Beverages/adverse effects*;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology*;Female;Flavanones/analysis;Food-Drug Interactions/physiology*;Forecasting;Furocoumarins/analysis;Humans;In Vitro Techniques;Linear Models;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Models, Statistical;Oxidation-Reduction;Testosterone/metabolism
21816140;Biomedical Technology;Dietary Supplements*/adverse effects;Drug-Related Side Effects and Adverse Reactions;Functional Food*/adverse effects;Humans;Medicine*;Nutritional Sciences*
21819160;Adamantane/administration & dosage;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Administration, Oral;Adult;Cross-Over Studies;Delayed-Action Preparations;Dipeptides/administration & dosage;Dipeptides/adverse effects;Dipeptides/pharmacokinetics*;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Drug Combinations;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics*;Male;Metformin/administration & dosage;Metformin/adverse effects;Metformin/pharmacokinetics*;Tablets;Therapeutic Equivalency;Young Adult
21819239;Administration, Oral;Anticoagulants/pharmacology*;Antithrombins/adverse effects;Antithrombins/therapeutic use*;Factor Xa Inhibitors;Food-Drug Interactions;Hemostatics/metabolism;Heparin, Low-Molecular-Weight/adverse effects;Heparin, Low-Molecular-Weight/therapeutic use*;Humans;Pharmacogenetics;Prothrombin/antagonists & inhibitors;Thrombin/therapeutic use;Thrombosis/drug therapy;Vitamin K/antagonists & inhibitors;Warfarin/adverse effects;Warfarin/therapeutic use*
21831129;Acute Coronary Syndrome/drug therapy*;Acute Coronary Syndrome/physiopathology;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Dose-Response Relationship, Drug;Drug Interactions;Drug Monitoring/methods;Food-Drug Interactions;Hemorrhage/chemically induced;Humans;Thrombosis/prevention & control*;Vitamin K/antagonists & inhibitors
21852006;Adolescent;Adult;Beverages/adverse effects;Caffeine/adverse effects;Caffeine/blood*;Coffee*/adverse effects;Female;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Warfarin/blood*
21856591;Adult;Carica/adverse effects*;Food-Drug Interactions;Goiter, Nodular/surgery;Humans;Hypothyroidism/complications*;Hypothyroidism/drug therapy*;Intestinal Absorption;Male;Thyroidectomy;Thyrotropin/blood;Thyroxine/blood;Thyroxine/pharmacokinetics;Thyroxine/therapeutic use*;Triiodothyronine/blood
21909143;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Food-Drug Interactions;Hematopoietic Stem Cell Transplantation*;Humans;Myocardial Infarction/blood;Myocardial Infarction/drug therapy*;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use*;Platelet Count;Thrombocytopenia/blood;Thrombocytopenia/drug therapy*;Thrombosis/blood;Thrombosis/drug therapy*;Transplantation, Homologous
21910510;Administration, Oral;Adult;Angiotensin I/blood;Angiotensin II/blood;Angiotensin II Type 1 Receptor Blockers/adverse effects*;Angiotensin II Type 1 Receptor Blockers/blood;Angiotensin II Type 1 Receptor Blockers/pharmacokinetics*;Angiotensin II Type 1 Receptor Blockers/urine;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics;Antihypertensive Agents/pharmacology;Biphenyl Compounds/adverse effects*;Biphenyl Compounds/blood;Biphenyl Compounds/pharmacokinetics*;Biphenyl Compounds/urine;Blood Pressure/drug effects;Dizziness/chemically induced;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Metabolic Clearance Rate;Middle Aged;Pyrimidines/adverse effects*;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Pyrimidines/urine;Renin/blood;Tetrazoles/adverse effects*;Tetrazoles/blood;Tetrazoles/pharmacokinetics*;Tetrazoles/urine;Young Adult
9527781;Adult;Analysis of Variance;Dietary Fats/adverse effects*;Double-Blind Method;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Humans;Indinavir/administration & dosage*;Indinavir/blood;Indinavir/pharmacokinetics*;Male;Metabolic Clearance Rate
21936891;Animals;Atherosclerosis/prevention & control;Cholesterol/blood;Cholesterol/metabolism;Cholesterol, Dietary/adverse effects;Cholesterol, HDL/blood*;Cholic Acid/adverse effects;Combined Modality Therapy;Dietary Supplements*;Fluorobenzenes/antagonists & inhibitors*;Fluorobenzenes/therapeutic use;Food-Drug Interactions*;Globulins/isolation & purification;Globulins/therapeutic use*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/chemistry*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Hypercholesterolemia/blood;Hypercholesterolemia/diet therapy*;Hypercholesterolemia/drug therapy;Hypercholesterolemia/metabolism;Lipoproteins/metabolism;Liver/metabolism;Male;Pyrimidines/antagonists & inhibitors*;Pyrimidines/therapeutic use;Rats;Rats, Wistar;Risk Factors;Rosuvastatin Calcium;Soybean Proteins/isolation & purification;Soybean Proteins/therapeutic use*;Sulfonamides/antagonists & inhibitors*;Sulfonamides/therapeutic use;Triglycerides/metabolism
22016977;Contraindications;Documentation*;Drug Administration Schedule;Drug Compounding/standards*;Drug Dosage Calculations;Drug Prescriptions/standards;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/standards*;Female;Food-Drug Interactions;Humans;Pregnancy;Terminology as Topic
22020317;Administration, Oral;Adult;Aged;Aged, 80 and over;Antimetabolites, Antineoplastic/administration & dosage;Antimetabolites, Antineoplastic/adverse effects;Antimetabolites, Antineoplastic/pharmacokinetics*;Antimetabolites, Antineoplastic/therapeutic use;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Drug Combinations;Fasting;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Oxonic Acid/administration & dosage;Oxonic Acid/adverse effects;Oxonic Acid/pharmacokinetics*;Oxonic Acid/therapeutic use;Proton Pump Inhibitors/administration & dosage;Proton Pump Inhibitors/pharmacology*;Proton Pump Inhibitors/therapeutic use;Tegafur/administration & dosage;Tegafur/adverse effects;Tegafur/pharmacokinetics*;Tegafur/therapeutic use;Treatment Outcome
22031686;Adult;Aged;Calcium Channel Blockers/adverse effects;Citrus paradisi/adverse effects*;Cross-Sectional Studies;Drug-Related Side Effects and Adverse Reactions*;Emergency Medical Services;Female;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Male;Middle Aged;Pharmacovigilance;Risk
22057852;Administration, Oral;Adult;Aged;Aged, 80 and over;Area Under Curve;Biological Availability;Cross-Over Studies;Diet, High-Fat;Drug Administration Schedule;Eating;Fasting;Fatigue/chemically induced;Female;Food*;Food-Drug Interactions;Histone Deacetylase Inhibitors/administration & dosage;Histone Deacetylase Inhibitors/adverse effects;Histone Deacetylase Inhibitors/pharmacokinetics*;Humans;Hydroxamic Acids/administration & dosage;Hydroxamic Acids/adverse effects;Hydroxamic Acids/pharmacokinetics*;Indoles;Male;Metabolic Clearance Rate;Middle Aged;Nausea/chemically induced;Neoplasms/drug therapy;Neoplasms/metabolism*;Neoplasms/pathology;Treatment Outcome;Vomiting/chemically induced
22058101;4-Aminopyridine/administration & dosage;4-Aminopyridine/adverse effects;4-Aminopyridine/pharmacokinetics*;Adolescent;Adult;Analysis of Variance;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Fasting/physiology;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Multiple Sclerosis/drug therapy*;Potassium Channel Blockers/administration & dosage;Potassium Channel Blockers/adverse effects;Potassium Channel Blockers/pharmacokinetics;Prospective Studies;Sex Factors;Walking/physiology;Young Adult
22122815;Adolescent;Adult;Antidepressive Agents, Second-Generation/administration & dosage*;Antidepressive Agents, Second-Generation/adverse effects;Antidepressive Agents, Second-Generation/pharmacokinetics;Area Under Curve;Biological Availability;Delayed-Action Preparations;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Piperazines/blood;Trazodone/administration & dosage*;Trazodone/adverse effects;Trazodone/pharmacokinetics
22124880;Adult;Amides/adverse effects;Amides/blood;Amides/metabolism;Amides/pharmacokinetics*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/metabolism;Antihypertensive Agents/pharmacokinetics*;Beverages/adverse effects*;Beverages/analysis;Biological Transport/drug effects;Citrus paradisi/chemistry*;Cross-Over Studies;Flavanones/analysis;Flavanones/pharmacology;Food-Drug Interactions*;Fruit/chemistry;Fumarates/adverse effects;Fumarates/blood;Fumarates/metabolism;Fumarates/pharmacokinetics*;HEK293 Cells;Half-Life;Humans;Intestinal Mucosa/enzymology*;Male;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism;Recombinant Proteins/antagonists & inhibitors;Recombinant Proteins/metabolism;Renin/antagonists & inhibitors;Terfenadine/analogs & derivatives;Terfenadine/metabolism;Young Adult
22129380;Animals;Antioxidants/administration & dosage;Antioxidants/analysis;Beverages/adverse effects;Beverages/analysis;Dietary Supplements*/adverse effects;Dietary Supplements*/analysis;Flavonoids/administration & dosage;Flavonoids/analysis;Food-Drug Interactions;Fruit*/chemistry;Functional Food*/adverse effects;Functional Food*/analysis;Humans;Phenols/administration & dosage;Phenols/analysis;Punicaceae*/chemistry
22129569;Administration, Oral;Adult;Area Under Curve;Asian Continental Ancestry Group*;Cardiovascular Agents/administration & dosage*;Cardiovascular Agents/adverse effects;Cardiovascular Agents/blood;Cardiovascular Agents/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions;Humans;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Republic of Korea;Tetrazoles/administration & dosage*;Tetrazoles/adverse effects;Tetrazoles/blood;Tetrazoles/pharmacokinetics*;Therapeutic Equivalency;Young Adult
22133697;Antipsychotic Agents/administration & dosage*;Antipsychotic Agents/adverse effects;Antipsychotic Agents/pharmacokinetics*;Dopamine Antagonists/administration & dosage*;Dopamine Antagonists/adverse effects;Dopamine Antagonists/pharmacokinetics*;Dopamine D2 Receptor Antagonists;Dose-Response Relationship, Drug;Evidence-Based Medicine;Food-Drug Interactions;Humans;Patient Selection;Piperazines/administration & dosage*;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Psychotic Disorders/diagnosis;Psychotic Disorders/drug therapy*;Psychotic Disorders/metabolism;Psychotic Disorders/psychology;Receptors, Dopamine D2/metabolism;Risk Assessment;Thiazoles/administration & dosage*;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*;Treatment Outcome
22137030;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Antioxidants/administration & dosage;Antioxidants/analysis;Antioxidants/therapeutic use*;Dietary Supplements*;Fatty Acids, Omega-3/therapeutic use;Fish Oils/therapeutic use*;Food-Drug Interactions*;Gene Expression Regulation/drug effects;Haptoglobins/genetics;Haptoglobins/metabolism;Hepatic Insufficiency/etiology;Hepatic Insufficiency/prevention & control;Injections, Intraperitoneal;Liver/drug effects*;Liver/metabolism;Liver/pathology;Liver/physiopathology;Male;NF-kappa B/genetics;NF-kappa B/metabolism;Oxidative Stress/drug effects;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Reperfusion Injury/metabolism;Reperfusion Injury/pathology;Reperfusion Injury/physiopathology;Reperfusion Injury/prevention & control*;Triiodothyronine/administration & dosage;Triiodothyronine/blood;Triiodothyronine/therapeutic use*;Tumor Necrosis Factor-alpha/genetics;Tumor Necrosis Factor-alpha/metabolism
22139686;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Transport/drug effects;Drug Interactions*;Food-Drug Interactions;Gene Expression Regulation/drug effects;Herb-Drug Interactions;Humans;Intestines/drug effects*;Intestines/metabolism;Kidney/drug effects*;Kidney/metabolism;Liver/drug effects*;Liver/metabolism;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Pharmacokinetics*;Plant Preparations/adverse effects;Plant Preparations/pharmacology
22149151;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Diclofenac/administration & dosage;Diclofenac/adverse effects;Diclofenac/analogs & derivatives*;Diclofenac/pharmacokinetics;Dietary Fats;Drug Administration Schedule;Food-Drug Interactions*;Humans;Male;Republic of Korea;Therapeutic Equivalency;Young Adult
22206795;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/urine;Area Under Curve;Biotransformation;Cross-Over Studies;Double-Blind Method;Feces/chemistry;Female;Food-Drug Interactions;Half-Life;Humans;Male;Metabolic Clearance Rate;Metabolomics;Middle Aged;Models, Biological;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/blood;Piperidines/pharmacokinetics*;Piperidines/urine;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Protein Kinase Inhibitors/urine;Quinazolines/administration & dosage;Quinazolines/adverse effects;Quinazolines/blood;Quinazolines/pharmacokinetics*;Quinazolines/urine;United Kingdom;Young Adult
22216470;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions;Humans;Patient Education as Topic;Rhabdomyolysis/chemically induced;Rhabdomyolysis/prevention & control*;Simvastatin/administration & dosage;Simvastatin/adverse effects*
22217686;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects*;Breast Neoplasms/drug therapy*;Drug Administration Schedule;Drug Interactions;Drug-Related Side Effects and Adverse Reactions/diagnosis*;Female;Food-Drug Interactions;Humans;Hungary;Medication Adherence*;Molecular Targeted Therapy*
22231999;Aged;Aged, 80 and over;Anticoagulants/therapeutic use*;Atrial Fibrillation/drug therapy;Female;Food-Drug Interactions*;Humans;International Normalized Ratio;Vaccinium macrocarpon/adverse effects*;Warfarin/metabolism;Warfarin/therapeutic use*
22265646;Acenocoumarol/adverse effects*;Alcoholic Beverages/adverse effects*;Anticoagulants/adverse effects*;Conjunctival Diseases/etiology*;Cooking*;Dipteryx/adverse effects*;Eye Hemorrhage/etiology*;Flavoring Agents/adverse effects*;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans
9545149;2-Hydroxypropyl-beta-cyclodextrin;Administration, Oral;Adolescent;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/antagonists & inhibitors;Antifungal Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Cyclodextrins/blood;Cyclodextrins/urine;Dose-Response Relationship, Drug;Drug Evaluation;Eating;Fasting;Food/adverse effects*;Food-Drug Interactions/physiology*;Humans;Itraconazole/administration & dosage;Itraconazole/analogs & derivatives;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male;Middle Aged;Pharmaceutical Solutions;beta-Cyclodextrins*
22294059;Area Under Curve;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/blood;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Data Interpretation, Statistical;Dietary Carbohydrates/administration & dosage;Dietary Carbohydrates/adverse effects;Dietary Fats/administration & dosage;Dietary Fats/adverse effects;Dihydropyridines/administration & dosage*;Dihydropyridines/blood;Dihydropyridines/chemistry;Dihydropyridines/pharmacokinetics*;Drug Administration Schedule;Drug Labeling*;Eating;Fasting;Female;Food-Drug Interactions*;Humans;Male;Pilot Projects;Stereoisomerism;Therapeutic Equivalency;Time Factors
22309265;Administration, Oral;Adult;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Blood Pressure/drug effects;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;KATP Channels/metabolism*;Male;Propylamines/administration & dosage;Propylamines/adverse effects;Propylamines/pharmacokinetics*;Sex Factors;Young Adult
22324070;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/therapeutic use;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/prevention & control;Dabigatran;Drug Approval*;Drug Interactions;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/prevention & control;Humans;Morpholines/administration & dosage;Morpholines/adverse effects;Morpholines/therapeutic use;Pyrazoles/administration & dosage;Pyrazoles/adverse effects;Pyrazoles/therapeutic use;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/therapeutic use;Pyridones/administration & dosage;Pyridones/adverse effects;Pyridones/therapeutic use;Rivaroxaban;Thiophenes/administration & dosage;Thiophenes/adverse effects;Thiophenes/therapeutic use;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/therapeutic use*
22349808;Administration, Oral;Adult;Area Under Curve;Capsules;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Fasting;Female;Food-Drug Interactions*;Headache/chemically induced;Humans;Male;Metabolic Clearance Rate;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Young Adult
22365344;Acenocoumarol/adverse effects*;Alcoholic Beverages/adverse effects*;Anticoagulants/adverse effects*;Conjunctival Diseases/etiology*;Cooking*;Dipteryx/adverse effects*;Eye Hemorrhage/etiology*;Flavoring Agents/adverse effects*;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans
22390368;Administration, Oral;Aged;Asian Continental Ancestry Group;Delayed-Action Preparations;Dopamine Agonists/administration & dosage;Dopamine Agonists/adverse effects;Dopamine Agonists/blood;Dopamine Agonists/pharmacokinetics;Female;Follow-Up Studies;Food-Drug Interactions*;Humans;Indoles/administration & dosage*;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Levodopa/administration & dosage;Male;Parkinson Disease/blood;Parkinson Disease/drug therapy*;Parkinson Disease/metabolism*;Tablets/administration & dosage;Tablets/adverse effects;Tablets/pharmacokinetics
22420652;Acetaminophen/adverse effects;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Biological Availability;Fasting;Food-Drug Interactions*;Gastrointestinal Diseases/chemically induced;Gastrointestinal Diseases/prevention & control*;Humans;Nonprescription Drugs/administration & dosage;Nonprescription Drugs/adverse effects;Nonprescription Drugs/pharmacokinetics
22456294;Adamantane/administration & dosage;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Adult;Analysis of Variance;Area Under Curve;Asian Continental Ancestry Group*;Biomarkers/blood;Blood Glucose/drug effects*;Cross-Over Studies;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Diabetes Mellitus, Type 2/ethnology;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage*;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Drug Administration Schedule;Drug Monitoring;Eating*;Feeding Behavior*;Female;Food-Drug Interactions*;Glucagon-Like Peptide 1/blood;Humans;Intestinal Absorption;Japan/epidemiology;Male;Middle Aged;Nitriles/administration & dosage*;Nitriles/adverse effects;Nitriles/pharmacokinetics*;Postprandial Period;Pyrrolidines/administration & dosage*;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics*;Treatment Outcome
22456303;Administration, Oral;Adolescent;Adult;Analysis of Variance;Area Under Curve;Biological Availability;Capsules;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;GABA Agonists/administration & dosage*;GABA Agonists/adverse effects;GABA Agonists/blood;GABA Agonists/pharmacokinetics*;Humans;Linear Models;Male;Middle Aged;Phosphinic Acids/administration & dosage*;Phosphinic Acids/adverse effects;Phosphinic Acids/blood;Phosphinic Acids/pharmacokinetics*;Propylamines/administration & dosage*;Propylamines/adverse effects;Propylamines/blood;Propylamines/pharmacokinetics*;Young Adult
22465646;Abdominal Pain/etiology;Citrus paradisi*;Colectomy;Electrocardiography;Female;Food-Drug Interactions*;Humans;Intestines/surgery;Ischemia/chemically induced*;Ischemia/surgery;Middle Aged;Multiple Organ Failure/complications;Piperidines/adverse effects*;Serotonin Agents/adverse effects*;Shock/drug therapy;Shock/etiology;Splanchnic Circulation/physiology*;Tryptamines/adverse effects*
9550749;Citrus/adverse effects*;Drug Synergism;Food-Drug Interactions*;Humans;Terfenadine/pharmacokinetics*;Terfenadine/therapeutic use
22473649;Administration, Oral;Antidotes/therapeutic use*;Blood Coagulation Factor Inhibitors/adverse effects*;Blood Coagulation Factor Inhibitors/therapeutic use;Blood Coagulation Factors/therapeutic use*;Charcoal/therapeutic use*;Drug Interactions;Drug Monitoring/methods;Factor Xa Inhibitors*;Hemorrhage/blood;Hemorrhage/chemically induced*;Hemorrhage/drug therapy*;Humans;Practice Guidelines as Topic;Thrombin/antagonists & inhibitors*
22480286;Anticoagulants*/administration & dosage;Anticoagulants*/adverse effects;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Atrial Fibrillation/blood;Atrial Fibrillation/drug therapy*;Benzimidazoles*/administration & dosage;Benzimidazoles*/adverse effects;Benzimidazoles*/pharmacokinetics;Benzimidazoles*/therapeutic use;Clinical Trials as Topic;Dabigatran;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Molecular Structure;Stroke/blood;Stroke/prevention & control*;Thromboembolism/blood;Thromboembolism/prevention & control*;Treatment Outcome;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*;beta-Alanine/pharmacokinetics;beta-Alanine/therapeutic use
22495943;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Anticoagulants/therapeutic use*;Arthroplasty, Replacement, Hip;Arthroplasty, Replacement, Knee;Atrial Fibrillation/blood;Atrial Fibrillation/complications;Atrial Fibrillation/drug therapy;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Factor Xa Inhibitors;Food-Drug Interactions;Formularies, Hospital*;Humans;Prothrombin/antagonists & inhibitors;Stroke/blood;Stroke/prevention & control;Thromboembolism/blood;Thromboembolism/etiology;Thromboembolism/prevention & control*
22499231;Animals;Beverages*/analysis;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/biosynthesis;Enzyme Induction;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Flavonoids/isolation & purification;Flavonoids/pharmacology*;Food-Drug Interactions;Fruit*/chemistry;Fruit*/growth & development;Liver/drug effects*;Liver/enzymology;Male;Mice;Mice, Inbred ICR;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Thailand;Up-Regulation
22514335;Animals;Benzo(a)pyrene/adverse effects;Charcoal/metabolism*;Clinical Trials as Topic;Coffee*;Food-Drug Interactions*;Humans;Inactivation, Metabolic;Male;Meat/adverse effects;Methylcholanthrene/adverse effects;Mice;Pharmaceutical Preparations/metabolism*;Pharmacokinetics;Polycyclic Aromatic Hydrocarbons/adverse effects;Rats;Smoking/adverse effects;Smoking/metabolism*
22528540;Antioxidants/administration & dosage;Antioxidants/adverse effects*;Ascorbic Acid/administration & dosage;Ascorbic Acid/adverse effects*;Dietary Supplements/adverse effects*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Hypervitaminosis A/chemically induced*;Vitamin A/administration & dosage;Vitamin A/adverse effects*;Vitamin E/administration & dosage;Vitamin E/adverse effects*;beta Carotene/administration & dosage;beta Carotene/adverse effects*
22530414;Anticoagulants/adverse effects*;Beverages/adverse effects*;Food-Drug Interactions*;Fruit/adverse effects*;Humans;International Normalized Ratio;Punicaceae/adverse effects*;Warfarin/adverse effects*
22615291;Adolescent;Adult;Antifungal Agents/administration & dosage*;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Capsules;Chemistry, Pharmaceutical;Cross-Over Studies;Eating;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Suspensions;Tablets;Triazoles/administration & dosage*;Triazoles/adverse effects;Triazoles/blood;Triazoles/pharmacokinetics*;Young Adult
22644797;Adult;Aged;Cross-Over Studies;Diarrhea/chemically induced;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Energy Intake*;Fasting;Fatigue/chemically induced;Female;Food-Drug Interactions*;Humans;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Indazoles/adverse effects;Indazoles/pharmacokinetics*;Male;Middle Aged;Nausea/chemically induced;Tablets;Young Adult
22648492;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacology;Anticoagulants/therapeutic use*;Drug Administration Schedule;Drug Design*;Drug Interactions;Drug Monitoring/methods;Food-Drug Interactions;Heparin, Low-Molecular-Weight/adverse effects;Heparin, Low-Molecular-Weight/therapeutic use;Humans;Time Factors;Venous Thromboembolism/drug therapy*;Venous Thromboembolism/pathology;Vitamin K/antagonists & inhibitors
9555148;Anti-Allergic Agents/adverse effects*;Anti-Allergic Agents/pharmacology;Citrus/adverse effects*;Food-Drug Interactions*;Humans;Terfenadine/adverse effects*;Terfenadine/pharmacology
22650326;Administration, Oral;Adult;Analysis of Variance;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group*;China;Cross-Over Studies;Double-Blind Method;Drug Administration Schedule;Fasting/blood;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;Least-Squares Analysis;Linear Models;Male;Metabolic Clearance Rate;Models, Biological;Postprandial Period;Quinolones/administration & dosage*;Quinolones/adverse effects;Quinolones/blood;Quinolones/pharmacokinetics*;Young Adult
22669570;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Fasting;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Sirolimus/adverse effects;Sirolimus/analogs & derivatives*;Sirolimus/pharmacokinetics;Stomatitis/chemically induced;Time Factors;Tonsillitis/chemically induced;Young Adult
22697192;Administration, Cutaneous;Adult;Adverse Drug Reaction Reporting Systems/statistics & numerical data;Aged;Depressive Disorder/drug therapy*;Drug Eruptions/etiology;Drug Interactions;Drug-Related Side Effects and Adverse Reactions;Female;Food-Drug Interactions*;Humans;Hypertension/chemically induced;Hypertension/prevention & control*;Male;Middle Aged;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects;Selegiline/administration & dosage*;Selegiline/adverse effects;Self-Injurious Behavior/chemically induced;Tyramine/adverse effects*;United States
22717215;Biological Availability;Dietary Supplements/adverse effects;Dietetics*;Energy Metabolism/drug effects;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*;Nutritional Status;Pharmacokinetics;Risk Factors
22717418;Adolescent;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Naltrexone/pharmacology;Narcotic Antagonists/pharmacology;Oxycodone/administration & dosage;Oxycodone/adverse effects;Oxycodone/pharmacokinetics*;Tablets;Therapeutic Equivalency;Young Adult
22735461;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Diet, High-Fat;Energy Intake;Factor Xa Inhibitors*;Fasting;Food-Drug Interactions*;Humans;Male;Partial Thromboplastin Time/statistics & numerical data;Prothrombin Time/statistics & numerical data;Pyridones/adverse effects;Pyridones/pharmacokinetics*;Pyridones/pharmacology*;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics*;Pyrrolidines/pharmacology*
22759078;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Administration, Oral;Adolescent;Adult;Antimalarials/adverse effects*;Antimalarials/pharmacokinetics*;Area Under Curve;Chromatography, Liquid;Dose-Response Relationship, Drug;Double-Blind Method;Fasting;Female;Food-Drug Interactions;Half-Life;Humans;Male;Mass Spectrometry;Middle Aged;Peroxides/adverse effects*;Peroxides/pharmacokinetics*;Young Adult
22769968;Adsorption;Cyclic GMP/physiology;Drug Interactions;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Gastrointestinal Diseases/physiopathology;Gastrointestinal Tract/drug effects;Gastrointestinal Tract/physiopathology;Hearing/drug effects;Heart/drug effects;Heart/physiopathology;Heart Diseases/chemically induced;Heart Diseases/physiopathology;Humans;Nervous System Diseases/chemically induced;Nervous System Diseases/physiopathology;Nitric Oxide/physiology;Phosphodiesterase 5 Inhibitors/adverse effects*;Phosphodiesterase 5 Inhibitors/pharmacokinetics*;Reproduction/drug effects;Tissue Distribution
22773284;Antibody Formation/drug effects;Antibody Formation/immunology;Breast Feeding*;Child Development/physiology*;Communicable Diseases/immunology*;Drug Contamination;Environmental Pollutants/adverse effects;Food-Drug Interactions/immunology;Health Promotion;Humans;Immunity, Cellular/drug effects;Immunity, Cellular/immunology;Infant, Newborn;Infection Control/methods*;Milk, Human/immunology*;Nervous System/growth & development;Vaccination/methods;Vaccines*/classification;Vaccines*/immunology;Vaccines*/pharmacology
9555149;Anti-Allergic Agents/adverse effects*;Citrus/adverse effects*;Food-Drug Interactions*;Terfenadine/adverse effects*
22788578;Animals;Anticarcinogenic Agents/adverse effects;Cardiotonic Agents/adverse effects*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements/adverse effects*;Enzyme Inhibitors/adverse effects;Food-Drug Interactions*;Humans;Immunologic Factors/adverse effects;Stilbenes/adverse effects*;Vasodilator Agents/adverse effects;Wine/adverse effects;Wine/analysis
22818558;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Benzimidazoles*/administration & dosage;Benzimidazoles*/adverse effects;Dabigatran;Drug Contamination;Drug Monitoring/methods*;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/prevention & control;Heparin/administration & dosage;Heparin/adverse effects*;Humans;Hypersensitivity/etiology;Hypersensitivity/prevention & control;Injections, Subcutaneous/adverse effects;Necrosis/etiology;Necrosis/prevention & control;Osteoporosis/chemically induced;Osteoporosis/prevention & control;Skin Diseases/chemically induced;Skin Diseases/prevention & control;Subcutaneous Tissue/drug effects;Thrombocytopenia/chemically induced;Thrombocytopenia/prevention & control;Warfarin*/administration & dosage;Warfarin*/adverse effects;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*
22834058;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Atrial Fibrillation/drug therapy*;Diet;Dose-Response Relationship, Drug;Food-Drug Interactions*;Health Behavior;Health Education;Humans;Risk Factors;Vegetables*;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Warfarin/administration & dosage*;Warfarin/adverse effects
22856466;Animals;Biomarkers/metabolism;Cell Proliferation/drug effects;Cell Shape/drug effects;Dietary Supplements/adverse effects;Epithelial Cells/drug effects;Epithelial Cells/metabolism;Epithelial Cells/pathology;Estrogen Replacement Therapy/methods*;Female;Flax/adverse effects;Flax/chemistry*;Food-Drug Interactions*;Hyperplasia;Menopause*/metabolism;Ovariectomy/adverse effects;Phytoestrogens/adverse effects;Phytoestrogens/therapeutic use*;Powders;Proliferating Cell Nuclear Antigen/metabolism;Random Allocation;Rats;Rats, Sprague-Dawley;Seeds/adverse effects;Seeds/chemistry*;Uterus/drug effects*;Uterus/metabolism;Uterus/pathology
22866966;Cardiovascular Diseases/etiology;Cardiovascular Diseases/prevention & control;Drug Interactions;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Medication Adherence;Pharmacogenetics*
22875751;Consumer Product Safety;Dietary Supplements*/adverse effects;Food-Drug Interactions*;Health Promotion*;Herb-Drug Interactions*;Humans;Patient Education as Topic;Professional-Patient Relations;Quality of Health Care;United States
22931521;Anticoagulants*/adverse effects;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Clinical Trials as Topic;Drug Discovery;Drug Interactions;Food-Drug Interactions;Glomerular Filtration Rate;Humans;Inactivation, Metabolic;Kidney Diseases/complications*;Kidney Diseases/metabolism;Thromboembolism/blood;Thromboembolism/complications;Thromboembolism/drug therapy*;Treatment Outcome
22932947;Adult;Antithyroid Agents/administration & dosage;Antithyroid Agents/blood;Antithyroid Agents/pharmacokinetics;Antithyroid Agents/therapeutic use;Capsules;Chemistry, Pharmaceutical;Coffee/adverse effects*;Cross-Over Studies;Drug Carriers/administration & dosage;Drug Carriers/pharmacokinetics*;Drug Carriers/therapeutic use;Female;Food-Drug Interactions*;Gels;Goiter, Nodular/drug therapy;Hormone Replacement Therapy;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy;Hypothyroidism/metabolism;Intestinal Absorption*;Male;Middle Aged;Neoplasm Recurrence, Local/drug therapy;Thyroid Gland/drug effects;Thyroid Gland/secretion;Thyroid Nodule/drug therapy;Thyrotropin/blood;Thyrotropin/secretion;Thyroxine/administration & dosage;Thyroxine/blood;Thyroxine/pharmacokinetics*;Thyroxine/therapeutic use
9578193;Aged;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics*;Antiparkinson Agents/therapeutic use;Area Under Curve;Female;Food-Drug Interactions*;Half-Life;Humans;Indoles/adverse effects;Indoles/pharmacokinetics*;Indoles/therapeutic use;Male;Middle Aged;Parkinson Disease/drug therapy;Parkinson Disease/metabolism*
22937625;Adult;Beverages/adverse effects*;Child;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans
22940371;Adolescent;Adult;Beverages;Citrus/chemistry*;Citrus paradisi/chemistry*;Colchicine/adverse effects;Colchicine/pharmacokinetics*;Drug Labeling;Female;Food-Drug Interactions*;Gout Suppressants/adverse effects;Gout Suppressants/pharmacokinetics;Humans;Male;Middle Aged;Time Factors;Young Adult
22943121;Animals;Depression/drug therapy*;Depression/physiopathology;Drug Design*;Drug Interactions;Food-Drug Interactions;Heart Failure/drug therapy;Heart Failure/physiopathology;Humans;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use*;Neurodegenerative Diseases/drug therapy;Neurodegenerative Diseases/physiopathology;Parkinson Disease/drug therapy;Parkinson Disease/physiopathology
22943633;Adult;Anthocyanins/analysis;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Beverages/adverse effects*;Beverages/analysis;Blueberry Plants/adverse effects*;Blueberry Plants/chemistry;Buspirone/pharmacokinetics*;Citrus paradisi/adverse effects;Citrus paradisi/chemistry;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors;Drug Interactions;Female;Fluconazole/pharmacology;Flurbiprofen/pharmacokinetics*;Food-Drug Interactions*;Furocoumarins/analysis;Humans;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Middle Aged;Phenols/analysis
22950522;Administration, Oral;Adolescent;Adult;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;Humans;Intracellular Signaling Peptides and Proteins/antagonists & inhibitors*;Male;Methotrexate/administration & dosage;Middle Aged;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics*;Protein-Serine-Threonine Kinases/antagonists & inhibitors*;Young Adult
22951237;Administration, Cutaneous;Administration, Oral;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects;Cross-Cultural Comparison;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Depressive Disorder, Major/diagnosis;Depressive Disorder, Major/drug therapy;Depressive Disorder, Major/psychology;Dose-Response Relationship, Drug;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;General Practice;Humans;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects;Practice Guidelines as Topic;Referral and Consultation;Risk Factors;Secondary Prevention;Treatment Outcome
22951238;Administration, Cutaneous;Administration, Oral;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects*;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Depressive Disorder, Treatment-Resistant/diagnosis;Depressive Disorder, Treatment-Resistant/drug therapy;Depressive Disorder, Treatment-Resistant/psychology;Drug Interactions;Food-Drug Interactions*;Humans;Hypertension, Malignant/chemically induced;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Serotonin Agents/administration & dosage;Serotonin Agents/adverse effects;Serotonin Syndrome/diagnosis;Serotonin Syndrome/etiology;Sympathomimetics/administration & dosage;Sympathomimetics/adverse effects;Tyramine/administration & dosage;Tyramine/adverse effects
22951239;Administration, Cutaneous;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Drug Interactions;Food-Drug Interactions*;Humans;Hypertension, Malignant/chemically induced;Hypertension, Malignant/diagnosis;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects;Risk Factors;Serotonin Syndrome/diagnosis;Serotonin Syndrome/etiology;Tyramine/administration & dosage;Tyramine/adverse effects
22951241;Administration, Cutaneous;Administration, Oral;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects*;Anxiety Disorders/diagnosis;Anxiety Disorders/drug therapy;Anxiety Disorders/psychology;Bipolar Disorder/diagnosis;Bipolar Disorder/drug therapy;Bipolar Disorder/psychology;Comorbidity;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Depressive Disorder, Treatment-Resistant/diagnosis;Depressive Disorder, Treatment-Resistant/drug therapy;Depressive Disorder, Treatment-Resistant/psychology;Diagnosis, Differential;Drug Interactions;Food-Drug Interactions;Humans;Hypertension, Malignant/chemically induced;Hypertension, Malignant/diagnosis;Medication Adherence;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects*;Patient Education as Topic;Primary Health Care*;Serotonin Syndrome/diagnosis;Serotonin Syndrome/etiology
22951980;Acetates/pharmacokinetics*;Adult;Anti-Asthmatic Agents/pharmacokinetics*;Beverages/adverse effects*;Biological Availability*;Citrus paradisi*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Prospective Studies;Quinolines/pharmacokinetics*;Young Adult
3640717;Aged;Biological Availability/drug effects;Dietetics;Drug Interactions*;Female;Food/adverse effects*;Humans;Intestinal Absorption/drug effects;Male
9604126;Administration, Oral;Adult;Analysis of Variance;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Middle Aged;Triazoles/adverse effects;Triazoles/pharmacokinetics*
22956350;Administration, Oral;Asian Continental Ancestry Group;Febuxostat;Female;Food-Drug Interactions;Gout Suppressants/administration & dosage;Gout Suppressants/adverse effects;Gout Suppressants/pharmacokinetics*;Humans;Indicators and Reagents;Male;Sex Characteristics;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*;Xanthine Oxidase/antagonists & inhibitors;Young Adult
22998389;Animals;Antioxidants/adverse effects;Antioxidants/metabolism*;Antioxidants/therapeutic use;Biotransformation;Dietary Supplements*/adverse effects;Enzyme Induction;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/metabolism;Enzyme Inhibitors/therapeutic use;Flavonoids/adverse effects;Flavonoids/metabolism*;Flavonoids/therapeutic use;Food-Drug Interactions;Glutathione Transferase/antagonists & inhibitors;Glutathione Transferase/biosynthesis*;Glutathione Transferase/chemistry;Glutathione Transferase/metabolism;Humans;Liver/drug effects;Liver/enzymology;Liver/metabolism;Xenobiotics/pharmacokinetics
23010558;Adult;Aged;Benzamides/administration & dosage;Benzamides/adverse effects;Benzamides/pharmacokinetics;Benzamides/therapeutic use*;Blood Glucose/analysis;Cross-Over Studies;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Dose-Response Relationship, Drug;Drug Administration Schedule;Enzyme Activators/administration & dosage;Enzyme Activators/adverse effects;Enzyme Activators/pharmacokinetics;Enzyme Activators/therapeutic use*;Fasting;Female;Food-Drug Interactions*;Glucokinase/metabolism;Half-Life;Humans;Hyperglycemia/prevention & control*;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/therapeutic use*;Male;Metabolic Clearance Rate;Middle Aged;Postprandial Period;Single-Blind Method;Sulfones/administration & dosage;Sulfones/adverse effects;Sulfones/pharmacokinetics;Sulfones/therapeutic use*
23027198;Adolescent;Adult;Aged;Antifungal Agents/administration & dosage;Antifungal Agents/therapeutic use*;Biological Availability;Chromatography, High Pressure Liquid;Drug Monitoring;Female;Food-Drug Interactions;Gastrointestinal Diseases/metabolism;Hematopoietic Stem Cell Transplantation;Humans;Immunosuppressive Agents/adverse effects;Leukemia, Myeloid, Acute/metabolism*;Male;Middle Aged;Multivariate Analysis;Myelodysplastic Syndromes/metabolism*;Prospective Studies;Spectrophotometry, Ultraviolet;Tacrolimus/adverse effects;Triazoles/administration & dosage;Triazoles/therapeutic use*;Young Adult
23097095;Coffee/adverse effects*;Drug Carriers/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Intestinal Absorption*;Male;Thyroxine/pharmacokinetics*
23102570;Antineoplastic Agents/therapeutic use*;Energy Drinks/adverse effects*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*
23104241;Administration, Oral;Adult;Anticonvulsants/adverse effects;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/adverse effects;Antipsychotic Agents/blood*;Antipsychotic Agents/pharmacokinetics;Antipsychotic Agents/therapeutic use*;Caffeine/adverse effects;Case-Control Studies;Central Nervous System Stimulants/adverse effects;Chi-Square Distribution;Chromatography, High Pressure Liquid;Clozapine/administration & dosage;Clozapine/adverse effects;Clozapine/blood*;Clozapine/pharmacokinetics;Clozapine/therapeutic use*;Cross-Sectional Studies;Drug Interactions;Drug Monitoring/methods;Drug Resistance*;Female;Food-Drug Interactions;Humans;Least-Squares Analysis;Logistic Models;Male;Middle Aged;Multivariate Analysis;Odds Ratio;Psychiatric Status Rating Scales;Risk Factors;Schizophrenia/blood;Schizophrenia/diagnosis;Schizophrenia/drug therapy*;Schizophrenic Psychology;Spectrophotometry, Ultraviolet;Treatment Failure;Valproic Acid/adverse effects
23117668;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use*;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics;Benzimidazoles/therapeutic use;Blood Coagulation/drug effects*;Blood Coagulation Tests;Dabigatran;Dose-Response Relationship, Drug;Drug Interactions;Drug Monitoring*;Food-Drug Interactions;Hemostasis/drug effects;Humans;Morpholines/adverse effects;Morpholines/pharmacokinetics;Morpholines/therapeutic use;Pyrazoles/adverse effects;Pyrazoles/pharmacokinetics;Pyrazoles/therapeutic use;Pyridones/adverse effects;Pyridones/pharmacokinetics;Pyridones/therapeutic use;Rivaroxaban;Switzerland;Thiophenes/adverse effects;Thiophenes/pharmacokinetics;Thiophenes/therapeutic use;Thromboembolism/blood;Thromboembolism/drug therapy*;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives;beta-Alanine/pharmacokinetics;beta-Alanine/therapeutic use
23165864;Aryl Hydrocarbon Hydroxylases/genetics;Cytochrome P-450 CYP2C19;Female;Food-Drug Interactions;Humans;Kidney Diseases/metabolism;Liver Diseases/metabolism;Male;Sex Characteristics;Thalidomide/adverse effects;Thalidomide/pharmacokinetics*
23184666;Adolescent;Adult;Analysis of Variance;Area Under Curve;Arrhythmias, Cardiac/chemically induced*;Arrhythmias, Cardiac/diagnosis;Arrhythmias, Cardiac/physiopathology;Biotransformation;Caffeine/administration & dosage;Caffeine/adverse effects*;Chi-Square Distribution;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism;Drug Interactions;Electrocardiography;Fasting/metabolism;Female;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Heart Rate/drug effects*;Hematologic Agents/administration & dosage;Hematologic Agents/adverse effects*;Hematologic Agents/blood;Hematologic Agents/pharmacokinetics*;Humans;Hydroxylation;Intestinal Absorption;London;Male;Metabolic Clearance Rate;Postprandial Period;Quinazolines/administration & dosage;Quinazolines/adverse effects*;Quinazolines/blood;Quinazolines/pharmacokinetics*;Young Adult
9611659;Adult;Antitubercular Agents/adverse effects*;Biogenic Amines/adverse effects*;Cheese/adverse effects*;Female;Food Hypersensitivity/diagnosis;Food Hypersensitivity/etiology;Food-Drug Interactions*;Humans;Isoniazid/adverse effects*
23184849;Acute Kidney Injury/chemically induced;Beverages/adverse effects*;Biological Availability;Breast Neoplasms/chemically induced;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Fruit/metabolism;Furocoumarins/metabolism;Humans;Metabolic Detoxication, Phase I*;Pharmaceutical Preparations/metabolism;Rhabdomyolysis/chemically induced;Risk Factors;Torsades de Pointes/chemically induced
23188923;Animals;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacokinetics;Dietary Supplements/adverse effects;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy;Plant Preparations/adverse effects;Plant Preparations/pharmacology
23230999;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Doxylamine/administration & dosage;Doxylamine/adverse effects;Doxylamine/analogs & derivatives*;Doxylamine/pharmacokinetics;Fasting/metabolism;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Tablets/administration & dosage;Tablets/adverse effects;Tablets/pharmacokinetics*;Tablets, Enteric-Coated;Young Adult
23256289;Alcohol Drinking/adverse effects;Antipsychotic Agents/adverse effects;Antipsychotic Agents/therapeutic use;Aripiprazole;Combined Modality Therapy;Depressive Disorder/drug therapy;Dietary Supplements/adverse effects*;Food*;Food-Drug Interactions*;Humans;Male;Malnutrition/chemically induced*;Malnutrition/diagnosis;Malnutrition/prevention & control;Middle Aged;Piperazines/adverse effects;Piperazines/therapeutic use;Prescription Drugs/adverse effects*;Quinolones/adverse effects;Quinolones/therapeutic use
23297175;Beverages*;Biological Availability;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Furocoumarins/adverse effects;Furocoumarins/analysis;Humans;Organic Anion Transporters/metabolism;Pharmacokinetics*
23331476;Beverages/adverse effects;Blood Glucose/analysis;Caffeine/adverse effects*;Diabetes Mellitus, Type 1/blood;Diabetes Mellitus, Type 1/drug therapy;Diabetes Mellitus, Type 1/metabolism;Diabetes Mellitus, Type 2/blood*;Diabetes Mellitus, Type 2/metabolism;Diabetes, Gestational/blood;Diabetes, Gestational/metabolism;Evidence-Based Medicine*;Female;Food-Drug Interactions;Humans;Hyperglycemia/chemically induced*;Hyperinsulinism/chemically induced;Hypoglycemia/chemically induced;Hypoglycemic Agents/therapeutic use;Insulin/therapeutic use;Insulin Resistance*;Male;Pregnancy;Randomized Controlled Trials as Topic
23362039;Aging*;Alcohol Drinking/adverse effects;Alcohol Drinking/epidemiology*;Alcoholism/epidemiology;Australia/epidemiology;Binge Drinking/epidemiology;Disease Susceptibility;Europe/epidemiology;Food-Drug Interactions;Humans;Hypnotics and Sedatives/adverse effects;Hypnotics and Sedatives/therapeutic use*;North America/epidemiology;Patient Compliance;Prevalence;Substance-Related Disorders/epidemiology
23373097;Beverages;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*
23399607;Citrus paradisi;Diabetes Mellitus, Type 2/drug therapy*;Diagnosis, Differential;Drug Interactions;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Male;Middle Aged;Musculoskeletal Pain/chemically induced*;Myositis/chemically induced*;Quality of Life;Simvastatin/adverse effects*;Simvastatin/therapeutic use
23419230;Administration, Cutaneous;Administration, Oral;Caregivers/education;Cognitive Therapy;Combined Modality Therapy;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Food-Drug Interactions;Humans;Medication Adherence*;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Motivational Interviewing;Patient Education as Topic;Treatment Failure
9620100;Acetaminophen/adverse effects;Acetaminophen/pharmacokinetics;Acetaminophen/pharmacology*;Acetaminophen/therapeutic use;Adolescent;Adult;Aged;Aged, 80 and over;Analgesics/adverse effects;Analgesics/pharmacokinetics;Analgesics/pharmacology*;Analgesics/therapeutic use;Benzophenones/administration & dosage;Benzophenones/pharmacokinetics;Benzophenones/pharmacology*;Benzophenones/therapeutic use;Biological Availability;Bromobenzenes/administration & dosage;Bromobenzenes/pharmacokinetics;Bromobenzenes/pharmacology*;Bromobenzenes/therapeutic use;Double-Blind Method;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Naproxen/adverse effects;Naproxen/pharmacokinetics;Naproxen/pharmacology*;Naproxen/therapeutic use;Orthopedic Procedures*;Pain Measurement;Pain, Postoperative/drug therapy*;Time Factors
23458226;Administration, Oral;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/blood;Anticoagulants/chemistry;Anticoagulants/pharmacokinetics*;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/blood;Food-Drug Interactions*;Half-Life;Humans;Infusions, Intravenous;Intestinal Absorption*;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Models, Statistical;Morpholines/administration & dosage;Morpholines/adverse effects;Morpholines/blood;Morpholines/chemistry;Morpholines/pharmacokinetics*;Postprandial Period;Rivaroxaban;Thiophenes/administration & dosage;Thiophenes/adverse effects;Thiophenes/blood;Thiophenes/chemistry;Thiophenes/pharmacokinetics*;Young Adult
23466967;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Antithrombins/administration & dosage;Antithrombins/adverse effects;Antithrombins/therapeutic use*;Atrial Fibrillation/complications*;Atrial Fibrillation/drug therapy;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/therapeutic use;Clinical Trials as Topic;Comorbidity;Dabigatran;Hemorrhage/chemically induced;Humans;Morpholines/administration & dosage;Morpholines/adverse effects;Morpholines/therapeutic use;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use*;Pyrazoles/administration & dosage;Pyrazoles/adverse effects;Pyrazoles/therapeutic use;Pyridones/administration & dosage;Pyridones/adverse effects;Pyridones/therapeutic use;Risk Assessment/methods;Rivaroxaban;Stroke/drug therapy;Stroke/prevention & control*;Thiophenes/administration & dosage;Thiophenes/adverse effects;Thiophenes/therapeutic use;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/therapeutic use;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives;beta-Alanine/therapeutic use
23478684;Anti-Arrhythmia Agents/adverse effects;Anti-Arrhythmia Agents/pharmacokinetics*;Anti-Arrhythmia Agents/therapeutic use;Beverages;Biological Availability;Citrus paradisi;Diet;Dietary Fiber;Feeding Behavior;Food-Drug Interactions/physiology*;Humans;Plants, Medicinal
23495418;Cardiovascular Agents/adverse effects*;Citrus paradisi*;Food-Drug Interactions*;Humans
23497763;Acetanilides/administration & dosage;Acetanilides/adverse effects;Acetanilides/blood;Acetanilides/pharmacokinetics*;Administration, Oral;Adrenergic beta-Agonists/administration & dosage;Adrenergic beta-Agonists/adverse effects;Adrenergic beta-Agonists/blood;Adrenergic beta-Agonists/pharmacokinetics*;Adult;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Reference Values;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/blood;Thiazoles/pharmacokinetics*
23529727;Administration, Oral;Adult;Amidohydrolases/antagonists & inhibitors*;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Ascorbic Acid/administration & dosage*;Biological Availability;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;Histamine H2 Antagonists/administration & dosage*;Humans;Male;Tablets;Treatment Outcome;Young Adult
23550054;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
23550055;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
9650536;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics;Angiotensin-Converting Enzyme Inhibitors/therapeutic use*;Calcium Channel Blockers/therapeutic use*;Diabetic Nephropathies/drug therapy;Diabetic Nephropathies/metabolism;Diuretics/therapeutic use*;Drug Therapy, Combination;Food-Drug Interactions;Heart Diseases/drug therapy*;Heart Diseases/metabolism;Humans;Hypertension/drug therapy*;Hypertension/metabolism;Myocardial Infarction/drug therapy;Myocardial Infarction/metabolism
23588433;Adrenergic alpha-Antagonists;Adrenergic beta-Antagonists;Antihypertensive Agents*/pharmacokinetics;Antihypertensive Agents*/pharmacology;Calcium Channel Blockers;Citrus paradisi;Diet;Diuretics;Food-Drug Interactions*;Humans
23636154;Adult;Aged;Aged, 80 and over;Cross-Sectional Studies;Drug Interactions*;Drug Monitoring;Female;Food-Drug Interactions;Humans;Internet;Male;Middle Aged;Nonprescription Drugs/administration & dosage;Nonprescription Drugs/adverse effects*;Patient Education as Topic/methods*;Prescription Drugs/administration & dosage;Prescription Drugs/adverse effects*;Sex Factors;Surveys and Questionnaires;United States
23757819;Aged;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans;Middle Aged
23789936;Administration, Oral;Aged;Aged, 80 and over;Biological Availability;Capsules;Disease Progression;Dose-Response Relationship, Drug;Dyspnea/chemically induced;Female;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Glycine/administration & dosage;Glycine/adverse effects;Glycine/analogs & derivatives*;Glycine/blood;Glycine/pharmacokinetics;Glycine/therapeutic use;Humans;Male;Middle Aged;Myelodysplastic Syndromes/blood;Myelodysplastic Syndromes/drug therapy*;Myelodysplastic Syndromes/enzymology;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics;Protein Kinase Inhibitors/therapeutic use*;Remission Induction;Sulfones/administration & dosage;Sulfones/adverse effects;Sulfones/blood;Sulfones/pharmacokinetics;Sulfones/therapeutic use*;Treatment Outcome;Urologic Diseases/chemically induced
23849436;Adult;Area Under Curve;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Phenoxyacetates/adverse effects;Phenoxyacetates/pharmacokinetics*;Tablets
24003187;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
24003188;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
24021514;Administration, Oral;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy*;Intestinal Absorption/physiology;Mental Disorders/blood;Mental Disorders/drug therapy*;Randomized Controlled Trials as Topic;Thyrotropin/blood;Thyroxine/administration & dosage*;Thyroxine/adverse effects;Thyroxine/pharmacokinetics*
24048240;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/therapeutic use;Food-Drug Interactions*;Humans
9663198;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use*;Clinical Trials as Topic;Diet;Female;Food-Drug Interactions;Heart Valve Prosthesis/adverse effects*;Humans;Practice Guidelines as Topic;Pregnancy;Pregnancy Complications, Cardiovascular/prevention & control;Thromboembolism/etiology;Thromboembolism/prevention & control*;Vitamin K/administration & dosage;Warfarin/pharmacokinetics;Warfarin/therapeutic use
9663817;Adolescent;Adult;Anthelmintics/administration & dosage;Anthelmintics/adverse effects;Anthelmintics/pharmacokinetics*;Anthelmintics/therapeutic use;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics*;Benzimidazoles/therapeutic use;Biological Availability;Child;Cross-Over Studies;Fascioliasis/drug therapy;Fascioliasis/metabolism*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged
9725481;Adult;Antihypertensive Agents/metabolism;Antihypertensive Agents/pharmacokinetics;Biological Availability;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/metabolism;Calcium Channel Blockers/pharmacokinetics;Dihydropyridines/adverse effects;Dihydropyridines/metabolism;Dihydropyridines/pharmacokinetics*;Double-Blind Method;Food-Drug Interactions*;Humans;Male
9784932;Administration, Oral;Administration, Rectal;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/pharmacokinetics*;Analgesics, Opioid/therapeutic use;Chemistry, Pharmaceutical;Child;Delayed-Action Preparations;Food-Drug Interactions;Humans;Morphine/administration & dosage;Morphine/pharmacokinetics*;Morphine/therapeutic use;Pain/drug therapy*
9786475;Adult;Anti-Infective Agents/administration & dosage*;Anti-Infective Agents/adverse effects;Anti-Infective Agents/metabolism;Anti-Infective Agents/pharmacokinetics*;Delayed-Action Preparations;Double-Blind Method;Fluoroquinolones*;Food-Drug Interactions;Humans;Male;Piperazines/administration & dosage*;Piperazines/adverse effects;Piperazines/metabolism;Piperazines/pharmacokinetics*;Quinolones/administration & dosage*;Quinolones/adverse effects;Quinolones/metabolism;Quinolones/pharmacokinetics*;Saliva/chemistry
9793622;Adolescent;Adult;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Dietary Fats;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Naproxen/adverse effects*;Naproxen/pharmacokinetics*;Reproducibility of Results;Spectrometry, Fluorescence
6282186;Animals;Bacteria/metabolism;Biological Availability;Biotransformation;Dietary Fiber/adverse effects;Drug-Related Side Effects and Adverse Reactions*;Enzyme Induction;Food*;Humans;Intestines/microbiology;Pharmaceutical Preparations/metabolism
9796864;Antidepressive Agents/adverse effects*;Antidepressive Agents/pharmacokinetics;Antidepressive Agents/pharmacology;Beverages/adverse effects*;Citrus/adverse effects*;Cytochrome P-450 CYP1A2/drug effects;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Enzyme Induction/drug effects;Food-Drug Interactions*;Humans;Infant;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/drug effects;Mixed Function Oxygenases/metabolism;Polymorphism, Genetic;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/pharmacokinetics;Serotonin Uptake Inhibitors/pharmacology
9808916;Antipsychotic Agents/adverse effects*;Child;Feeding and Eating Disorders/chemically induced*;Feeding and Eating Disorders/diet therapy;Food-Drug Interactions;Humans;Male;Risperidone/adverse effects*;Weight Gain/drug effects
9829163;Aged;Alzheimer Disease/drug therapy;Depression/drug therapy;Food-Drug Interactions;Humans;Monoamine Oxidase/physiology;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/classification;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use;Parkinson Disease/drug therapy;Tyramine/adverse effects
9833595;Adolescent;Adult;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Oxazoles/adverse effects;Oxazoles/metabolism;Oxazoles/pharmacokinetics*;Oxazolidinones*;Serotonin Receptor Agonists/adverse effects;Serotonin Receptor Agonists/metabolism;Serotonin Receptor Agonists/pharmacokinetics*;Tryptamines
9845494;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use*;Biological Availability;Dose-Response Relationship, Drug;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;HIV Infections/blood;HIV Infections/etiology;HIV Infections/prevention & control*;Health Personnel*;Humans;Occupational Exposure/adverse effects*;Patient Compliance
9875172;Beverages/adverse effects*;Citrus/adverse effects*;Complementary Therapies;Female;Food-Drug Interactions*;Humans;Middle Aged;Nifedipine/adverse effects*;Phytotherapy;United States;Vasodilator Agents/adverse effects*
9882026;Animals;Avitaminosis/chemically induced;Biological Availability;Digestive System/drug effects*;Dose-Response Relationship, Drug;Fat Substitutes/adverse effects*;Fat Substitutes/pharmacokinetics;Fatty Acids/adverse effects*;Fatty Acids/pharmacokinetics;Food-Drug Interactions;Humans;Sucrose/adverse effects;Sucrose/analogs & derivatives*;Sucrose/pharmacokinetics
9884817;Antifungal Agents/pharmacokinetics;Antifungal Agents/pharmacology;Antifungal Agents/therapeutic use*;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Itraconazole/pharmacokinetics;Itraconazole/pharmacology;Itraconazole/therapeutic use*;Organ Specificity
9918208;Administration, Oral;Adult;Aged;Antimetabolites, Antineoplastic/administration & dosage*;Antimetabolites, Antineoplastic/adverse effects;Antimetabolites, Antineoplastic/pharmacokinetics;Biological Availability;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Infusions, Intravenous;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/metabolism;Quinazolines/administration & dosage*;Quinazolines/adverse effects;Quinazolines/pharmacokinetics
10048159;Alcohol Drinking/adverse effects*;Animals;Cytochrome P-450 CYP2E1/metabolism;Dietary Carbohydrates/administration & dosage*;Dietary Carbohydrates/metabolism;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Food-Drug Interactions;Hepatitis, Alcoholic/etiology;Hepatitis, Alcoholic/metabolism*;Hepatitis, Alcoholic/pathology;Male;Necrosis;Rats;Rats, Sprague-Dawley
6752254;Aged;Anemia, Hypochromic/chemically induced;Anemia, Hypochromic/drug therapy;Avitaminosis/chemically induced;Diet/adverse effects*;Drug Interactions;Drug Therapy*;Drug-Related Side Effects and Adverse Reactions;Humans;Kinetics;Nutritional Requirements;Vitamins/therapeutic use
10192596;Acute Disease;Bread/analysis;Cheese/analysis;Chromatography, High Pressure Liquid;Diet/adverse effects*;Food Analysis/statistics & numerical data;Food-Drug Interactions*;Humans;Hypertension/chemically induced;Monoamine Oxidase Inhibitors/adverse effects*;Soybeans/chemistry*;Tyramine/adverse effects*;Tyramine/analysis
10206085;Adolescent;Adult;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting;Food-Drug Interactions/physiology*;Humans;Hypoglycemic Agents/blood*;Male;Thiazoles/adverse effects;Thiazoles/blood*;Thiazolidinediones*
10354963;Absorption;Adolescent;Adult;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Eating;Fasting;Female;Food-Drug Interactions;Headache/chemically induced;Humans;Lamivudine/adverse effects;Lamivudine/pharmacokinetics*;Male;Metabolic Clearance Rate;Middle Aged;Nausea/chemically induced;Tablets;Therapeutic Equivalency;Zidovudine/adverse effects;Zidovudine/pharmacokinetics*
10391425;Diet, Protein-Restricted/adverse effects;Dietary Carbohydrates/administration & dosage;Dietary Fats/administration & dosage;Epilepsy/diet therapy*;Food-Drug Interactions;Humans;Ketosis*/etiology;Pharmaceutical Services*/standards;Starvation/complications;Starvation/physiopathology*
10423213;Anticoagulants/adverse effects*;Beverages*;Citrus*;Food-Drug Interactions;Humans;Male;Middle Aged;Warfarin/adverse effects*
10423596;Adult;Area Under Curve;Biological Availability;Butyrophenones/administration & dosage;Butyrophenones/adverse effects;Butyrophenones/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacology;Food-Drug Interactions;Half-Life;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/adverse effects;Histamine H1 Antagonists/pharmacokinetics*;Humans;Male;Middle Aged;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Tablets
10431417;Cheese*;Female;Food-Drug Interactions*;Headache/chemically induced*;Humans;Hypertension/chemically induced*;Middle Aged;Monoamine Oxidase Inhibitors/adverse effects*;Tranylcypromine/adverse effects
10440622;Adolescent;Adult;Animals;Anti-Infective Agents/adverse effects;Anti-Infective Agents/pharmacokinetics*;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Fluoroquinolones*;Food-Drug Interactions*;Humans;Male;Milk
10471981;Adult;Biological Availability;Cross-Over Studies;Fasting;Female;Food-Drug Interactions/physiology*;Humans;Indoles/adverse effects;Indoles/blood*;Male;Models, Statistical;Time Factors
10496300;Animals;Antimalarials/administration & dosage;Antimalarials/adverse effects;Antimalarials/pharmacokinetics;Antimalarials/pharmacology*;Artemisinins*;Clinical Trials as Topic;Drug Combinations;Drug Resistance, Microbial;Drug Resistance, Multiple;Ethanolamines/administration & dosage;Ethanolamines/adverse effects;Ethanolamines/pharmacokinetics*;Ethanolamines/pharmacology*;Fluorenes/administration & dosage;Fluorenes/adverse effects;Fluorenes/pharmacokinetics*;Fluorenes/pharmacology*;Food-Drug Interactions;Humans;Malaria/metabolism*;Plasmodium falciparum/physiology*;Sesquiterpenes/pharmacokinetics*
7560252;Adolescent;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/adverse effects;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Drug Tolerance;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Isoxazoles/administration & dosage;Isoxazoles/adverse effects;Isoxazoles/pharmacokinetics*;Male;Metabolic Clearance Rate;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Time Factors
10507245;Acetylcholinesterase/blood*;Butyrylcholinesterase/blood*;Cholinesterase Inhibitors/administration & dosage;Cholinesterase Inhibitors/pharmacokinetics;Cholinesterase Inhibitors/pharmacology*;Cross-Over Studies;Fasting;Food*;Food-Drug Interactions/physiology*;Humans;Time Factors;Trichlorfon/administration & dosage;Trichlorfon/adverse effects;Trichlorfon/pharmacokinetics;Trichlorfon/pharmacology*
10583024;Absorption;Adolescent;Adult;Age Factors;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Etidronic Acid/administration & dosage;Etidronic Acid/adverse effects;Etidronic Acid/analogs & derivatives*;Etidronic Acid/pharmacokinetics;Fasting;Female;Food-Drug Interactions*;Humans;Male;Risedronate Sodium;Sex Factors;Time Factors
10594469;Adult;Aging;Antihypertensive Agents/administration & dosage*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Digestive System/metabolism;Doxazosin/administration & dosage*;Doxazosin/adverse effects;Doxazosin/pharmacokinetics*;Female;Food-Drug Interactions;Half-Life;Humans;Male;Sex Characteristics;Therapeutic Equivalency
10610011;AIDS-Related Opportunistic Infections/metabolism;AIDS-Related Opportunistic Infections/prevention & control;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects*;Antifungal Agents/pharmacokinetics*;Atovaquone;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects*;Naphthoquinones/pharmacokinetics*;Pneumonia, Pneumocystis/prevention & control;Trimethoprim, Sulfamethoxazole Drug Combination/pharmacokinetics
10718785;Administration, Oral;Adult;Biological Availability;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacology;Eating;Fasting;Food-Drug Interactions;Humans;Hydantoins;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Imidazolidines*;Male;Piperazines/adverse effects;Piperazines/pharmacokinetics*
10721388;Benzodiazepines/adverse effects;Beverages/adverse effects*;Calcium Channel Blockers/adverse effects;Cisapride/adverse effects;Citrus/adverse effects*;Cyclosporine/adverse effects;Cytochrome P-450 Enzyme Inhibitors;Drug Prescriptions*;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Terfenadine/adverse effects
10732665;Cheese/adverse effects*;Cheese/analysis;Diet*;Food/adverse effects*;Food-Drug Interactions*;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Tyramine/adverse effects
10740993;Aged;Antidepressive Agents, Second-Generation/adverse effects*;Antidepressive Agents, Second-Generation/pharmacokinetics;Antidepressive Agents, Second-Generation/therapeutic use;Beverages*;Citrus*;Female;Fluoxetine/adverse effects*;Fluoxetine/pharmacokinetics;Fluoxetine/therapeutic use;Food-Drug Interactions*;Humans
10741622;Adult;Antihypertensive Agents/pharmacology;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/pharmacology;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions;Heart Rate/drug effects;Humans;Male;Mixed Function Oxygenases/metabolism;Nisoldipine/adverse effects;Nisoldipine/blood;Nisoldipine/pharmacokinetics;Nisoldipine/pharmacology*;Reference Values;Time Factors;Vasodilator Agents/pharmacology
10809344;Adult;Aged;Data Collection;Depression/drug therapy*;Drug Interactions;Female;Humans;Hypericum/therapeutic use*;Male;Mental Disorders/drug therapy*;Middle Aged;Phytotherapy*;Plants, Medicinal*;Retrospective Studies;Self Medication/adverse effects*
